{ "documentInfo": { "documentType": "https://xbrl.org/2021/xbrl-json", "features": { "xbrl:canonicalValues": true }, "namespaces": { "ifrs-full": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "iso4217": "http://www.xbrl.org/2003/iso4217", "oxfordinstrumentplc": "http://oxfordinstrumentplc.com/xbrl/2022", "scheme": "http://standards.iso.org/iso/17442", "xbrl": "https://xbrl.org/2021", "xbrli": "http://www.xbrl.org/2003/instance" }, "taxonomy": [ "http://oxfordinstrumentplc.com/xbrl/2022/213800J364EZD6UCE231-2024-03-31.xsd" ] }, "facts": { "fact-2": { "value": "Tubney Woods, Abingdon, Oxon OX13 5QX", "dimensions": { "concept": "ifrs-full:AddressOfRegisteredOfficeOfEntity", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-1": { "value": "Public Limited Company", "dimensions": { "concept": "ifrs-full:LegalFormOfEntity", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-294": { "value": "Oxford Instruments plc", "dimensions": { "concept": "ifrs-full:NameOfUltimateParentOfGroup", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-293": { "value": "Oxford Instruments plc (\u2018OI plc\u2019) is the ultimate holding company of a group of subsidiary undertakings (the \u2018Group\u2019) which is a leading global provider of technology and expertise to academic and commercial partners. ", "dimensions": { "concept": "ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-297": { "value": "470400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Revenue", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-298": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:Revenue", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-299": { "value": "470400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Revenue", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-300": { "value": "444700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Revenue", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-301": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:Revenue", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-302": { "value": "444700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Revenue", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-303": { "value": "228000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CostOfSales", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-304": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:CostOfSales", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-305": { "value": "228000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CostOfSales", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-306": { "value": "214500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CostOfSales", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-307": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:CostOfSales", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-308": { "value": "214500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CostOfSales", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-309": { "value": "242400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GrossProfit", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-310": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GrossProfit", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-311": { "value": "242400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GrossProfit", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-312": { "value": "230200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GrossProfit", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-313": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GrossProfit", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-314": { "value": "230200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GrossProfit", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-315": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherOperatingIncomeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-316": { "value": "3300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherOperatingIncomeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-317": { "value": "3300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherOperatingIncomeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-318": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherOperatingIncomeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-319": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherOperatingIncomeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-320": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherOperatingIncomeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-321": { "value": "39100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ResearchAndDevelopmentExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-322": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ResearchAndDevelopmentExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-323": { "value": "39100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ResearchAndDevelopmentExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-324": { "value": "35900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ResearchAndDevelopmentExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-325": { "value": "800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ResearchAndDevelopmentExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-326": { "value": "36700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ResearchAndDevelopmentExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-327": { "value": "74500000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:SellingAndMarketing", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-328": { "value": "-0", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:SellingAndMarketing", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-329": { "value": "74500000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:SellingAndMarketing", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-330": { "value": "65400000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:SellingAndMarketing", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-331": { "value": "-0", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:SellingAndMarketing", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-332": { "value": "65400000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:SellingAndMarketing", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-333": { "value": "58700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdministrativeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-334": { "value": "14600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdministrativeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-335": { "value": "73300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdministrativeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-336": { "value": "52900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdministrativeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-337": { "value": "10300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdministrativeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-338": { "value": "63200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdministrativeExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-339": { "value": "10200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-340": { "value": "-700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-341": { "value": "9500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-342": { "value": "4500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-343": { "value": "3000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-344": { "value": "7500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-345": { "value": "80300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-346": { "value": "-12000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-347": { "value": "68300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-348": { "value": "80500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-349": { "value": "-8100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-350": { "value": "72400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-351": { "value": "4700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceIncome", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-352": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceIncome", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-353": { "value": "4700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceIncome", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-354": { "value": "2700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceIncome", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-355": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceIncome", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-356": { "value": "2700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceIncome", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-357": { "value": "1700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceCosts", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-358": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceCosts", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-359": { "value": "1700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceCosts", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-360": { "value": "1200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceCosts", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-361": { "value": "400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceCosts", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-362": { "value": "1600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:FinanceCosts", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-363": { "value": "83300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossBeforeTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-364": { "value": "-12000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossBeforeTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-365": { "value": "71300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossBeforeTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-366": { "value": "82000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossBeforeTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-367": { "value": "-8500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossBeforeTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-368": { "value": "73500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossBeforeTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-369": { "value": "20300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-370": { "value": "300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-371": { "value": "20600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-372": { "value": "17000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-373": { "value": "-2100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-374": { "value": "14900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-375": { "value": "63000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-376": { "value": "-12300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-377": { "value": "50700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-378": { "value": "65000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP" } }, "fact-379": { "value": "-6400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:AdjustingItemsMember", "unit": "iso4217:GBP" } }, "fact-380": { "value": "58600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-381": { "value": "1.09", "decimals": 3, "dimensions": { "concept": "ifrs-full:BasicEarningsLossPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-382": { "value": "0.877", "decimals": 3, "dimensions": { "concept": "ifrs-full:BasicEarningsLossPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-383": { "value": "1.127", "decimals": 3, "dimensions": { "concept": "ifrs-full:BasicEarningsLossPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-384": { "value": "1.016", "decimals": 3, "dimensions": { "concept": "ifrs-full:BasicEarningsLossPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-385": { "value": "1.075", "decimals": 3, "dimensions": { "concept": "ifrs-full:DilutedEarningsLossPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-386": { "value": "0.865", "decimals": 3, "dimensions": { "concept": "ifrs-full:DilutedEarningsLossPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-387": { "value": "1.113", "decimals": 3, "dimensions": { "concept": "ifrs-full:DilutedEarningsLossPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "oxfordinstrumentplc:ConsolidatedStatementOfIncomeAxis": "oxfordinstrumentplc:Adjustedmember", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-388": { "value": "1.003", "decimals": 3, "dimensions": { "concept": "ifrs-full:DilutedEarningsLossPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-389": { "value": "50700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-390": { "value": "58600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-391": { "value": "-5500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-392": { "value": "5300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-393": { "value": "-19400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-394": { "value": "-38600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-395": { "value": "-4800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-396": { "value": "-9700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-397": { "value": "-20200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-398": { "value": "-23600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-399": { "value": "30600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-400": { "value": "35000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-5": { "value": "80500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:PropertyPlantAndEquipment", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-6": { "value": "59300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:PropertyPlantAndEquipment", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-7": { "value": "137900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IntangibleAssetsAndGoodwill", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-8": { "value": "132100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IntangibleAssetsAndGoodwill", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-9": { "value": "32400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:RightofuseAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-10": { "value": "31400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:RightofuseAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-11": { "value": "1300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentReceivables", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-12": { "value": "500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentReceivables", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-13": { "value": "200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentDerivativeFinancialAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-14": { "value": "400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentDerivativeFinancialAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-15": { "value": "16100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentRecognisedAssetsDefinedBenefitPlan", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-16": { "value": "26400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentRecognisedAssetsDefinedBenefitPlan", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-17": { "value": "13700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DeferredTaxAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-18": { "value": "12500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DeferredTaxAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-19": { "value": "282100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-20": { "value": "262600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-21": { "value": "108400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Inventories", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-22": { "value": "81400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Inventories", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-23": { "value": "114700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:TradeAndOtherCurrentReceivables", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-24": { "value": "113200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:TradeAndOtherCurrentReceivables", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-25": { "value": "1000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentTaxAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-26": { "value": "500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentTaxAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-27": { "value": "2300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentDerivativeFinancialAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-28": { "value": "1600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentDerivativeFinancialAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-29": { "value": "97800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-30": { "value": "112700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-31": { "value": "324200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-32": { "value": "309400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-33": { "value": "606300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Assets", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-34": { "value": "572000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Assets", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-35": { "value": "2900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssuedCapital", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-36": { "value": "2900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssuedCapital", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-37": { "value": "62600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:SharePremium", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-38": { "value": "62600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:SharePremium", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-39": { "value": "200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherReserves", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-40": { "value": "200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherReserves", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-41": { "value": "7400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ReserveOfExchangeDifferencesOnTranslation", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-42": { "value": "12900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ReserveOfExchangeDifferencesOnTranslation", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-43": { "value": "292600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:RetainedEarnings", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-44": { "value": "265400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:RetainedEarnings", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-45": { "value": "365700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-46": { "value": "344000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-47": { "value": "900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:LongtermBorrowings", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-48": { "value": "900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:LongtermBorrowings", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-49": { "value": "28600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentLeaseLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-50": { "value": "26200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentLeaseLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-51": { "value": "12900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DeferredTaxLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-52": { "value": "7800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DeferredTaxLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-53": { "value": "42400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-54": { "value": "34900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:NoncurrentLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-55": { "value": "13100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ShorttermBorrowings", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-56": { "value": "11600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ShorttermBorrowings", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-57": { "value": "166200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:TradeAndOtherCurrentPayables", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-58": { "value": "159400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:TradeAndOtherCurrentPayables", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-59": { "value": "4800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentLeaseLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-60": { "value": "5200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentLeaseLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-61": { "value": "7600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentTaxLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-62": { "value": "8100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentTaxLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-63": { "value": "100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentDerivativeFinancialLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-64": { "value": "1200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentDerivativeFinancialLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-65": { "value": "6400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentProvisions", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-66": { "value": "7600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentProvisions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-67": { "value": "198200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-68": { "value": "193100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CurrentLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-69": { "value": "240600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Liabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-70": { "value": "228000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Liabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-71": { "value": "606300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:EquityAndLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-72": { "value": "572000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:EquityAndLiabilities", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-73": { "value": "2900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-74": { "value": "62600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-75": { "value": "200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-76": { "value": "12900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-77": { "value": "265400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-78": { "value": "344000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-79": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-80": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-81": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-82": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-83": { "value": "50700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-84": { "value": "50700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-85": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-86": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-87": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-88": { "value": "-5500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-89": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-90": { "value": "-5500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-91": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-92": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-93": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-94": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-95": { "value": "-19400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-96": { "value": "-19400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-97": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-98": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-99": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-100": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-101": { "value": "-4800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-102": { "value": "-4800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-103": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-104": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-105": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-106": { "value": "-5500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-107": { "value": "36100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-108": { "value": "30600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-109": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-110": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-111": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-112": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-113": { "value": "3000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-114": { "value": "3000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-115": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-116": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-117": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-118": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-119": { "value": "500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-120": { "value": "500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-121": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-122": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-123": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-124": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-125": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-126": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-127": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-128": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-129": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-130": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-131": { "value": "11400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-132": { "value": "11400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-133": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-134": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-135": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-136": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-137": { "value": "-8900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-138": { "value": "-8900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-139": { "value": "2900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-140": { "value": "62600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-141": { "value": "200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-142": { "value": "7400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-143": { "value": "292600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-144": { "value": "365700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-145": { "value": "2900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-146": { "value": "62500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-147": { "value": "200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-148": { "value": "7600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-149": { "value": "243200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-150": { "value": "316400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-151": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-152": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-153": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-154": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-155": { "value": "58600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-156": { "value": "58600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-157": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-158": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-159": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-160": { "value": "5300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-161": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-162": { "value": "5300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-163": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-164": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-165": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-166": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-167": { "value": "-38600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-168": { "value": "-38600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-169": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-170": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-171": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-172": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-173": { "value": "-9700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-174": { "value": "-9700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-175": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-176": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-177": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-178": { "value": "5300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-179": { "value": "29700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-180": { "value": "35000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-181": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-182": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-183": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-184": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-185": { "value": "2400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-186": { "value": "2400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-187": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-188": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-189": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-190": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-191": { "value": "-700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-192": { "value": "-700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-193": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-194": { "value": "100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-195": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-196": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-197": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-198": { "value": "100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IssueOfEquity", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-199": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-200": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-201": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-202": { "value": "-0", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-203": { "value": "10600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-204": { "value": "10600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-205": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-206": { "value": "100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-207": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-208": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-209": { "value": "-7500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-210": { "value": "-7400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-211": { "value": "2900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:GBP" } }, "fact-212": { "value": "62600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:GBP" } }, "fact-213": { "value": "200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:OtherReservesMember", "unit": "iso4217:GBP" } }, "fact-214": { "value": "12900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember", "unit": "iso4217:GBP" } }, "fact-215": { "value": "265400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:GBP" } }, "fact-216": { "value": "344000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-217": { "value": "50700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-218": { "value": "58600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-219": { "value": "20600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForIncomeTaxExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-220": { "value": "14900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForIncomeTaxExpense", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-221": { "value": "3000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForFinanceIncomeCost", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-222": { "value": "1100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForFinanceIncomeCost", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-223": { "value": "-700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-224": { "value": "3000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-225": { "value": "0", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForWitecPostAcquisitionGrossMarginAdjustment", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-226": { "value": "500000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForWitecPostAcquisitionGrossMarginAdjustment", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-227": { "value": "0", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForImpairmentOfCapitalisedDevelopmentCosts", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-228": { "value": "800000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForImpairmentOfCapitalisedDevelopmentCosts", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-229": { "value": "5000000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForAmortisationOfRightOfUseAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-230": { "value": "4600000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForAmortisationOfRightOfUseAssets", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-231": { "value": "5300000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForDepreciationOfPropertyPlantAndEquipment", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-232": { "value": "4800000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForDepreciationOfPropertyPlantAndEquipment", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-233": { "value": "9800000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForAmortisationOfIntangibles", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-234": { "value": "10700000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForAmortisationOfIntangibles", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-235": { "value": "3000000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForChargeInRespectOfEquitySettledEmployeeShareSchemes", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-236": { "value": "2400000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForChargeInRespectOfEquitySettledEmployeeShareSchemes", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-237": { "value": "8000000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:CashPaymentsToThePensionSchemeMoreThanTheChargeToOperatingProfitClassifiedAsOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-238": { "value": "11700000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:CashPaymentsToThePensionSchemeMoreThanTheChargeToOperatingProfitClassifiedAsOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-239": { "value": "-26300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-240": { "value": "-15600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-241": { "value": "-2700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-242": { "value": "-19600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-243": { "value": "-2800000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForIncreaseInPayablesAndProvisions", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-244": { "value": "17400000", "decimals": -5, "dimensions": { "concept": "oxfordinstrumentplc:AdjustmentsForIncreaseInPayablesAndProvisions", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-245": { "value": "7100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInDepositsFromCustomers", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-246": { "value": "9200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInDepositsFromCustomers", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-247": { "value": "59400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInOperations", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-248": { "value": "72900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInOperations", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-249": { "value": "900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:InterestPaidClassifiedAsOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-250": { "value": "700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:InterestPaidClassifiedAsOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-251": { "value": "16100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-252": { "value": "5700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-253": { "value": "42400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-254": { "value": "66500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-255": { "value": "500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-256": { "value": "200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-257": { "value": "27000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-258": { "value": "32300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-259": { "value": "13400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-260": { "value": "4800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-261": { "value": "700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:PaymentsForDevelopmentProjectExpenditure", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-262": { "value": "600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:PaymentsForDevelopmentProjectExpenditure", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-263": { "value": "3100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:InterestReceivedClassifiedAsInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-264": { "value": "1100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:InterestReceivedClassifiedAsInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-265": { "value": "-37500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-266": { "value": "-36400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-267": { "value": "0", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProceedsFromIssuingShares", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-268": { "value": "100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:ProceedsFromIssuingShares", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-269": { "value": "800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:InterestPaidClassifiedAsFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-270": { "value": "500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:InterestPaidClassifiedAsFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-271": { "value": "4000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-272": { "value": "5100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-273": { "value": "1800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-274": { "value": "500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-275": { "value": "11400000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaidClassifiedAsFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-276": { "value": "10600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:DividendsPaidClassifiedAsFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-277": { "value": "-18000000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-278": { "value": "-16600000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-279": { "value": "-13100000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-280": { "value": "13500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-281": { "value": "101500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-282": { "value": "87700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-283": { "value": "-2900000", "decimals": -5, "dimensions": { "concept": "ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-284": { "value": "300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents", "entity": "scheme:213800J364EZD6UCE231", "period": "2021-04-01T00:00:00/2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-285": { "value": "85500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-286": { "value": "101500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-287": { "value": "97800000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-288": { "value": "112700000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-289": { "value": "12300000", "decimals": -5, "dimensions": { "concept": "ifrs-full:BankOverdraftsClassifiedAsCashEquivalents", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-290": { "value": "11200000", "decimals": -5, "dimensions": { "concept": "ifrs-full:BankOverdraftsClassifiedAsCashEquivalents", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-291": { "value": "85500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "entity": "scheme:213800J364EZD6UCE231", "period": "2024-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-292": { "value": "101500000", "decimals": -5, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00", "unit": "iso4217:GBP" } }, "fact-401": { "value": "
Oxford Instruments plc
Oxford Instruments plc (the \u2018Company\u2019) is a company incorporated and domiciled in the UK. The Group Financial Statements have been prepared in accordance with UK adopted International Accounting Standards (IAS) in conformity with the requirements of the Companies Act 2006 and interpretations issued by the IFRS Interpretations Committee (IFRIC) applicable to companies reporting under UK adopted IFRS. The accounting policies set out below have, unless otherwise stated, been applied consistently to all periods presented in these Group Financial Statements. The Financial Statements have been prepared on a going concern basis based on the Directors\u2019 opinion, after making reasonable enquiries, that the Group has adequate resources to continue in operational existence for the foreseeable future. The Group\u2019s business activities and factors that are considered likely to affect its performance and position in the future are set out in the Strategic Report on pages 10 to 33. The Finance Review on pages 58 to 69 discloses information relevant to the Group\u2019s financial position, its cash flows, borrowing facilities and liquidity. The directors have considered the appropriateness of the going concern basis of preparation following a detailed assessment of the risks to the Group as outlined above, up to 30 June 2025, being a period of at least 12 months from approval of the Report and Financial Statements. On 19 March 2024 the Group entered into a new multi- currency revolving facility agreement, which is committed until March 2028 with 15-month and 12-month extension options at the end of the first and second years respectively. The facility has been entered into with four banks and comprises a Euro-denominated multi-currency facility of \u20ac95m and a US Dollar denominated multi-currency facility of $150m. Debt covenants are net debt to EBITDA less than 3.0 times and EBITDA to interest greater than 4.0 times. At the date of approving these financial statements, the facility remains undrawn. The relatively diverse nature of the Group together with its current financial strength provides a solid foundation. In its going concern assessment, the directors considered several scenarios, including base case and downside scenarios. The assessment is based on Board-approved budget, incorporating severe but plausible scenarios in the forecast. These scenarios reflected a 25% reduction in the Group\u2019s performance, a 25% increase in working capital and a third scenario of incorporating both. In each scenario the Group\u2019s cash balances remained positive and the facility remains undrawn throughout the going concern period to 30 June 2025. Based on this assessment, incorporating a review of current position, the scenarios, the principal risks and mitigation, the Directors have a reasonable expectation that the group will be able to continue operating and meet its liabilities as the fall due over the period to 30 June 2025 and there are no material uncertainties which may cast significant doubt over its ability to continue as a going concern. (a) Changes in accounting standards IFRS 17 Insurance Contracts provides consistent principles for all aspects of accounting for insurance contracts within the scope of the standard. The standard is effective for years beginning on or after 1 January 2023 with a requirement to restate comparatives. The Group has reviewed whether its arrangements meet the accounting definition of an insurance contract. While some contracts may transfer an element of insurance risk, they relate to warranty and service type agreements that are issued in connection with the Group\u2019s sales of its goods or services and therefore will continue to be measured under IFRS 15 Revenue from Contracts with Customers and IAS 37 Provisions, Contingent Liabilities and Contingent Assets. The Directors are not aware of any other contracts where IFRS 17 would have a material impact on the Consolidated Financial Statements. There are no other new standards or interpretations issued by the IASB that had a significant impact on the Consolidated Financial Statements. There are no standards or amendments that are not yet effective and that would be expected to have a material impact on the Group in the current or future reporting periods and on foreseeable future transactions. (b) Significant estimates and judgements The preparation of Financial Statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Significant judgements In the opinion of the Group there is one key judgement made in the preparation of the Financial Statements in respect of which taking a different view would have a material impact on the Financial Statements: Provision for inventory Provision is made for obsolete, slow moving and defective stock where there is evidence of impairment, to reduce the carrying value to its net realisable value. This requires consideration of several factors including but not limited to recent usage, expected future demand, new product introduction plans and likely realisable values to estimate the excess quantities and net realisable value. The level of provisioning requires certain estimates regarding future demand and possible design changes to identify excess quantities. Amounts provided represent in aggregate the Group\u2019s best estimate of the levels of provisioning required. Significant estimates Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods. Two key areas where estimates have been used and assumptions applied have been identified as follows: Measurement of defined benefit scheme liabilities The Group recognises and measures costs relating to defined benefit pension schemes in accordance with IAS 19 (Revised) Employee Benefits. In applying IAS 19 (Revised) the costs are assessed in accordance with the advice of independent qualified actuaries. This requires certain estimates and assumptions in relation to future changes in salaries and inflation, as well as mortality rates, expected returns on plan assets and the selection of suitable discount rates. The factors affecting these assumptions are influenced by wider macroeconomic factors that are largely outside of the Group\u2019s control. Sensitivity analysis is set out in Note 24. Provisions for IP-related claims Provisions for IP-related claims are recognised in the period when it becomes probable that there will be a future outflow of funds resulting from past expectations or events which can be reasonably estimated. The timing of recognition requires the application of judgement to existing facts and circumstances which can be subject to change. Amounts provided represent the Group\u2019s best estimate of exposure based on currently available information. Key assumptions surrounding estimation uncertainty relate to estimating potential royalty or profit sharing rates surrounding any product-related intellectual property claims (see Note 21). Acquisition of First Light Imaging SAS (First Light Imaging) On the acquisition of a business in order to comply with IFRS 3 (Revised) Business Combinations it is necessary to reflect the assets and liabilities acquired at their fair value. This requires certain estimates and assumptions in relation to, inter alia, the forecast performance of the acquired business, the expected life of certain intangible assets and the likely future customer base of the business. In order to assist in undertaking this Fair Value exercise, the Group appointed an external firm of advisors. The exercise is incomplete as at the date of this report so the fair value adjustments are reported on a provisional basis. The provisional fair value adjustments arising from this review are set out in Note 11 on page 171. (c) Basis of preparation and consolidation The Financial Statements are presented in Sterling, rounded to the nearest \u00a30.1m and are prepared on the historical cost basis except as described below under the heading \u2018(e) Financial instruments\u2019. The Group Financial Statements include the accounts of Oxford Instruments plc and its subsidiary companies adjusted to eliminate intra-Group balances and any unrealised gains and losses or income and expenses arising from intra-Group transactions. Subsidiaries are entities controlled by the Group. Control exists when the Group is exposed to or has rights to variable returns from its investment with the investee and has the ability to affect those returns through its power over the investee. In assessing control, potential voting rights that are currently exercisable or convertible are taken into account. The results of subsidiary companies are included in the Consolidated Financial Statements from the date that control commences until the date that control ceases. The acquisition method is used to account for the acquisition of subsidiaries. (d) Consideration of climate change In preparing the Financial Statements, the Directors have considered the impact of climate change, particularly in the context of the risks identified in the TCFD disclosure, see pages 40 to 50. There has been no material impact identified on the financial reporting judgements and estimates. In particular, the Directors considered the impact of climate change in respect of the following areas: \u2022 going concern and viability of the Group; \u2022 cash flow forecasts used in the impairment assessments of non-current assets including goodwill; and \u2022 carrying value and useful economic lives of property, plant and equipment. Whilst there is currently no medium-term impact expected from climate change, the Directors are aware of the ever- changing risks attached to climate change and will regularly assess these risks against judgements and estimates made in preparation of the Group\u2019s Financial Statements. (e) Financial instruments Financial assets and liabilities are recognised in the Group\u2019s Consolidated Statement of Financial Position when the Group becomes a party to the contractual provisions of the instrument. Forward foreign exchange contracts (derivative financial instruments) of the Group are used to hedge its exposure to foreign currency risks arising from operational, financing and investment activities. The Group does not hold or issue derivative financial instruments for trading purposes. The Group has chosen not to apply hedge accounting in respect of these exposures. All derivatives are initially recognised at fair value; attributable transaction costs are recognised in profit or loss as incurred. Foreign exchange contracts are classified as \u2018fair value through profit and loss\u2019 under IFRS 9. Subsequent to initial recognition, derivatives are measured at fair value and gains or losses on the settlement of such derivatives are recognised in operating expenses. Where such derivatives relate to the following
year\u2019s exposure, any gains or losses resulting from the
change in fair value are recognised as an adjusting item
in operating expenses.
The fair value of forward exchange contracts is their market
price at the Consolidated Statement of Financial Position
date, being the present value of the forward price. The gain or loss on remeasurement to fair value of forward exchange contracts is recognised immediately in the Consolidated Statement of Income. Contingent purchase consideration is measured at fair value at the date of acquisition and subsequently carried at fair value, with movements recognised in the Consolidated Statement of Income. Interest-bearing borrowings are recognised initially at fair value less attributable transaction costs. Subsequent to initial recognition, interest-bearing borrowings are stated at amortised cost with any difference between cost and redemption value being recognised in the Consolidated Statement of Income over the period of the borrowing on an effective interest basis .
A receivable is recognised for products when control passes
over to customer, and for installation when the customer
confirms acceptance of the installation, since this is the point
in time that the consideration is unconditional because only
the passage of time is required before the payment is due.
In the case of fixed-price contracts, the customer pays
the fixed amount based on a payment schedule. If the
performance obligations met by the Group exceed the
payment, a contract asset is recognised. If the payments
exceed the performance obligation, a contract liability
is recognised.
In the NanoScience business, which is part of the Research
& Discovery segment, certain contracts for the sale of
more complex systems are deemed to comprise just one
performance condition as customers are unable to realise
the economic benefit from having received the equipment
without the specialist installation. Given the highly
interdependent nature of the product and installation, this
performance condition is met, and the revenue recognised,
when the customer confirms acceptance of the installed
product at their premises.
In the Service & Healthcare segment, revenue for fixed term
maintenance and support contracts is recognised over time
using the output method by determining the proportion of
the elapsed time relative to the contract period. Where the
Service & Healthcare segment makes asset sales, similar
considerations as those set out for the other segments as
outlined above are applied.
Revenue excludes value added tax and similar sales-based
taxes and is stated before commission payable to agents
which is recognised in cost of sales.
(r) Income taxes
Income tax on the profit or loss for the year comprises
current and deferred tax. Income tax is recognised in profit or
loss except to the extent that it relates to items recognised
directly in equity, in which case it is recognised in equity.
Current tax is the expected tax payable on the taxable
income for the year, using tax rates enacted or substantively
enacted at the reporting date, and any adjustment to tax
payable in respect of previous years.
Tax positions are reviewed to assess whether a provision
should be made based on prevailing circumstances.
Tax provisions are included within current taxation
liabilities. Deferred tax positions are measured on an
undiscounted basis.
Additional income taxes that arise from the distribution of
dividends are recognised at the same time as the liability
to pay the related dividend.
Where there is uncertainty surrounding an income tax
position, consideration is given to whether the tax authority
(with full knowledge of the facts) would probably be
more or less likely to accept the uncertain tax position. If
the conclusion reached is that it is probable that the tax
authority would not accept a tax position a provision is
calculated either as the most likely outcome (where the
possible outcomes are binary or concentrated on one value)
or as the expected value (where there is a range of possible
outcomes) depending on which method would provide the
better prediction for the resolution of the uncertainty .
(n) Customer deposits Customer deposits are classified as contract liabilities and included within trade and other payables in the Statement of Financial Position. Customer deposits represent the cash payments received or consideration due from customers prior to the recognition of revenue in respect of product sales; for example, deposits received on order (and shipment in the case of complex products where revenue is not recognised until installation) . (o) Government grants Grants from governments are recognised at their fair value where there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions. Government grants relating to costs are deferred and recognised in the Consolidated Statement of Income over the period necessary to match them with the costs they are intended to compensate. Government grants relating to property, plant and equipment are deducted from the carrying amount of the asset and are credited to the Consolidated Statement of Income on a straight- line basis over the expected useful economic lives of the related assets. (p) Interest-bearing borrowings Interest-bearing borrowings are recognised initially at fair value less attributable transaction costs. Subsequent to initial recognition, interest-bearing borrowings are stated at amortised cost with any difference between cost and redemption value being recognised in the Consolidated Statement of Income over the period of the borrowings on an effective interest basis. (q) Revenue Revenue is recognised in the Consolidated Statement of Income when the performance conditions in the contract with the customer are met. In most cases where the contract includes the sale of both a product and installation then the sale of the product and the related installation are treated as two separate performance conditions. This is because the Group considers that the customer is able to benefit from the product even if the Group does not supply installation, i.e. it would be possible for them to arrange installation by a third party. In such situations, revenue in respect of the product is recognised when control passes to the customer which is normally upon shipment of the product. Revenue in respect of the installation is recognised when the customer confirms acceptance of the installation. Revenue in respect of both product and installation is recognised at a point when it is considered the performance conditions are met. Revenue is allocated between the product and installation based on the relative standalone selling prices of those products and installation activities. Where it is difficult to establish a standalone selling price by market comparator, the standalone selling price is estimated, where required, by applying the cost plus margin approach (t) Segment reporting An operating segment is a distinguishable component of the Group that engages in business activities from which it may earn revenues and incur expenses, including any revenues and expenses that relate to transactions with any of the Group\u2019s other components. Operating components are combined into aggregated operating segments to the extent that they have similar economic characteristics. Aggregated operating segments\u2019 operating results are reviewed regularly by the Group\u2019s Board of Directors to make decisions about resources to be allocated to the segment and to assess its performance, for which discrete financial information is available. Segment results that are reported to the Board include items directly attributable to a segment as well as those that can be allocated on a reasonable basis. A reportable segment is an aggregated operating segment in respect of which revenue or profit exceeds 10% of the Group total. Discrete financial information is disclosed for each reportable segment s) Leases The Group recognises a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. The estimated useful lives of right- of-use assets are determined on the same basis as those of property and equipment. In addition, the right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the lessee\u2019s incremental borrowing rate. Generally, the Group uses its incremental borrowing rate as the discount rate. Lease payments included in the measurement of the lease liability comprise fixed payments. The lease liability is measured at amortised cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, if there is a change in the Group\u2019s estimate of the amount expected to be payable under a residual value guarantee, or if the Group changes its assessment of whether it will exercise a purchase, extension or termination option. If such remeasurement is required, it is performed using the original incremental borrowing rate, unless there is a change in estimated lease term; in which case it is performed using a new incremental borrowing rate. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero. Short-term leases and leases of low-value assets The Group has elected not to recognise right-of-use assets and lease liabilities for short-term leases of machinery that have a lease term of 12 months or less and leases of low- value assets, including IT equipment. The Group recognises the lease payments associated with these leases as an expense on a straight-line basis over the lease term ", "dimensions": { "concept": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-403": { "value": "Oxford Instruments plc
Oxford Instruments plc (the \u2018Company\u2019) is a company
incorporated and domiciled in the UK.
The Group Financial Statements have been prepared in
accordance with UK adopted International Accounting
Standards (IAS) in conformity with the requirements of the
Companies Act 2006 and interpretations issued by the IFRS
Interpretations Committee (IFRIC) applicable to companies
reporting under UK adopted IFRS.
The accounting policies set out below have, unless
otherwise stated, been applied consistently to all periods
presented in these Group Financial Statements.
The Financial Statements have been prepared on a
going concern basis based on the Directors\u2019 opinion, after
making reasonable enquiries, that the Group has adequate
resources to continue in operational existence for the
foreseeable future.
The Group\u2019s business activities and factors that are
considered likely to affect its performance and position in the
future are set out in the Strategic Report on pages 10 to 33.
The Finance Review on pages 58 to 69 discloses information
relevant to the Group\u2019s financial position, its cash flows,
borrowing facilities and liquidity.
The directors have considered the appropriateness of the
going concern basis of preparation following a detailed
assessment of the risks to the Group as outlined above, up
to 30 June 2025, being a period of at least 12 months from
approval of the Report and Financial Statements.
On 19 March 2024 the Group entered into a new multi-
currency revolving facility agreement, which is committed
until March 2028 with 15-month and 12-month extension
options at the end of the first and second years respectively.
The facility has been entered into with four banks and
comprises a Euro-denominated multi-currency facility of
\u20ac95m and a US Dollar denominated multi-currency facility
of $150m. Debt covenants are net debt to EBITDA less than
3.0 times and EBITDA to interest greater than 4.0 times. At
the date of approving these financial statements, the facility
remains undrawn.
The relatively diverse nature of the Group together with
its current financial strength provides a solid foundation.
In its going concern assessment, the directors considered
several scenarios, including base case and downside
scenarios. The assessment is based on Board-approved
budget, incorporating severe but plausible scenarios in
the forecast. These scenarios reflected a 25% reduction
in the Group\u2019s performance, a 25% increase in working
capital and a third scenario of incorporating both. In each
scenario the Group\u2019s cash balances remained positive and
the facility remains undrawn throughout the going concern
period to 30 June 2025.
Based on this assessment, incorporating a review of current
position, the scenarios, the principal risks and mitigation, the
Directors have a reasonable expectation that the group will
be able to continue operating and meet its liabilities as the
fall due over the period to 30 June 2025 and there are no
material uncertainties which may cast significant doubt over
its ability to continue as a going concern.
", "dimensions": { "concept": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-3": { "value": "Oxford Instruments plc", "dimensions": { "concept": "ifrs-full:NameOfReportingEntityOrOtherMeansOfIdentification", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-295": { "value": "Oxford Instruments plc", "dimensions": { "concept": "ifrs-full:NameOfParentEntity", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-4": { "value": "UK", "dimensions": { "concept": "ifrs-full:CountryOfIncorporation", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-296": { "value": "UK", "dimensions": { "concept": "ifrs-full:DomicileOfEntity", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-404": { "value": "
(a) Changes in accounting standards
IFRS 17 Insurance Contracts provides consistent principles
for all aspects of accounting for insurance contracts within
the scope of the standard. The standard is effective for years
beginning on or after 1 January 2023 with a requirement to
restate comparatives.
The Group has reviewed whether its arrangements meet the
accounting definition of an insurance contract. While some
contracts may transfer an element of insurance risk, they
relate to warranty and service type agreements that are
issued in connection with the Group\u2019s sales of its goods or
services and therefore will continue to be measured under
IFRS 15 Revenue from Contracts with Customers and IAS 37
Provisions, Contingent Liabilities and Contingent Assets.
The Directors are not aware of any other contracts where
IFRS 17 would have a material impact on the Consolidated
Financial Statements.
There are no other new standards or interpretations
issued by the IASB that had a significant impact on the
Consolidated Financial Statements.
There are no standards or amendments that are not yet
effective and that would be expected to have a material
impact on the Group in the current or future reporting periods
and on foreseeable future transactions.
", "dimensions": { "concept": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-449": { "value": "(a) Changes in accounting standards IFRS 17 Insurance Contracts provides consistent principles for all aspects of accounting for insurance contracts within the scope of the standard. The standard is effective for years beginning on or after 1 January 2023 with a requirement to restate comparatives. The Group has reviewed whether its arrangements meet the accounting definition of an insurance contract. While some contracts may transfer an element of insurance risk, they relate to warranty and service type agreements that are issued in connection with the Group\u2019s sales of its goods or services and therefore will continue to be measured under IFRS 15 Revenue from Contracts with Customers and IAS 37 Provisions, Contingent Liabilities and Contingent Assets. The Directors are not aware of any other contracts where IFRS 17 would have a material impact on the Consolidated Financial Statements. There are no other new standards or interpretations issued by the IASB that had a significant impact on the Consolidated Financial Statements. There are no standards or amendments that are not yet effective and that would be expected to have a material impact on the Group in the current or future reporting periods and on foreseeable future transactions.", "dimensions": { "concept": "ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-405": { "value": "
(b) Significant estimates and judgements
The preparation of Financial Statements requires
management to make judgements, estimates and
assumptions that affect the application of accounting
policies and the reported amounts of assets, liabilities,
income and expenses. Actual results may differ from
these estimates.
Significant judgements
In the opinion of the Group there is one key judgement made
in the preparation of the Financial Statements in respect of
which taking a different view would have a material impact
on the Financial Statements:
Provision for inventory
Provision is made for obsolete, slow moving and defective
stock where there is evidence of impairment, to reduce
the carrying value to its net realisable value. This requires
consideration of several factors including but not limited
to recent usage, expected future demand, new product
introduction plans and likely realisable values to estimate
the excess quantities and net realisable value. The level
of provisioning requires certain estimates regarding future
demand and possible design changes to identify excess
quantities. Amounts provided represent in aggregate the
Group\u2019s best estimate of the levels of provisioning required.
Significant estimates
Revisions to accounting estimates are recognised in the
period in which the estimate is revised if the revision affects
only that period or in the period of the revision and future
periods if the revision affects both current and future periods.
Two key areas where estimates have been used and
assumptions applied have been identified as follows:
Measurement of defined benefit scheme liabilities
The Group recognises and measures costs relating to
defined benefit pension schemes in accordance with IAS 19
(Revised) Employee Benefits. In applying IAS 19 (Revised)
the costs are assessed in accordance with the advice
of independent qualified actuaries. This requires certain
estimates and assumptions in relation to future changes in
salaries and inflation, as well as mortality rates, expected
returns on plan assets and the selection of suitable discount
rates. The factors affecting these assumptions are influenced
by wider macroeconomic factors that are largely outside of
the Group\u2019s control. Sensitivity analysis is set out in Note 24.
Provisions for IP-related claims
Provisions for IP-related claims are recognised in the period
when it becomes probable that there will be a future outflow
of funds resulting from past expectations or events which
can be reasonably estimated. The timing of recognition
requires the application of judgement to existing facts and
circumstances which can be subject to change. Amounts
provided represent the Group\u2019s best estimate of exposure
based on currently available information.
Key assumptions surrounding estimation uncertainty
relate to estimating potential royalty or profit sharing rates
surrounding any product-related intellectual property claims
(see Note 21).
Acquisition of First Light Imaging SAS
(First Light Imaging)
On the acquisition of a business in order to comply with IFRS
3 (Revised) Business Combinations it is necessary to reflect
the assets and liabilities acquired at their fair value. This
requires certain estimates and assumptions in relation to,
inter alia, the forecast performance of the acquired business,
the expected life of certain intangible assets and the likely
future customer base of the business. In order to assist in
undertaking this Fair Value exercise, the Group appointed an
external firm of advisors. The exercise is incomplete as at the
date of this report so the fair value adjustments are reported
on a provisional basis. The provisional fair value adjustments
arising from this review are set out in Note 11 on page 171.
", "dimensions": { "concept": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-406": { "value": "
(c) Basis of preparation and consolidation
The Financial Statements are presented in Sterling, rounded
to the nearest \u00a30.1m and are prepared on the historical cost
basis except as described below under the heading \u2018(e)
Financial instruments\u2019.
The Group Financial Statements include the accounts
of Oxford Instruments plc and its subsidiary companies
adjusted to eliminate intra-Group balances and any
unrealised gains and losses or income and expenses
arising from intra-Group transactions.
Subsidiaries are entities controlled by the Group. Control exists
when the Group is exposed to or has rights to variable returns
from its investment with the investee and has the ability to
affect those returns through its power over the investee. In
assessing control, potential voting rights that are currently
exercisable or convertible are taken into account. The results
of subsidiary companies are included in the Consolidated
Financial Statements from the date that control commences
until the date that control ceases. The acquisition method is
used to account for the acquisition of subsidiaries.
", "dimensions": { "concept": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-450": { "value": "(c) Basis of preparation and consolidation The Financial Statements are presented in Sterling, rounded to the nearest \u00a30.1m and are prepared on the historical cost basis except as described below under the heading \u2018(e) Financial instruments\u2019. The Group Financial Statements include the accounts of Oxford Instruments plc and its subsidiary companies adjusted to eliminate intra-Group balances and any unrealised gains and losses or income and expenses arising from intra-Group transactions. Subsidiaries are entities controlled by the Group. Control exists when the Group is exposed to or has rights to variable returns from its investment with the investee and has the ability to affect those returns through its power over the investee. In assessing control, potential voting rights that are currently exercisable or convertible are taken into account. The results of subsidiary companies are included in the Consolidated Financial Statements from the date that control commences until the date that control ceases. The acquisition method is used to account for the acquisition of subsidiaries. ", "dimensions": { "concept": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-407": { "value": "(d) Consideration of climate change In preparing the Financial Statements, the Directors have considered the impact of climate change, particularly in the context of the risks identified in the TCFD disclosure, see pages 40 to 50. There has been no material impact identified on the financial reporting judgements and estimates. In particular, the Directors considered the impact of climate change in respect of the following areas: \u2022 going concern and viability of the Group; \u2022 cash flow forecasts used in the impairment assessments of non-current assets including goodwill; and \u2022 carrying value and useful economic lives of property, plant and equipment. Whilst there is currently no medium-term impact expected from climate change, the Directors are aware of the ever- changing risks attached to climate change and will regularly assess these risks against judgements and estimates made in preparation of the Group\u2019s Financial Statements", "dimensions": { "concept": "oxfordinstrumentplc:DescriptionOfAccountingPolicyForClimateChange", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-484": { "value": "(e) Financial instruments Financial assets and liabilities are recognised in the Group\u2019s Consolidated Statement of Financial Position when the Group becomes a party to the contractual provisions of the instrument. Forward foreign exchange contracts (derivative financial instruments) of the Group are used to hedge its exposure to foreign currency risks arising from operational, financing and investment activities. The Group does not hold or issue derivative financial instruments for trading purposes. The Group has chosen not to apply hedge accounting in respect of these exposures. All derivatives are initially recognised at fair value; attributable transaction costs are recognised in profit or loss as incurred. Foreign exchange contracts are classified as \u2018fair value through profit and loss\u2019 under IFRS 9. Subsequent to initial recognition, derivatives are measured at fair value and gains or losses on the settlement of such derivatives are recognised in operating expenses. Where such derivatives relate to the following
year\u2019s exposure, any gains or losses resulting from the
change in fair value are recognised as an adjusting item
in operating expenses.
The fair value of forward exchange contracts is their market
price at the Consolidated Statement of Financial Position
date, being the present value of the forward price. The gain or loss on remeasurement to fair value of forward exchange contracts is recognised immediately in the Consolidated Statement of Income. Contingent purchase consideration is measured at fair value at the date of acquisition and subsequently carried at fair value, with movements recognised in the Consolidated Statement of Income. Interest-bearing borrowings are recognised initially at fair value less attributable transaction costs. Subsequent to initial recognition, interest-bearing borrowings are stated at amortised cost with any difference between cost and redemption value being recognised in the Consolidated Statement of Income over the period of the borrowing on an effective interest basis ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-451": { "value": "(e) Financial instruments Financial assets and liabilities are recognised in the Group\u2019s Consolidated Statement of Financial Position when the Group becomes a party to the contractual provisions of the instrument. Forward foreign exchange contracts (derivative financial instruments) of the Group are used to hedge its exposure to foreign currency risks arising from operational, financing and investment activities. The Group does not hold or issue derivative financial instruments for trading purposes. The Group has chosen not to apply hedge accounting in respect of these exposures. All derivatives are initially recognised at fair value; attributable transaction costs are recognised in profit or loss as incurred. Foreign exchange contracts are classified as \u2018fair value through profit and loss\u2019 under IFRS 9. Subsequent to initial recognition, derivatives are measured at fair value and gains or losses on the settlement of such derivatives are recognised in operating expenses. Where such derivatives relate to the following
year\u2019s exposure, any gains or losses resulting from the
change in fair value are recognised as an adjusting item
in operating expenses.
The fair value of forward exchange contracts is their market
price at the Consolidated Statement of Financial Position
date, being the present value of the forward price. The gain or loss on remeasurement to fair value of forward exchange contracts is recognised immediately in the Consolidated Statement of Income. Contingent purchase consideration is measured at fair value at the date of acquisition and subsequently carried at fair value, with movements recognised in the Consolidated Statement of Income. Interest-bearing borrowings are recognised initially at fair value less attributable transaction costs. Subsequent to initial recognition, interest-bearing borrowings are stated at amortised cost with any difference between cost and redemption value being recognised in the Consolidated Statement of Income over the period of the borrowing on an effective interest basis ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-408": { "value": "(e) Financial instruments Financial assets and liabilities are recognised in the Group\u2019s Consolidated Statement of Financial Position when the Group becomes a party to the contractual provisions of the instrument. Forward foreign exchange contracts (derivative financial instruments) of the Group are used to hedge its exposure to foreign currency risks arising from operational, financing and investment activities. The Group does not hold or issue derivative financial instruments for trading purposes. The Group has chosen not to apply hedge accounting in respect of these exposures. All derivatives are initially recognised at fair value; attributable transaction costs are recognised in profit or loss as incurred. Foreign exchange contracts are classified as \u2018fair value through profit and loss\u2019 under IFRS 9. Subsequent to initial recognition, derivatives are measured at fair value and gains or losses on the settlement of such derivatives are recognised in operating expenses. Where such derivatives relate to the following
year\u2019s exposure, any gains or losses resulting from the
change in fair value are recognised as an adjusting item
in operating expenses.
The fair value of forward exchange contracts is their market
price at the Consolidated Statement of Financial Position
date, being the present value of the forward price. The gain or loss on remeasurement to fair value of forward exchange contracts is recognised immediately in the Consolidated Statement of Income. Contingent purchase consideration is measured at fair value at the date of acquisition and subsequently carried at fair value, with movements recognised in the Consolidated Statement of Income. Interest-bearing borrowings are recognised initially at fair value less attributable transaction costs. Subsequent to initial recognition, interest-bearing borrowings are stated at amortised cost with any difference between cost and redemption value being recognised in the Consolidated Statement of Income over the period of the borrowing on an effective interest basis . ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-402": { "value": "
(f) Property, plant and equipment
Property, plant and equipment is stated at historical cost
less provisions for impairment (see accounting policy k)
and depreciation which, with the exception of freehold land
which is not depreciated and rental assets (see below), is
provided on a straight-line basis over each asset\u2019s estimated
economic life. Depreciation is provided based on historical
cost less estimated residual value. The principal estimated
economic lives used for this purpose are:
Freehold buildings, long 50 years
leasehold land and buildings
Furniture and fittings
10 years
Machinery and other equipment
5 to 10 years
Computer equipment
4 years
Vehicles
4 years
Machinery and other equipment, computer equipment
and vehicles are included within the \u2018Plant and equipment\u2019
subheading in Note 12.
For leasehold improvements, where the length of the lease
is less than the principal estimated economic lives noted
above, the length of the lease is used.
(g) Intangible assets
(i) Goodwill
All business combinations are accounted for by applying the
acquisition method. Goodwill represents amounts arising on
acquisition of subsidiaries. In respect of business acquisitions
that have occurred since 31 March 2004, goodwill represents
the difference between the cost of the acquisition and the
fair value of the assets, liabilities and contingent liabilities
acquired. In respect of acquisitions prior to this date, goodwill
is included on the basis of its deemed cost, which represents
the amount recorded under previous GAAP.
The Group expenses transaction costs associated with
its acquisitions and movements in liabilities relating to
contingent consideration within the Consolidated Statement
of Income in conformity with IFRS 3.
Goodwill arising on acquisitions is stated at cost less any
accumulated impairment losses and allocated to cash
generating units that are anticipated to benefit from the
combination. It is not amortised but is tested annually for
impairment (see accounting policy k), or more frequently
when there is an indicator that the unit may be impaired.
( ii) Development costs
Research & Development costs are charged to the
Consolidated Statement of Income in the year in which they
are incurred unless development expenditure is applied to
a plan or design for the production of new or substantially
improved products, in which case they are capitalised.
The criteria for capitalisation include demonstration of
the technical feasibility of completing a new intangible
asset that will be available for sale and that the asset
will generate probable future economic benefits. Where
expenditure meets the criteria, development costs are
capitalised and amortised through the Consolidated
Statement of Income over their useful economic lives.
(iii) Acquired intangible assets
An intangible asset acquired with a subsidiary undertaking is
recognised as an intangible asset if it is separable from the
acquired business or arises from contractual or legal rights,
is expected to generate future economic benefits and its
fair value can be reliably measured. The asset is amortised
through the Consolidated Statement of Income over its
useful economic life.
(iv) Amortisation
Amortisation of intangible assets is charged to the
Consolidated Statement of Income on a systematic basis
in proportion to the use of the assets over their estimated
useful economic lives as follows:
Capitalised development costs
3 to 5 years
Technology-related acquired intangibles
5 to 14 years
Customer-related acquired intangibles 6 months
to 15 years
Development costs acquired intangibles
10 years
Software
10 years
Customer-related acquired intangible assets include a
number of different types of asset. For example, the shorter
end of the useful economic life relates to the order book of
acquired businesses, whilst the longer useful economic life
relates to assets such as trademarks .
(h) Trade and other receivables
Trade and other receivables are initially recognised at fair
value and subsequently stated at their amortised cost
less appropriate provision for impairment. The provision for
impairment of receivables is based on lifetime expected
credit losses, which is then updated for any reasonable and
supportable forward-looking information and expectations.
Lifetime expected credit losses are calculated by assessing
historic credit loss experience. The movement in the provision
is recognised in the Consolidated Statement of Income.
(i) Inventories
Inventories are stated at the lower of cost and net realisable
value. Cost includes materials, direct labour, an attributable
proportion of production overheads based on normal
operating capacity and all other expenditure incurred in
acquiring the inventories and bringing them to their existing
location and condition. Net realisable value is the estimated
selling price in the ordinary course of business, less the
estimated costs of completion and selling expenses.
Provision is made for obsolete, slow moving and defective
stock where appropriate in light of recent usage, expected
future requirements, new product introduction plans and
likely realisable values.
As outlined in Note (r) below, the revenue associated with
both the sale and installation of certain complex products is
recognised at the time that the installation is completed. The
net realisable value associated with complex products is
included in finished goods inventories where the installation
has not yet been completed.
(j) Cash and cash equivalents Cash and cash equivalents are carried in the Statement of Financial Position at amortised cost. Cash and cash equivalents comprise cash balances and call deposits and are carried at amortised cost. Bank overdrafts that are repayable on demand and form an integral part of the Group\u2019s cash management are included as a component of cash and cash equivalents for the purpose of the Statement of Cash Flows. (k) Impairment of non-current assets All non-current assets are tested for impairment whenever events or circumstances indicate that their carrying value may be impaired. Additionally, goodwill is subject to an annual impairment review. For the purposes of impairment testing, assets are grouped together into the smallest group of assets that generates cash flows from continuing use that are largely independent of the cash inflows from other groups of assets. An impairment loss is recognised in the Consolidated Statement of Income under the administration and shared services heading, to the extent that an asset\u2019s carrying value, or a cash generating unit\u2019s carrying value, exceeds its recoverable amount, which represents the higher of its net realisable value and its value in use. Value in use is the present value of the future cash flows expected to be derived from the asset or from the cash generating unit to which it relates. The present value is calculated using a discount rate that reflects the current market assessment of the time value of money and the risks specific to the asset concerned. Impairment losses recognised in previous periods for an asset other than goodwill are reversed if there has been a change in estimates used to determine the asset\u2019s recoverable amount, but only to the extent that the carrying amount of the asset does not exceed its carrying amount had the impairment loss not been recognised in previous periods. Impairment losses in respect of goodwill are not reversed. Impairment losses recognised in respect of cash generating units are allocated first to reduce the carrying amount of any goodwill allocated to cash generating units and then to reduce the carrying amount of the other assets in the unit. (l) Employee benefits The Group operates a number of defined benefit and defined contribution plans which require contributions to be made to independent trustee-administered funds. (i) Defined contribution plans Obligations for contributions to defined contribution pension plans are recognised as an expense in the Consolidated Statement of Income as incurred. (ii) Defined benefit plans The Group\u2019s net obligation in respect of defined benefit pension plans is calculated separately for each plan by estimating the amount of future benefit that current and past employees have earned in return for their service in prior periods. That benefit is discounted to determine its present value and is deducted from the fair value of any plan assets. Surpluses in schemes are recognised as assets only if they represent economic benefits available to the Group in the future. The calculation is performed by a qualified actuary using the projected unit credit method. All actuarial gains and losses in calculating the Group\u2019s net obligation are recognised in the Consolidated Statement of Comprehensive Income in the year. The charge to the Consolidated Statement of Income reflects the current service cost. The interest expense or income is calculated on the net defined benefit asset by applying the discount rate to the net defined benefit asset, and is included within financial expenditure or financial income in the Consolidated Statement of Income respectively. (iii) Share-based payment transactions The fair value of equity settled share option programmes is measured at grant date and charged to the Consolidated Statement of Income, with a corresponding increase in equity, on a straight-line basis over the period during which the employees become unconditionally entitled to the options. The fair value of the options granted is measured using an option valuation model, taking into account the terms and conditions upon which the options were granted. The amount recognised as an expense is adjusted to reflect the actual number of share options that vest, except where forfeiture is only due to market performance conditions not being met. (m) Provisions A provision is recognised in the Consolidated Statement of Financial Position when the Group has a present legal or constructive obligation as a result of a past event and it is probable that an outflow of economic benefits will be required to settle the obligation. A provision for warranty and product-related liability is recognised when the underlying products are sold. A provision for restructuring is recognised when the Group has approved a detailed and formal restructuring plan and the restructuring has either commenced or has been announced publicly. A provision for onerous contracts is recognised when the expected benefits to be derived by the Group from a contract are lower than the unavoidable cost of meeting its obligations under the contract. A provision for a claim or dispute is made when it is considered probable that an adverse outcome will occur and the amount of the loss can be reasonably estimated. Contractual and other provisions represent the Directors\u2019 best estimate of the cost of settling future obligations where the Directors, taking into account professional advice received, assess that it is more likely than not that such proceedings may be successful. If the effect is material, provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and, where appropriate, the risks specific to the liabilities. ", "dimensions": { "concept": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-454": { "value": "(f) Property, plant and equipment Property, plant and equipment is stated at historical cost less provisions for impairment (see accounting policy k) and depreciation which, with the exception of freehold land which is not depreciated and rental assets (see below), is provided on a straight-line basis over each asset\u2019s estimated economic life. Depreciation is provided based on historical cost less estimated residual value. The principal estimated economic lives used for this purpose are:
Freehold buildings, long 50 years
leasehold land and buildings
Furniture and fittings
10 years
Machinery and other equipment
5 to 10 years
Computer equipment
4 years
Vehicles
4 years
Machinery and other equipment, computer equipment and vehicles are included within the \u2018Plant and equipment\u2019 subheading in Note 12. For leasehold improvements, where the length of the lease is less than the principal estimated economic lives noted above, the length of the lease is used. ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForDepreciationExpenseExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-412": { "value": "(f) Property, plant and equipment Property, plant and equipment is stated at historical cost less provisions for impairment (see accounting policy k) and depreciation which, with the exception of freehold land which is not depreciated and rental assets (see below), is provided on a straight-line basis over each asset\u2019s estimated economic life. Depreciation is provided based on historical cost less estimated residual value. The principal estimated economic lives used for this purpose are:
Freehold buildings, long 50 years
leasehold land and buildings
Furniture and fittings
10 years
Machinery and other equipment
5 to 10 years
Computer equipment
4 years
Vehicles
4 years
Machinery and other equipment, computer equipment and vehicles are included within the \u2018Plant and equipment\u2019 subheading in Note 12. For leasehold improvements, where the length of the lease is less than the principal estimated economic lives noted above, the length of the lease is used. ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-410": { "value": "(g) Intangible assets (i) Goodwill All business combinations are accounted for by applying the acquisition method. Goodwill represents amounts arising on acquisition of subsidiaries. In respect of business acquisitions that have occurred since 31 March 2004, goodwill represents the difference between the cost of the acquisition and the fair value of the assets, liabilities and contingent liabilities acquired. In respect of acquisitions prior to this date, goodwill is included on the basis of its deemed cost, which represents the amount recorded under previous GAAP. The Group expenses transaction costs associated with its acquisitions and movements in liabilities relating to contingent consideration within the Consolidated Statement of Income in conformity with IFRS 3. Goodwill arising on acquisitions is stated at cost less any accumulated impairment losses and allocated to cash generating units that are anticipated to benefit from the combination. It is not amortised but is tested annually for impairment (see accounting policy k), or more frequently when there is an indicator that the unit may be impaired. ( ii) Development costs Research & Development costs are charged to the Consolidated Statement of Income in the year in which they are incurred unless development expenditure is applied to a plan or design for the production of new or substantially improved products, in which case they are capitalised. The criteria for capitalisation include demonstration of the technical feasibility of completing a new intangible asset that will be available for sale and that the asset will generate probable future economic benefits. Where expenditure meets the criteria, development costs are capitalised and amortised through the Consolidated Statement of Income over their useful economic lives. (iii) Acquired intangible assets An intangible asset acquired with a subsidiary undertaking is recognised as an intangible asset if it is separable from the acquired business or arises from contractual or legal rights, is expected to generate future economic benefits and its fair value can be reliably measured. The asset is amortised through the Consolidated Statement of Income over its useful economic life. (iv) Amortisation Amortisation of intangible assets is charged to the Consolidated Statement of Income on a systematic basis in proportion to the use of the assets over their estimated useful economic lives as follows:
Capitalised development costs
3 to 5 years
Technology-related acquired intangibles
5 to 14 years
Customer-related acquired intangibles 6 months
to 15 years
Development costs acquired intangibles
10 years
Software
10 years
Customer-related acquired intangible assets include a number of different types of asset. For example, the shorter end of the useful economic life relates to the order book of acquired businesses, whilst the longer useful economic life relates to assets such as trademarks . ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-452": { "value": "(i) Goodwill All business combinations are accounted for by applying the acquisition method. Goodwill represents amounts arising on acquisition of subsidiaries. In respect of business acquisitions that have occurred since 31 March 2004, goodwill represents the difference between the cost of the acquisition and the fair value of the assets, liabilities and contingent liabilities acquired. In respect of acquisitions prior to this date, goodwill is included on the basis of its deemed cost, which represents the amount recorded under previous GAAP. The Group expenses transaction costs associated with its acquisitions and movements in liabilities relating to contingent consideration within the Consolidated Statement of Income in conformity with IFRS 3. Goodwill arising on acquisitions is stated at cost less any accumulated impairment losses and allocated to cash generating units that are anticipated to benefit from the combination. It is not amortised but is tested annually for impairment (see accounting policy k), or more frequently when there is an indicator that the unit may be impaired.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-485": { "value": "( ii) Development costs Research & Development costs are charged to the Consolidated Statement of Income in the year in which they are incurred unless development expenditure is applied to a plan or design for the production of new or substantially improved products, in which case they are capitalised. The criteria for capitalisation include demonstration of the technical feasibility of completing a new intangible asset that will be available for sale and that the asset will generate probable future economic benefits. Where expenditure meets the criteria, development costs are capitalised and amortised through the Consolidated Statement of Income over their useful economic lives. ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-453": { "value": "ii) Development costs Research & Development costs are charged to the Consolidated Statement of Income in the year in which they are incurred unless development expenditure is applied to a plan or design for the production of new or substantially improved products, in which case they are capitalised. The criteria for capitalisation include demonstration of the technical feasibility of completing a new intangible asset that will be available for sale and that the asset will generate probable future economic benefits. Where expenditure meets the criteria, development costs are capitalised and amortised through the Consolidated Statement of Income over their useful economic lives. (iii) Acquired intangible assets An intangible asset acquired with a subsidiary undertaking is recognised as an intangible asset if it is separable from the acquired business or arises from contractual or legal rights, is expected to generate future economic benefits and its fair value can be reliably measured. The asset is amortised through the Consolidated Statement of Income over its useful economic life. (iv) Amortisation Amortisation of intangible assets is charged to the Consolidated Statement of Income on a systematic basis in proportion to the use of the assets over their estimated useful economic lives as follows:
Capitalised development costs
3 to 5 years
Technology-related acquired intangibles
5 to 14 years
Customer-related acquired intangibles 6 months
to 15 years
Development costs acquired intangibles
10 years
Software
10 years
Customer-related acquired intangible assets include a number of different types of asset. For example, the shorter end of the useful economic life relates to the order book of acquired businesses, whilst the longer useful economic life relates to assets such as trademarks ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-409": { "value": "(h) Trade and other receivables Trade and other receivables are initially recognised at fair value and subsequently stated at their amortised cost less appropriate provision for impairment. The provision for impairment of receivables is based on lifetime expected credit losses, which is then updated for any reasonable and supportable forward-looking information and expectations. Lifetime expected credit losses are calculated by assessing historic credit loss experience. The movement in the provision is recognised in the Consolidated Statement of Income.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-411": { "value": "(i) Inventories Inventories are stated at the lower of cost and net realisable value. Cost includes materials, direct labour, an attributable proportion of production overheads based on normal operating capacity and all other expenditure incurred in acquiring the inventories and bringing them to their existing location and condition. Net realisable value is the estimated selling price in the ordinary course of business, less the estimated costs of completion and selling expenses. Provision is made for obsolete, slow moving and defective stock where appropriate in light of recent usage, expected future requirements, new product introduction plans and likely realisable values. As outlined in Note (r) below, the revenue associated with both the sale and installation of certain complex products is recognised at the time that the installation is completed. The net realisable value associated with complex products is included in finished goods inventories where the installation has not yet been completed.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-416": { "value": "
(j) Cash and cash equivalents
Cash and cash equivalents are carried in the Statement of
Financial Position at amortised cost.
Cash and cash equivalents comprise cash balances and call
deposits and are carried at amortised cost. Bank overdrafts
that are repayable on demand and form an integral part of
the Group\u2019s cash management are included as a component
of cash and cash equivalents for the purpose of the
Statement of Cash Flows.
18 Cash and cash equivalents
2024 2023
\u00a3m \u00a3m
Cash balances
97.8
112.7
Bank overdrafts (Note 19)
(12.3)
(11.2)
Cash and cash equivalents in the Consolidated Statement of Cash Flows
85.5
101.5
", "dimensions": { "concept": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-413": { "value": "
(k) Impairment of non-current assets
All non-current assets are tested for impairment whenever
events or circumstances indicate that their carrying value
may be impaired. Additionally, goodwill is subject to an
annual impairment review.
For the purposes of impairment testing, assets are grouped
together into the smallest group of assets that generates
cash flows from continuing use that are largely independent
of the cash inflows from other groups of assets.
An impairment loss is recognised in the Consolidated
Statement of Income under the administration and shared
services heading, to the extent that an asset\u2019s carrying
value, or a cash generating unit\u2019s carrying value, exceeds
its recoverable amount, which represents the higher of its
net realisable value and its value in use. Value in use is the
present value of the future cash flows expected to be derived
from the asset or from the cash generating unit to which it
relates. The present value is calculated using a discount rate
that reflects the current market assessment of the time value
of money and the risks specific to the asset concerned.
Impairment losses recognised in previous periods for an
asset other than goodwill are reversed if there has been
a change in estimates used to determine the asset\u2019s
recoverable amount, but only to the extent that the carrying
amount of the asset does not exceed its carrying amount
had the impairment loss not been recognised in previous
periods. Impairment losses in respect of goodwill are
not reversed.
Impairment losses recognised in respect of cash generating
units are allocated first to reduce the carrying amount of
any goodwill allocated to cash generating units and then to
reduce the carrying amount of the other assets in the unit.
", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-414": { "value": "
(l) Employee benefits
The Group operates a number of defined benefit and defined
contribution plans which require contributions to be made to
independent trustee-administered funds.
(i) Defined contribution plans
Obligations for contributions to defined contribution pension
plans are recognised as an expense in the Consolidated
Statement of Income as incurred.
(ii) Defined benefit plans
The Group\u2019s net obligation in respect of defined benefit
pension plans is calculated separately for each plan by
estimating the amount of future benefit that current and past
employees have earned in return for their service in prior
periods. That benefit is discounted to determine its present
value and is deducted from the fair value of any plan assets.
Surpluses in schemes are recognised as assets only if they represent economic benefits available to the Group in the future. The calculation is performed by a qualified actuary using the projected unit credit method. All actuarial gains and losses in calculating the Group\u2019s net obligation are recognised in the Consolidated Statement of Comprehensive Income in the year. The charge to the Consolidated Statement of Income reflects the current service cost. The interest expense or income is calculated on the net defined benefit asset by applying the discount rate to the net defined benefit asset, and is included within financial expenditure or financial income in the Consolidated Statement of Income respectively. (iii) Share-based payment transactions The fair value of equity settled share option programmes is measured at grant date and charged to the Consolidated Statement of Income, with a corresponding increase in equity, on a straight-line basis over the period during which the employees become unconditionally entitled to the options. The fair value of the options granted is measured using an option valuation model, taking into account the terms and conditions upon which the options were granted. The amount recognised as an expense is adjusted to reflect the actual number of share options that vest, except where forfeiture is only due to market performance conditions not being met", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-455": { "value": "
(iii) Share-based payment transactions
The fair value of equity settled share option programmes is
measured at grant date and charged to the Consolidated
Statement of Income, with a corresponding increase in
equity, on a straight-line basis over the period during which
the employees become unconditionally entitled to the
options. The fair value of the options granted is measured
using an option valuation model, taking into account the
terms and conditions upon which the options were granted.
The amount recognised as an expense is adjusted to reflect
the actual number of share options that vest, except where
forfeiture is only due to market performance conditions not
being met.
", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-415": { "value": "
(m) Provisions
A provision is recognised in the Consolidated Statement
of Financial Position when the Group has a present legal
or constructive obligation as a result of a past event and
it is probable that an outflow of economic benefits will be
required to settle the obligation. A provision for warranty
and product-related liability is recognised when the
underlying products are sold. A provision for restructuring is
recognised when the Group has approved a detailed and
formal restructuring plan and the restructuring has either
commenced or has been announced publicly.
A provision for onerous contracts is recognised when
the expected benefits to be derived by the Group from a
contract are lower than the unavoidable cost of meeting
its obligations under the contract. A provision for a claim
or dispute is made when it is considered probable that an
adverse outcome will occur and the amount of the loss
can be reasonably estimated.
Contractual and other provisions represent the Directors\u2019
best estimate of the cost of settling future obligations
where the Directors, taking into account professional advice
received, assess that it is more likely than not that such
proceedings may be successful.
If the effect is material, provisions are determined by
discounting the expected future cash flows at a pre-tax
rate that reflects current market assessments of the time
value of money and, where appropriate, the risks specific
to the liabilities.
", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-421": { "value": "(r) Income taxes Income tax on the profit or loss for the year comprises current and deferred tax. Income tax is recognised in profit or loss except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity. Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous years. Tax positions are reviewed to assess whether a provision should be made based on prevailing circumstances. Tax provisions are included within current taxation liabilities. Deferred tax positions are measured on an undiscounted basis. Additional income taxes that arise from the distribution of dividends are recognised at the same time as the liability to pay the related dividend. Where there is uncertainty surrounding an income tax position, consideration is given to whether the tax authority (with full knowledge of the facts) would probably be more or less likely to accept the uncertain tax position. If the conclusion reached is that it is probable that the tax authority would not accept a tax position a provision is calculated either as the most likely outcome (where the possible outcomes are binary or concentrated on one value) or as the expected value (where there is a range of possible outcomes) depending on which method would provide the better prediction for the resolution of the uncertainty ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-456": { "value": "(r) Income taxes Income tax on the profit or loss for the year comprises current and deferred tax. Income tax is recognised in profit or loss except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity. Current tax is the expected tax payable on the taxable income for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to tax payable in respect of previous years. Tax positions are reviewed to assess whether a provision should be made based on prevailing circumstances. Tax provisions are included within current taxation liabilities. Deferred tax positions are measured on an undiscounted basis. Additional income taxes that arise from the distribution of dividends are recognised at the same time as the liability to pay the related dividend. Where there is uncertainty surrounding an income tax position, consideration is given to whether the tax authority (with full knowledge of the facts) would probably be more or less likely to accept the uncertain tax position. If the conclusion reached is that it is probable that the tax authority would not accept a tax position a provision is calculated either as the most likely outcome (where the possible outcomes are binary or concentrated on one value) or as the expected value (where there is a range of possible outcomes) depending on which method would provide the better prediction for the resolution of the uncertainty .", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-419": { "value": "(n) Customer deposits Customer deposits are classified as contract liabilities and included within trade and other payables in the Statement of Financial Position. Customer deposits represent the cash payments received or consideration due from customers prior to the recognition of revenue in respect of product sales; for example, deposits received on order (and shipment in the case of complex products where revenue is not recognised until installation) ", "dimensions": { "concept": "oxfordinstrumentplc:DescriptionOfAccountingPolicyForCustomerDeposits", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-417": { "value": "
(o) Government grants
Grants from governments are recognised at their fair
value where there is a reasonable assurance that the
grant will be received and the Group will comply with all
attached conditions.
Government grants relating to costs are deferred and
recognised in the Consolidated Statement of Income
over the period necessary to match them with the costs
they are intended to compensate. Government grants
relating to property, plant and equipment are deducted
from the carrying amount of the asset and are credited
to the Consolidated Statement of Income on a straight-
line basis over the expected useful economic lives of the
related assets.
", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-418": { "value": "
(p) Interest-bearing borrowings
Interest-bearing borrowings are recognised initially at fair
value less attributable transaction costs. Subsequent to
initial recognition, interest-bearing borrowings are stated
at amortised cost with any difference between cost and
redemption value being recognised in the Consolidated
Statement of Income over the period of the borrowings
on an effective interest basis.
", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-420": { "value": "
(q) Revenue
Revenue is recognised in the Consolidated Statement of
Income when the performance conditions in the contract
with the customer are met.
In most cases where the contract includes the sale of both
a product and installation then the sale of the product
and the related installation are treated as two separate
performance conditions. This is because the Group considers
that the customer is able to benefit from the product even
if the Group does not supply installation, i.e. it would be
possible for them to arrange installation by a third party.
In such situations, revenue in respect of the product is
recognised when control passes to the customer which is
normally upon shipment of the product. Revenue in respect
of the installation is recognised when the customer confirms
acceptance of the installation. Revenue in respect of both
product and installation is recognised at a point when it is
considered the performance conditions are met.
Revenue is allocated between the product and installation
based on the relative standalone selling prices of those
products and installation activities. Where it is difficult to
establish a standalone selling price by market comparator,
the standalone selling price is estimated, where required,
by applying the cost plus margin approach .
A receivable is recognised for products when control passes over to customer, and for installation when the customer confirms acceptance of the installation, since this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due. In the case of fixed-price contracts, the customer pays the fixed amount based on a payment schedule. If the performance obligations met by the Group exceed the payment, a contract asset is recognised. If the payments exceed the performance obligation, a contract liability is recognised. In the NanoScience business, which is part of the Research & Discovery segment, certain contracts for the sale of more complex systems are deemed to comprise just one performance condition as customers are unable to realise the economic benefit from having received the equipment without the specialist installation. Given the highly interdependent nature of the product and installation, this performance condition is met, and the revenue recognised, when the customer confirms acceptance of the installed product at their premises. In the Service & Healthcare segment, revenue for fixed term maintenance and support contracts is recognised over time using the output method by determining the proportion of the elapsed time relative to the contract period. Where the Service & Healthcare segment makes asset sales, similar considerations as those set out for the other segments as outlined above are applied. Revenue excludes value added tax and similar sales-based taxes and is stated before commission payable to agents which is recognised in cost of sales. ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-423": { "value": "(t) Segment reporting An operating segment is a distinguishable component of the Group that engages in business activities from which it may earn revenues and incur expenses, including any revenues and expenses that relate to transactions with any of the Group\u2019s other components. Operating components are combined into aggregated operating segments to the extent that they have similar economic characteristics. Aggregated operating segments\u2019 operating results are reviewed regularly by the Group\u2019s Board of Directors to make decisions about resources to be allocated to the segment and to assess its performance, for which discrete financial information is available. Segment results that are reported to the Board include items directly attributable to a segment as well as those that can be allocated on a reasonable basis. A reportable segment is an aggregated operating segment in respect of which revenue or profit exceeds 10% of the Group total. Discrete financial information is disclosed for each reportable segment ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-422": { "value": "( s) Leases The Group recognises a right-of-use asset and a lease liability at the lease commencement date. The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term. The estimated useful lives of right- of-use assets are determined on the same basis as those of property and equipment. In addition, the right-of-use asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability. The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the lessee\u2019s incremental borrowing rate. Generally, the Group uses its incremental borrowing rate as the discount rate. Lease payments included in the measurement of the lease liability comprise fixed payments. The lease liability is measured at amortised cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, if there is a change in the Group\u2019s estimate of the amount expected to be payable under a residual value guarantee, or if the Group changes its assessment of whether it will exercise a purchase, extension or termination option. If such remeasurement is required, it is performed using the original incremental borrowing rate, unless there is a change in estimated lease term; in which case it is performed using a new incremental borrowing rate. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right-of-use asset, or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero. Short-term leases and leases of low-value assets The Group has elected not to recognise right-of-use assets and lease liabilities for short-term leases of machinery that have a lease term of 12 months or less and leases of low- value assets, including IT equipment. The Group recognises the lease payments associated with these leases as an expense on a straight-line basis over the lease term .", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-457": { "value": "1 Segment information The Group has nine operating segments. These operating segments have been combined into three aggregated operating segments to the extent that they have similar economic characteristics, with relevance to products and services, type and class of customer, methods of sale and distribution and the regulatory environment in which they operate. Each of these three aggregated operating segments is a reportable segment. The aggregated operating segments are as follows: \u2022 the Materials & Characterisation segment comprises a group of businesses focusing on applied R&D and commercial customers, enabling the fabrication and characterisation of materials and devices down to the atomic scale; \u2022 the Research & Discovery segment comprises a group of businesses providing advanced solutions that create unique environments and enable measurements down to the molecular and atomic level which are used in fundamental research; and \u2022 the Service & Healthcare segment provides customer service and support for the Group\u2019s products and the service of third- party healthcare imaging systems. The Group\u2019s internal management structure and financial reporting systems differentiate the three aggregated operating segments based on the economic characteristics discussed above. Reportable segment results include items directly attributable to a segment as well as those which can be allocated on a reasonable basis. The operating results of each are regularly reviewed by the Chief Operating Decision Maker, which is deemed to be the Executive Directors. Discrete financial information is available for each segment and used by the Executive Directors for decisions on resource allocation and to assess performance. No asset information is presented below as this information is not presented in reporting to the Group\u2019s Executive Directors. On 9 January 2024, the Group acquired 100% of the issued share capital of First Light Imaging which has been integrated into the Research & Discovery segment. Further information can be found in Note 11. Results
Materials & Research & Service &
Characterisation Discovery Healthcare Total
2024 \u00a3m \u00a3m \u00a3m \u00a3m
Total segment revenue
252.2
142.1
76.1
470.4
Segment adjusted operating profit
46.4
13.6
20.3
80.3
Materials & Research & Service &
Characterisation Discovery Healthcare Total
2023 \u00a3m \u00a3m \u00a3m \u00a3m
Total segment revenue
234.5
139.4
70.8
444.7
Segment adjusted operating profit
40.5
18.0
22.0
80.5
Revenue in the Materials & Characterisation and Research & Discovery segments represents the sale of products. Revenue in the Service & Healthcare segment relates to service income. No individual customer accounts for more than 10% of revenue. As at 31 March 2024, the Group had unfulfilled performance obligations under IFRS 15 of \u00a3301.5m (2023: \u00a3319.6m). It is anticipated that \u00a3277.3m (2023: \u00a3303.0m) of this balance will be satisfied within one year. The remainder is anticipated to be satisfied in the following financial year Reconciliation of reportable segment profit
Materials & Research & Service & Unallocated
Characterisation Discovery Healthcare Group items Total
2024 \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Segment adjusted operating profit
46.4
13.6
20.3
\u2013
80.3
Intellectual property litigation settlement
\u2013
3.3
\u2013
\u2013
3.3
Adjustments relating to defined benefit pension schemes
\u2013
\u2013
\u2013
(0.4)
(0.4)
Transaction-related costs
\u2013
(1.0)
\u2013
\u2013
(1.0)
Restructuring costs and charges associated with
management changes
(1.7)
\u2013
\u2013
(2.0)
(3.7)
Intellectual property litigation costs
\u2013
(0.4)
\u2013
\u2013
(0.4)
Amortisation and impairment of acquired intangibles
(3.0)
(6.1)
\u2013
\u2013
(9.1)
Fair value movement on financial derivatives
\u2013
\u2013
\u2013
(0.7)
(0.7)
Financial income
\u2013
\u2013
\u2013
4.7
4.7
Financial expenditure
\u2013
\u2013
\u2013
(1.7)
(1.7)
Profit/(loss) before income tax
41.7
9.4
20.3
(0.1)
71.3
Materials & Research & Service & Unallocated
Characterisation Discovery Healthcare Group items Total
2023 \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Segment adjusted operating profit
40.5
18.0
22.0
\u2013
80.5
Restructuring costs
(0.4)
\u2013
\u2013
\u2013
(0.4)
Release of provision on disposal
\u2013
\u2013
0.4
\u2013
0.4
Intellectual property litigation
\u2013
(0.5)
\u2013
\u2013
(0.5)
Impairment of capitalised development costs
(0.8)
\u2013
\u2013
\u2013
(0.8)
WITec post-acquisition gross margin adjustment
(0.5)
\u2013
\u2013
\u2013
(0.5)
Amortisation and impairment of acquired intangibles
(3.1)
(6.2)
\u2013
\u2013
(9.3)
Fair value movement on financial derivatives
\u2013
\u2013
\u2013
3.0
3.0
Financial income
\u2013
\u2013
\u2013
2.7
2.7
Financial expenditure
\u2013
\u2013
\u2013
(1.6)
(1.6)
Profit before income tax
35.7
11.3
22.4
4.1
73.5
2024
Materials & Research & Service & Unallocated
Characterisation Discovery Healthcare Group items Total
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Capital expenditure
(18.0)
(6.6)
(0.1)
(2.3)
(27.0)
Depreciation of property, plant and equipment
(3.3)
(1.5)
\u2013
(0.5)
(5.3)
Amortisation of right-of-use assets
(2.4)
(0.4)
\u2013
(2.2)
(5.0)
Amortisation and impairment of acquired intangibles
(3.5)
(6.3)
\u2013
\u2013
(9.8)
Capitalised development expenditure
(0.1)
(0.6)
\u2013
\u2013
(0.7)
Materials & Research & Service & Unallocated Characterisation Discovery Healthcare Group items Total 2023 \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m Capital expenditure (28.6) (2.7) \u2013 (1.0) (32.3) Depreciation of property, plant and equipment (3.0) (1.2) \u2013 (0.6) (4.8) Amortisation of right-of-use assets (2.1) (0.5) \u2013 (2.0) (4.6) Amortisation and impairment of acquired intangibles (6.0) (6.3) \u2013 \u2013 (12.3) Capitalised development expenditure (0.4) (0.2) \u2013 \u2013 (0.6 The Group\u2019s revenue by destination of the end user is as follows: Revenue
2024 2023
\u00a3m \u00a3m
UK
30.4
29.4
China
127. 4
107.4
Japan
43.5
46.7
USA
111.6
121.2
Germany
35.5
32.1
Rest of Europe
50.3
43.4
Rest of Asia
50.6
47.1
Rest of World
21.1
17.4
470.4
444.7
2024 2023
Non-current assets (excluding deferred tax) \u00a3m \u00a3m
UK
191.0
189.6
Germany
32.1
34.8
USA
12.5
13.9
Japan
6.2
1.9
China
4.0
2.9
Rest of Europe
22.1
6.5
Rest of Asia
0.2
0.2
Rest of World
0.3
0.3
268.4
250.1
", "dimensions": { "concept": "ifrs-full:DisclosureOfRevenueExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-424": { "value": "1 Segment information The Group has nine operating segments. These operating segments have been combined into three aggregated operating segments to the extent that they have similar economic characteristics, with relevance to products and services, type and class of customer, methods of sale and distribution and the regulatory environment in which they operate. Each of these three aggregated operating segments is a reportable segment. The aggregated operating segments are as follows: \u2022 the Materials & Characterisation segment comprises a group of businesses focusing on applied R&D and commercial customers, enabling the fabrication and characterisation of materials and devices down to the atomic scale; \u2022 the Research & Discovery segment comprises a group of businesses providing advanced solutions that create unique environments and enable measurements down to the molecular and atomic level which are used in fundamental research; and \u2022 the Service & Healthcare segment provides customer service and support for the Group\u2019s products and the service of third- party healthcare imaging systems. The Group\u2019s internal management structure and financial reporting systems differentiate the three aggregated operating segments based on the economic characteristics discussed above. Reportable segment results include items directly attributable to a segment as well as those which can be allocated on a reasonable basis. The operating results of each are regularly reviewed by the Chief Operating Decision Maker, which is deemed to be the Executive Directors. Discrete financial information is available for each segment and used by the Executive Directors for decisions on resource allocation and to assess performance. No asset information is presented below as this information is not presented in reporting to the Group\u2019s Executive Directors. On 9 January 2024, the Group acquired 100% of the issued share capital of First Light Imaging which has been integrated into the Research & Discovery segment. Further information can be found in Note 11. Results
Materials & Research & Service &
Characterisation Discovery Healthcare Total
2024 \u00a3m \u00a3m \u00a3m \u00a3m
Total segment revenue
252.2
142.1
76.1
470.4
Segment adjusted operating profit
46.4
13.6
20.3
80.3
Materials & Research & Service &
Characterisation Discovery Healthcare Total
2023 \u00a3m \u00a3m \u00a3m \u00a3m
Total segment revenue
234.5
139.4
70.8
444.7
Segment adjusted operating profit
40.5
18.0
22.0
80.5
Revenue in the Materials & Characterisation and Research & Discovery segments represents the sale of products. Revenue in the Service & Healthcare segment relates to service income. No individual customer accounts for more than 10% of revenue. As at 31 March 2024, the Group had unfulfilled performance obligations under IFRS 15 of \u00a3301.5m (2023: \u00a3319.6m). It is anticipated that \u00a3277.3m (2023: \u00a3303.0m) of this balance will be satisfied within one year. The remainder is anticipated to be satisfied in the following financial year . Reconciliation of reportable segment profit
Materials & Research & Service & Unallocated
Characterisation Discovery Healthcare Group items Total
2024 \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Segment adjusted operating profit
46.4
13.6
20.3
\u2013
80.3
Intellectual property litigation settlement
\u2013
3.3
\u2013
\u2013
3.3
Adjustments relating to defined benefit pension schemes
\u2013
\u2013
\u2013
(0.4)
(0.4)
Transaction-related costs
\u2013
(1.0)
\u2013
\u2013
(1.0)
Restructuring costs and charges associated with
management changes
(1.7)
\u2013
\u2013
(2.0)
(3.7)
Intellectual property litigation costs
\u2013
(0.4)
\u2013
\u2013
(0.4)
Amortisation and impairment of acquired intangibles
(3.0)
(6.1)
\u2013
\u2013
(9.1)
Fair value movement on financial derivatives
\u2013
\u2013
\u2013
(0.7)
(0.7)
Financial income
\u2013
\u2013
\u2013
4.7
4.7
Financial expenditure
\u2013
\u2013
\u2013
(1.7)
(1.7)
Profit/(loss) before income tax
41.7
9.4
20.3
(0.1)
71.3
Materials & Research & Service & Unallocated
Characterisation Discovery Healthcare Group items Total
2023 \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Segment adjusted operating profit
40.5
18.0
22.0
\u2013
80.5
Restructuring costs
(0.4)
\u2013
\u2013
\u2013
(0.4)
Release of provision on disposal
\u2013
\u2013
0.4
\u2013
0.4
Intellectual property litigation
\u2013
(0.5)
\u2013
\u2013
(0.5)
Impairment of capitalised development costs
(0.8)
\u2013
\u2013
\u2013
(0.8)
WITec post-acquisition gross margin adjustment
(0.5)
\u2013
\u2013
\u2013
(0.5)
Amortisation and impairment of acquired intangibles
(3.1)
(6.2)
\u2013
\u2013
(9.3)
Fair value movement on financial derivatives
\u2013
\u2013
\u2013
3.0
3.0
Financial income
\u2013
\u2013
\u2013
2.7
2.7
Financial expenditure
\u2013
\u2013
\u2013
(1.6)
(1.6)
Profit before income tax
35.7
11.3
22.4
4.1
73.5
2024
Materials & Research & Service & Unallocated
Characterisation Discovery Healthcare Group items Total
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Capital expenditure
(18.0)
(6.6)
(0.1)
(2.3)
(27.0)
Depreciation of property, plant and equipment
(3.3)
(1.5)
\u2013
(0.5)
(5.3)
Amortisation of right-of-use assets
(2.4)
(0.4)
\u2013
(2.2)
(5.0)
Amortisation and impairment of acquired intangibles
(3.5)
(6.3)
\u2013
\u2013
(9.8)
Capitalised development expenditure
(0.1)
(0.6)
\u2013
\u2013
(0.7)
Materials & Research & Service & Unallocated
Characterisation Discovery Healthcare Group items Total
2023 \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Capital expenditure
(28.6)
(2.7)
\u2013
(1.0)
(32.3)
Depreciation of property, plant and equipment
(3.0)
(1.2)
\u2013
(0.6)
(4.8)
Amortisation of right-of-use assets
(2.1)
(0.5)
\u2013
(2.0)
(4.6)
Amortisation and impairment of acquired intangibles
(6.0)
(6.3)
\u2013
\u2013
(12.3)
Capitalised development expenditure
(0.4)
(0.2)
\u2013
\u2013
(0.6 )
The Group\u2019s revenue by destination of the end user is as follows:
Revenue
2024 2023
\u00a3m \u00a3m
UK
30.4
29.4
China
127. 4
107.4
Japan
43.5
46.7
USA
111.6
121.2
Germany
35.5
32.1
Rest of Europe
50.3
43.4
Rest of Asia
50.6
47.1
Rest of World
21.1
17.4
470.4
444.7
2024 2023
Non-current assets (excluding deferred tax) \u00a3m \u00a3m
UK
191.0
189.6
Germany
32.1
34.8
USA
12.5
13.9
Japan
6.2
1.9
China
4.0
2.9
Rest of Europe
22.1
6.5
Rest of Asia
0.2
0.2
Rest of World
0.3
0.3
268.4
250.1
", "dimensions": { "concept": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-425": { "value": "
2 Adjusting items
In the preparation of adjusted numbers, the Directors exclude certain items in order to assist with comparability between
peers and to give what they consider to be a better indication of the underlying performance of the business. In determining
whether an event or transaction is an adjusting item, the Directors consider quantitative as well as qualitative factors such as
the frequency or predictability of occurrence. Examples of exceptional items include acquisition-related costs, one-time past
service costs on defined benefit pension schemes, and one-time intellectual property litigation costs.
These adjusting items are excluded in the calculation of adjusted operating profit, adjusted profit before tax, adjusted profit for
the year, adjusted EBITDA, adjusted EPS, adjusted cash conversion and adjusted effective tax rate. Details of adjusting items
are given below.
Adjusted EBITDA is calculated by adding back depreciation of property, plant and equipment, amortisation of right-of-use
assets and amortisation of intangible assets to adjusted operating profit, and can be found in the Consolidated Statement of
Cash Flows. The calculation of adjusted EPS can be found in Note 10. Adjusted effective tax rate is calculated by dividing the
share of tax attributable to adjusted profit before tax by adjusted profit before tax. The definition of cash conversion is set out
in the Finance Review.
Reconciliation between operating profit and profit before income tax and adjusted profit
2024
2023
Operating Profit before Operating Profit before
profit income tax profit income tax
\u00a3m \u00a3m \u00a3m \u00a3m
Statutory measure
68.3
71.3
72.4
73.5
Intellectual property litigation settlement
(3.3)
(3.3)
\u2013
\u2013
Release of provision on disposal
\u2013
\u2013
(0.4)
(0.4)
Adjustments relating to defined benefit pension schemes
0.4
0.4
\u2013
\u2013
Transaction-related costs
1.0
1.0
\u2013
\u2013
WITec post-acquisition gross margin adjustment
\u2013
\u2013
0.5
0.5
Restructuring costs and charges associated with
management changes
3.7
3.7
0.4
0.4
Intellectual property litigation costs
0.4
0.4
0.5
0.5
Impairment of capitalised development costs
\u2013
\u2013
0.8
0.8
Amortisation and impairment of acquired intangibles
9.1
9.1
9.3
9.3
Fair value movement on financial derivatives
0.7
0.7
(3.0)
(3.0)
Unwind of discount in respect of contingent consideration
\u2013
\u2013
\u2013
0.4
Total adjusting items
12.0
12.0
8.1
8.5
Adjusted measure
80.3
83.3
80.5
82.0
Adjusted income tax expense
(20.3)
(17.0)
Adjusted profit
80.3
63.0
80.5
65.0
Adjusted effective tax rates
24.4%
20.7%
Intellectual property litigation settlement This represents one-off settlement income in the Research & Discovery segment from defending our intellectual property. Release of provision on disposal The costs in the prior year represent the release of the provision on disposal of the OI Healthcare business in the US in 2020. Adjustments relating to defined benefit pension schemes During the year, the Group recognised a one-off charge of \u00a30.4m in respect of removing the pension increase exchange at retirement option for deferred members. This past service cost is reflected in the retirement benefit obligations as shown in Note 24. Transaction-related costs These represent the costs of one-off charges incurred at the balance sheet date relating to transactional work. WITec post-acquisition gross margin adjustment The finished goods and work-in-progress inventories were revalued to fair value, based on selling price less costs to sell. The adjustments in the prior period relate to the gross margin which would have been earned on post-acquisition sales to 31 March 2023, but which has been absorbed into the acquisition date fair value. This has not occurred, as all such inventory at the acquisition date had been delivered to customers by 31 March 2023. Restructuring costs and charges associated with management changes In the current year, these represent \u00a31.7m of costs associated with the relocation of production facilities within the semiconductor business and charges of \u00a32.0m incurred in respect of the recruitment of the new CEO and one-off dual-running costs associated with this appointment. In the prior year, these represent the costs of one-off restructuring charges within the Materials & Characterisation segment ntellectual property litigation costs These represent one-off legal costs to defend our intellectual property. Impairment of capitalised development costs During the prior year, the Group reviewed the capitalised development costs to ensure they remained directly related to targeted product or software developments. The one-off non-cash impairment relates to delays in market launch of specific development projects within the Materials & Characterisation segment. Amortisation and impairment of acquired intangibles Adjusted profit excludes the non-cash amortisation and impairment of acquired intangible assets and goodwill. Fair value movement on financial derivatives Under IFRS 9, all derivative financial instruments are recognised initially at fair value. Subsequent to initial recognition, they are also measured at fair value. In respect of instruments used to hedge foreign exchange risk and interest rate risk, the Group does not take advantage of the hedge accounting rules provided for in IFRS 9 since that standard requires certain stringent criteria to be met in order to hedge account, which, in the particular circumstances of the Group, are considered by the Board not to bring any significant economic benefit. Accordingly, the Group accounts for these derivative financial instruments at fair value through profit or loss. To the extent that instruments are hedges of future transactions, adjusted profit for the year is stated before changes in the valuation of these instruments so that the underlying performance of the Group can be more clearly seen. Unwind of discount in respect of contingent consideration Adjusted profit in the prior year excluded the unwind of the discount in respect of the contingent consideration on the acquisition of WITec. Adjusted income tax expense Statutory income tax is adjusted for the income tax impact on the adjusting items described above. In the current year, adjusted income tax also includes a prior year adjustment in relation to deferred tax recognised on the Asylum intangibles. Reconciliation of changes in cash and cash equivalents to movement in net cash after borrowings
2024 2023
\u00a3m \u00a3m
Net (decrease)/increase in cash and cash equivalents
(13.1)
13.5
Effect of exchange rate fluctuations on cash held
(2.9)
0.3
Movement in net cash in the year
(16.0)
13.8
Bank loans at First Light Imaging acquired
(2.2)
\u2013
Repayment of borrowings
1.8
0.5
Net cash after borrowings at the start of the year
100.2
85.9
Net cash after borrowings at the end of the year
83.8
100.2
Reconciliation of net cash after borrowings to Statement of Financial Position
2024 2023
\u00a3m \u00a3m
Bank loans at First Light Imaging
(0.8)
\u2013
Covid-19 loan at WiTec
(0.9)
(1.3)
Overdrafts
(12.3)
(11.2)
Cash and cash equivalents
97. 8
112.7
Net cash after borrowings at the end of the year
83.8
100.2
", "dimensions": { "concept": "oxfordinstrumentplc:DisclosureOfAdjustingItems", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-426": { "value": "
3 Research and development (R&D)
The total research and development spend by the Group is as follows:
Materials & Research &
Characterisation Discovery Total
2024 \u00a3m \u00a3m \u00a3m
R&D expense charged to the Consolidated Statement of Income
28.0
11.1
39.1
Less: depreciation of R&D-related fixed assets
\u2013
(0.2)
(0.2)
Add: amounts capitalised as fixed assets
0.2
\u2013
0.2
Less: amortisation and impairment of R&D costs
previously capitalised as intangibles
(0.5)
(0.1)
(0.6)
Add: amounts capitalised as intangible assets
0.1
0.6
0.7
Total cash spent on R&D during the year
27.8
11.4
39.2
Materials & Research &
Characterisation Discovery Total
2023 \u00a3m \u00a3m \u00a3m
R&D expense charged to the Consolidated Statement of Income
26.5
10.2
36.7
Less: depreciation of R&D-related fixed assets
\u2013
(0.3)
(0.3)
Add: amounts capitalised as fixed assets
\u2013
\u2013
\u2013
Less: amortisation of R&D costs previously capitalised as intangibles
(2.1)
(0.1)
(2.2)
Add: amounts capitalised as intangible assets
0.4
0.2
0.6
Total cash spent on R&D during the year
24.8
10.0
34.8
5 Auditor\u2019s remuneration
2024 2023
\u00a3\u2019000 \u00a3\u2019000
Audit of these Financial Statements
345
250
Amounts received by the auditor and its associates in respect of:
\u2013 Audit of Financial Statement of subsidiaries pursuant to legislation
757
542
\u2013 Audit-related assurance services
50
47
\u2013 Other assurance services
8
8
Total fees payable to the auditor and its associates
1,160
847
", "dimensions": { "concept": "ifrs-full:DisclosureOfExpensesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-458": { "value": "3 Research and development (R&D) The total research and development spend by the Group is as follows:
Materials & Research &
Characterisation Discovery Total
2024 \u00a3m \u00a3m \u00a3m
R&D expense charged to the Consolidated Statement of Income
28.0
11.1
39.1
Less: depreciation of R&D-related fixed assets
\u2013
(0.2)
(0.2)
Add: amounts capitalised as fixed assets
0.2
\u2013
0.2
Less: amortisation and impairment of R&D costs
previously capitalised as intangibles
(0.5)
(0.1)
(0.6)
Add: amounts capitalised as intangible assets
0.1
0.6
0.7
Total cash spent on R&D during the year
27.8
11.4
39.2
Materials & Research &
Characterisation Discovery Total
2023 \u00a3m \u00a3m \u00a3m
R&D expense charged to the Consolidated Statement of Income
26.5
10.2
36.7
Less: depreciation of R&D-related fixed assets
\u2013
(0.3)
(0.3)
Add: amounts capitalised as fixed assets
\u2013
\u2013
\u2013
Less: amortisation of R&D costs previously capitalised as intangibles
(2.1)
(0.1)
(2.2)
Add: amounts capitalised as intangible assets
0.4
0.2
0.6
Total cash spent on R&D during the year
24.8
10.0
34.8
", "dimensions": { "concept": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-427": { "value": "4 Employee information Personnel costs incurred during the year were as follows:
2024 2023
\u00a3m \u00a3m
Wages and salaries
131.5
121.9
Social security costs
15.5
17.1
Contributions to defined contribution plans (Note 24)
6.4
6.1
Defined benefit income (Note 24)
(1.0)
(1.1)
Charge in respect of employee share options
3.0
2.4
155.4
146.4
Directors\u2019 emoluments are disclosed in the Remuneration Report on pages 120 to 143 of this Report and Financial Statements
The average monthly number of people employed by the Group (including Directors and temporary employees) during the
year was as follows:
2024 2023
Number Number
Production
894
796
Sales and Marketing
555
495
Research and Development
487
456
Administration and Shared Services
308
280
2,244
2,027
", "dimensions": { "concept": "ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-459": { "value": "
5 Auditor\u2019s remuneration
2024 2023
\u00a3\u2019000 \u00a3\u2019000
Audit of these Financial Statements
345
250
Amounts received by the auditor and its associates in respect of:
\u2013 Audit of Financial Statement of subsidiaries pursuant to legislation
757
542
\u2013 Audit-related assurance services
50
47
\u2013 Other assurance services
8
8
Total fees payable to the auditor and its associates
1,160
847
", "dimensions": { "concept": "ifrs-full:DisclosureOfAuditorsRemunerationExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-460": { "value": "
6 Financial income
2024 2023
\u00a3m \u00a3m
Interest receivable
3.2
1.1
Interest credit on pension scheme net assets
1.5
1.6
4.7
2.7
", "dimensions": { "concept": "ifrs-full:DisclosureOfFinanceIncomeExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-428": { "value": "6 Financial income
2024 2023
\u00a3m \u00a3m
Interest receivable
3.2
1.1
Interest credit on pension scheme net assets
1.5
1.6
4.7
2.7
7 Financial expenditure
2024 2023
\u00a3m \u00a3m
Bank interest payable
0.9
0.7
Interest on lease liabilities
0.8
0.5
Unwind of discount on contingent consideration
\u2013
0.4
1.7
1.6
", "dimensions": { "concept": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-491": { "value": "6 Financial income
2024 2023
\u00a3m \u00a3m
Interest receivable
3.2
1.1
Interest credit on pension scheme net assets
1.5
1.6
4.7
2.7
", "dimensions": { "concept": "ifrs-full:DisclosureOfInterestIncomeExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-486": { "value": "6 Financial income
2024 2023
\u00a3m \u00a3m
Interest receivable
3.2
1.1
Interest credit on pension scheme net assets
1.5
1.6
4.7
2.7
7 Financial expenditure
2024 2023
\u00a3m \u00a3m
Bank interest payable
0.9
0.7
Interest on lease liabilities
0.8
0.5
Unwind of discount on contingent consideration
\u2013
0.4
1.7
1.6
", "dimensions": { "concept": "ifrs-full:DisclosureOfInterestIncomeExpenseExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-461": { "value": "
7 Financial expenditure
2024 2023
\u00a3m \u00a3m
Bank interest payable
0.9
0.7
Interest on lease liabilities
0.8
0.5
Unwind of discount on contingent consideration
\u2013
0.4
1.7
1.6
", "dimensions": { "concept": "ifrs-full:DisclosureOfFinanceCostExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-492": { "value": "7 Financial expenditure
2024 2023
\u00a3m \u00a3m
Bank interest payable
0.9
0.7
Interest on lease liabilities
0.8
0.5
Unwind of discount on contingent consideration
\u2013
0.4
1.7
1.6
", "dimensions": { "concept": "ifrs-full:DisclosureOfInterestExpenseExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-429": { "value": "8 Taxation Income tax expense
2024 2023
\u00a3m \u00a3m
Recognised in the Consolidated Statement of Income
Current tax expense
Current year
17.1
10.2
Adjustment in respect of prior years
1.1
0.3
18.2
10.5
Deferred tax expense
Origination and reversal of temporary differences
1.6
5.1
Adjustment in respect of prior years
0.8
(0.7)
2.4
4.4
Total tax expense
20.6
14.9
Reconciliation of effective tax rate
Profit before income tax
71.3
73.5
Income tax using the weighted average statutory tax rate of 25% (2023: 21%)
17.8
15.4
Effect of:
Tax rates other than the weighted average statutory rate
(0.2)
0.3
Change in rate at which deferred tax recognised
\u2013
1.0
Transaction costs, deferred consideration and impairments not deductible for tax
0.4
\u2013
Non-taxable income and expenses
0.7
(1.4)
Adjustment in respect of prior years
1.9
(0.4)
Total tax expense
20.6
14.9
Taxation credit recognised directly in other comprehensive income
Current tax \u2013 relating to employee benefits
(2.1)
\u2013
Deferred tax \u2013 relating to employee benefits
(2.7)
(9.7)
Taxation (credit)/charge recognised directly in equity
Current tax \u2013 relating to share options
(0.6)
\u2013
Deferred tax \u2013 relating to share options
1.1
(0.7)
The rate of UK corporation tax increased to 25% from 1 April 2023. The UK deferr ed tax assets and liabilities have been calculated based on the enacted rate of 25%. The Group carries tax provisions in relation to uncertain tax positions arising from the possible outcome of negotiations with tax authorities. The provision is calculated using the expected value method from a range of possibilities and assumes that the tax authorities have full knowledge of the facts. Such provisions reflect the geographical spread of the Group\u2019s operations and the variety of jurisdictions in which it carries out its activities Deferred tax
Property,
plant and Employee Intangible
equipment Inventory benefits assets Tax losses Other Total
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Balance at 1 April 2022
(0.9)
3.2
( 7. 8)
(7.0)
6.7
4.1
(1.7)
Recognised in income
(3.1)
0.4
(2.5)
2.0
(1.5)
0.3
(4.4)
Recognised in other comprehensive income
\u2013
\u2013
9.7
\u2013
\u2013
\u2013
9.7
Recognised directly in equity
\u2013
\u2013
0.7
\u2013
\u2013
\u2013
0.7
Effect of movements in foreign exchange rates
\u2013
0.1
\u2013
\u2013
0.3
\u2013
0.4
Balance at 31 March 2023
(4.0)
3.7
0.1
(5.0)
5.5
4.4
4.7
Recognised in income
(3.4)
0.7
1.0
1.4
(2.1)
\u2013
(2.4)
Recognised in other comprehensive income
\u2013
\u2013
2.7
\u2013
\u2013
\u2013
2.7
Recognised directly in equity
\u2013
\u2013
(1.1)
\u2013
\u2013
\u2013
(1.1)
Acquired on business combination
\u2013
\u2013
\u2013
(2.5)
\u2013
\u2013
(2.5)
Effect of movements in foreign exchange rates
(0.1)
(0.1)
(0.3)
\u2013
\u2013
(0.1)
(0.6)
Balance at 31 March 2024
(7.5)
4.3
2.4
(6.1)
3.4
4.3
0.8
The deferred tax category of \u2018Other\u2019 includes deferred tax recognised on accounting general liability accruals/provisions, deferred revenue and bad debts. Deferred tax is recognised on provisions made against inventory on which tax relief has not yet been granted. Certain deferred tax assets and liabilities have been offset as follows:
Assets
Liabilities
Net
2024 2023 2024 2023 2024 2023
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Gross assets/(liabilities)
15.6
15.6
(14.8)
(10.9)
0.8
4.7
Offset
(1.9)
(3.1)
1.9
3.1
\u2013
\u2013
Net assets/(liabilities)
13.7
12.5
(12.9)
(7.8)
0.8
4.7
Deferred tax assets have not been recognised in respect of the following items:
2024 2023
\u00a3m \u00a3m
Tax losses
0.5
0.3
The tax losses and the deductible temporary differences do not expire under current tax legislation. Deferred tax assets recognised on tax losses relate to gross unrecognised losses of \u00a32.3m (2023: \u00a31.1m). Deferred tax assets have not been recognised in respect of these items as it is not probable that future taxable profits will be available in the subsidiaries concerned against which the Group can utilise the brought forward tax losses. No deferred tax liability has been recognised in respect of \u00a359.2m (2023: \u00a350.6m) of undistributed earnings of overseas subsidiaries since the majority of such distributions would not be taxable. In other cases the Group considers that it is able to control the timing of remittances so that any tax is not expected to arise in the foreseeable future .", "dimensions": { "concept": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-462": { "value": "deferr Deferred tax
Property,
plant and Employee Intangible
equipment Inventory benefits assets Tax losses Other Total
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Balance at 1 April 2022
(0.9)
3.2
( 7. 8)
(7.0)
6.7
4.1
(1.7)
Recognised in income
(3.1)
0.4
(2.5)
2.0
(1.5)
0.3
(4.4)
Recognised in other comprehensive income
\u2013
\u2013
9.7
\u2013
\u2013
\u2013
9.7
Recognised directly in equity
\u2013
\u2013
0.7
\u2013
\u2013
\u2013
0.7
Effect of movements in foreign exchange rates
\u2013
0.1
\u2013
\u2013
0.3
\u2013
0.4
Balance at 31 March 2023
(4.0)
3.7
0.1
(5.0)
5.5
4.4
4.7
Recognised in income
(3.4)
0.7
1.0
1.4
(2.1)
\u2013
(2.4)
Recognised in other comprehensive income
\u2013
\u2013
2.7
\u2013
\u2013
\u2013
2.7
Recognised directly in equity
\u2013
\u2013
(1.1)
\u2013
\u2013
\u2013
(1.1)
Acquired on business combination
\u2013
\u2013
\u2013
(2.5)
\u2013
\u2013
(2.5)
Effect of movements in foreign exchange rates
(0.1)
(0.1)
(0.3)
\u2013
\u2013
(0.1)
(0.6)
Balance at 31 March 2024
(7.5)
4.3
2.4
(6.1)
3.4
4.3
0.8
The deferred tax category of \u2018Other\u2019 includes deferred tax recognised on accounting general liability accruals/provisions, deferred revenue and bad debts. Deferred tax is recognised on provisions made against inventory on which tax relief has not yet been granted. Certain deferred tax assets and liabilities have been offset as follows:
Assets
Liabilities
Net
2024 2023 2024 2023 2024 2023
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Gross assets/(liabilities)
15.6
15.6
(14.8)
(10.9)
0.8
4.7
Offset
(1.9)
(3.1)
1.9
3.1
\u2013
\u2013
Net assets/(liabilities)
13.7
12.5
(12.9)
(7.8)
0.8
4.7
Deferred tax assets have not been recognised in respect of the following items:
2024 2023
\u00a3m \u00a3m
Tax losses
0.5
0.3
The tax losses and the deductible temporary differences do not expire under current tax legislation. Deferred tax assets recognised on tax losses relate to gross unrecognised losses of \u00a32.3m (2023: \u00a31.1m). Deferred tax assets have not been recognised in respect of these items as it is not probable that future taxable profits will be available in the subsidiaries concerned against which the Group can utilise the brought forward tax losses. No deferred tax liability has been recognised in respect of \u00a359.2m (2023: \u00a350.6m) of undistributed earnings of overseas subsidiaries since the majority of such distributions would not be taxable. In other cases the Group considers that it is able to control the timing of remittances so that any tax is not expected to arise in the foreseeable future ", "dimensions": { "concept": "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-487": { "value": "deferr Deferred tax
Property,
plant and Employee Intangible
equipment Inventory benefits assets Tax losses Other Total
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Balance at 1 April 2022
(0.9)
3.2
( 7. 8)
(7.0)
6.7
4.1
(1.7)
Recognised in income
(3.1)
0.4
(2.5)
2.0
(1.5)
0.3
(4.4)
Recognised in other comprehensive income
\u2013
\u2013
9.7
\u2013
\u2013
\u2013
9.7
Recognised directly in equity
\u2013
\u2013
0.7
\u2013
\u2013
\u2013
0.7
Effect of movements in foreign exchange rates
\u2013
0.1
\u2013
\u2013
0.3
\u2013
0.4
Balance at 31 March 2023
(4.0)
3.7
0.1
(5.0)
5.5
4.4
4.7
Recognised in income
(3.4)
0.7
1.0
1.4
(2.1)
\u2013
(2.4)
Recognised in other comprehensive income
\u2013
\u2013
2.7
\u2013
\u2013
\u2013
2.7
Recognised directly in equity
\u2013
\u2013
(1.1)
\u2013
\u2013
\u2013
(1.1)
Acquired on business combination
\u2013
\u2013
\u2013
(2.5)
\u2013
\u2013
(2.5)
Effect of movements in foreign exchange rates
(0.1)
(0.1)
(0.3)
\u2013
\u2013
(0.1)
(0.6)
Balance at 31 March 2024
(7.5)
4.3
2.4
(6.1)
3.4
4.3
0.8
The deferred tax category of \u2018Other\u2019 includes deferred tax recognised on accounting general liability accruals/provisions, deferred revenue and bad debts. Deferred tax is recognised on provisions made against inventory on which tax relief has not yet been granted. Certain deferred tax assets and liabilities have been offset as follows:
Assets
Liabilities
Net
2024 2023 2024 2023 2024 2023
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Gross assets/(liabilities)
15.6
15.6
(14.8)
(10.9)
0.8
4.7
Offset
(1.9)
(3.1)
1.9
3.1
\u2013
\u2013
Net assets/(liabilities)
13.7
12.5
(12.9)
(7.8)
0.8
4.7
Deferred tax assets have not been recognised in respect of the following items:
2024 2023
\u00a3m \u00a3m
Tax losses
0.5
0.3
The tax losses and the deductible temporary differences do not expire under current tax legislation. Deferred tax assets recognised on tax losses relate to gross unrecognised losses of \u00a32.3m (2023: \u00a31.1m). Deferred tax assets have not been recognised in respect of these items as it is not probable that future taxable profits will be available in the subsidiaries concerned against which the Group can utilise the brought forward tax losses. No deferred tax liability has been recognised in respect of \u00a359.2m (2023: \u00a350.6m) of undistributed earnings of overseas subsidiaries since the majority of such distributions would not be taxable. In other cases the Group considers that it is able to control the timing of remittances so that any tax is not expected to arise in the foreseeable future ", "dimensions": { "concept": "ifrs-full:DisclosureOfTaxReceivablesAndPayablesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-431": { "value": "
9 Dividends
The following dividends per share were paid by the Group:
2024 2023
pence pence
Previous period final dividend
14.9
13.7
Current period interim dividend
4.9
4.6
19.8
18.3
The following dividends per share were proposed by the Group in respect of each accounting period presented:
2024 2023
pence pence
Interim dividend
4.9
4.6
Final dividend
15.9
14.9
20. 8
19.5
The final dividend for the year to 31 March 2023 of 14.9 pence per share was approved by shareholders at the Annual General
Meeting on 19 September 2023 and was paid on 12 October 2023. The interim dividend for the year to 31 March 2024 of 4.9
pence was approved by a sub-committee of the Board on 13 November 2023 and was paid on 12 January 2024.
The proposed final dividend for the year ended 31 March 2024 of 15.9 pence per share was not provided at the year end and
is subject to shareholder approval at the Annual General Meeting on 25 July 2024. It is expected to be paid on 20 August
2024, to shareholders on the register on the record date of 12 July 2024, with an ex-dividend date of 11 July 2024 and with the
last date of election for the Dividend Reinvestment Plan (DRIP) being 30 July 2024.
", "dimensions": { "concept": "ifrs-full:DisclosureOfDividendsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-463": { "value": "20.8", "decimals": 4, "dimensions": { "concept": "ifrs-full:DividendsRecognisedAsDistributionsToOwnersPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-464": { "value": "19.5", "decimals": 4, "dimensions": { "concept": "ifrs-full:DividendsRecognisedAsDistributionsToOwnersPerShare", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00", "unit": "iso4217:GBP/xbrli:shares" } }, "fact-430": { "value": "
10 Earnings per share
Basic earnings per ordinary share (EPS) is calculated by dividing the profit attributable to equity shareholders of the parent
by the weighted average number of ordinary shares in issue during the year, excluding ordinary shares held by the Employee
Benefit Trust, which have been treated as if they had been cancelled.
For the purposes of calculating diluted and diluted adjusted EPS, the weighted average number of ordinary shares is adjusted
to include the weighted average number of ordinary shares that would be issued on the conversion of all potentially dilutive
ordinary shares expected to vest, relating to the company\u2019s share-based payment plans. Potential ordinary shares are only
treated as dilutive when their conversion to ordinary shares would decrease EPS.
The following table shows the weight average number of shares used in the calculation and the effect of share options on the
calculation of diluted earnings per share:
2024 2023
Shares million Shares million
Weighted average number of shares outstanding
57.9
57.7
Less: weighted average number of shares held by Employee Benefit Trust
(0.1)
\u2013
Weighted average number of shares used in calculation of basic earnings per share
57. 8
57.7
Effect of shares under option
0.8
0.7
Number of ordinary shares per diluted earnings per share calculations
58.6
58.4
Basic and diluted EPS are based on the profit for the period attributable to equity shareholders of the parent, as reported
in the Consolidated Statement of Income. Adjusted and diluted adjusted EPS are based on adjusted profit for the period,
as reported in Note 2:
2024
2023
\u00a3m
Pence
\u00a3m
Pence
Profit attributable to equity shareholders of the parent/Basic EPS
50.7
87.7
58.6
101.6
Total underlying adjustments to profit before tax (Note 2)
12.0
20.8
8.5
14.7
Related tax effects
0.3
0.5
(2.1)
(3.6)
Adjusted profit attributable to equity shareholders
of the parent/adjusted EPS
63.0
109.0
65.0
112.7
Diluted basic EPS
86.5
100.3
Diluted adjusted EPS
107. 5
111.3
", "dimensions": { "concept": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-432": { "value": "11 Acquisitions Acquisition of First Light Imaging On 9 January 2024, the Group acquired 100% of the issued share capital of First Light Imaging SAS (\u2018First Light Imaging\u2019) on a cash-free, debt-free basis for consideration of \u20ac18.7m (\u00a316.0m), of which \u20ac3.0m (\u00a32.5m) was conditional on trading performance over a period of 12 months from the acquisition. The conditions for the deferred consideration were meeting certain revenue, order and margin thresholds. In the calculations below, it has been assumed that these thresholds have been met. The book and provisional fair value of the assets and liabilities acquired is given in the table below. Provisional values have been used for all assets and liabilities, including deferred tax, because the initial acquisition accounting is incomplete at the date of this report. Fair value adjustments have been made to better align the accounting policies of the acquired business with the Group accounting policies and to reflect the fair value of assets and liabilities acquired.
Provisional Provisional fair
Book value adjustments value
\u00a3m \u00a3m \u00a3m
Intangible assets
0.1
10.3
10.4
Property, plant and equipment
0.5
\u2013
0.5
Right-of-use assets
0.7
\u2013
0.7
Inventories
1.7
\u2013
1.7
Trade and other receivables
2.9
\u2013
2.9
Deferred tax
\u2013
(2.6)
(2.6)
Trade and other payables
(2.1)
\u2013
(2.1)
Lease liabilities
(0.7)
\u2013
(0.7)
Bank loans
(2.2)
\u2013
(2.2)
Cash
0.6
\u2013
0.6
Net assets acquired
1.5
7.7
9.2
Goodwill
5.4
Total consideration
14.6
Net debt acquired
1.6
Deferred consideration after discounting to transaction date
(2.8)
Net cash outflow relating to the acquisition
13.4
The goodwill arising is considered to represent the value of the acquired workforce and the value of technology that has not been individually fair valued. Acquisition-related costs in the year of \u00a30.7m were expensed to the Consolidated Statement of Income as an adjusting item in the administration and shared services cost line. There were no acquisition-related costs in the prior year. The acquisition contributed revenue of \u00a30.6m, adjusted operating loss of \u00a30.6m and a statutory loss before tax of \u00a30.6m to the Group\u2019s profit for the prior year. If the acquisition had occurred on the first day of the year the acquisition would have contributed revenue of \u00a35.7m, adjusted operating profit of \u00a30.3m and a statutory result before tax of \u00a30.3m in the year. Acquisition of WITec On 31 August 2021, the Group acquired 100% of the issued share capital of WITec Wissenschaftliche Instrumente und Technologie GmbH (\u2018WITec\u2019) on a cash-free, debt-free basis for consideration of \u20ac42m (\u00a336.0m), of which \u20ac5m (\u00a34.3m) was conditional on trading performance over a period of 12 months from the acquisition. The conditions for the deferred consideration were meeting certain revenue, order and margin thresholds. In the prior year, contingent consideration of \u00a34.8m was paid based on the performance of the Oxford Instruments WITec business in the year to 31 August 2022. The difference of \u00a30.5m between contingent consideration provided at acquisition and that paid in January 2023 was due to an adjustment to the net assets purchased", "dimensions": { "concept": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-433": { "value": "
12 Property, plant and equipment
Land and Plant and Fixtures and
buildings equipment fittings Total
\u00a3m \u00a3m \u00a3m \u00a3m
Cost
Balance at 1 April 2022
21.8
40.4
8.3
70.5
Additions
24.2
6.0
2.1
32.3
Disposals
(0.1)
(3.7)
(0.3)
(4.1)
Exchange differences
\u2013
0.4
0.1
0.5
Balance at 31 March 2023 and 1 April 2023
45.9
43.1
10.2
99.2
Additions \u2013 business combinations
0.1
0.3
0.1
0.5
Additions
15.8
9.7
1.5
27.0
Disposals
(0.6)
(0.5)
(0.1)
(1.2)
Exchange differences
0.3
0.4
(0.2)
0.5
Balance at 31 March 2024
61.5
53.0
11.5
126.0
Depreciation and impairment losses
Balance at 1 April 2022
5.5
27.4
5.9
38.8
Depreciation charge for the year
0.4
4.0
0.4
4.8
Disposals
\u2013
(3.7)
(0.3)
(4.0)
Exchange differences
\u2013
0.3
\u2013
0.3
Balance at 31 March 2023 and 1 April 2023
5.9
28.0
6.0
39.9
Depreciation charge for the year
0.5
4.2
0.6
5.3
Disposals
(0.5)
(0.5)
(0.1)
(1.1)
Exchange differences
\u2013
1.4
\u2013
1.4
Balance at 31 March 2024
5.9
33.1
6.5
45.5
Carrying amounts
Balance at 1 April 2022
16.3
13.0
2.4
31.7
Balance at 31 March 2023 and 1 April 2023
40.0
15.1
4.2
59.3
Balance at 31 March 2024
55.6
19.9
5.0
80.5
Included within land and buildings are assets under construction with additions in the year of \u00a312.2m and a carrying amount
of \u00a333.2m (2023: \u00a331.3m).
", "dimensions": { "concept": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-465": { "value": "12 Property, plant and equipment
Land and Plant and Fixtures and
buildings equipment fittings Total
\u00a3m \u00a3m \u00a3m \u00a3m
Cost
Balance at 1 April 2022
21.8
40.4
8.3
70.5
Additions
24.2
6.0
2.1
32.3
Disposals
(0.1)
(3.7)
(0.3)
(4.1)
Exchange differences
\u2013
0.4
0.1
0.5
Balance at 31 March 2023 and 1 April 2023
45.9
43.1
10.2
99.2
Additions \u2013 business combinations
0.1
0.3
0.1
0.5
Additions
15.8
9.7
1.5
27.0
Disposals
(0.6)
(0.5)
(0.1)
(1.2)
Exchange differences
0.3
0.4
(0.2)
0.5
Balance at 31 March 2024
61.5
53.0
11.5
126.0
Depreciation and impairment losses
Balance at 1 April 2022
5.5
27.4
5.9
38.8
Depreciation charge for the year
0.4
4.0
0.4
4.8
Disposals
\u2013
(3.7)
(0.3)
(4.0)
Exchange differences
\u2013
0.3
\u2013
0.3
Balance at 31 March 2023 and 1 April 2023
5.9
28.0
6.0
39.9
Depreciation charge for the year
0.5
4.2
0.6
5.3
Disposals
(0.5)
(0.5)
(0.1)
(1.1)
Exchange differences
\u2013
1.4
\u2013
1.4
Balance at 31 March 2024
5.9
33.1
6.5
45.5
Carrying amounts
Balance at 1 April 2022
16.3
13.0
2.4
31.7
Balance at 31 March 2023 and 1 April 2023
40.0
15.1
4.2
59.3
Balance at 31 March 2024
55.6
19.9
5.0
80.5
Included within land and buildings are assets under construction with additions in the year of \u00a312.2m and a carrying amount of \u00a333.2m (2023: \u00a331.3m).", "dimensions": { "concept": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-488": { "value": "13 Intangible assets
Customer- Technology- Development Development
related related costs costs
acquired acquired acquired internally
Goodwill intangibles intangibles intangibles generated Software Total
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Cost
Balance at 1 April 2022
122.6
33.1
98.2
1.8
49.2
4.3
309.2
Additions \u2013 internally generated
\u2013
\u2013
\u2013
\u2013
0.6
\u2013
0.6
Disposals
\u2013
\u2013
\u2013
\u2013
(12.5)
\u2013
(12.5)
Effect of movements in foreign
exchange rates
2.0
1.0
2.8
\u2013
\u2013
\u2013
5.8
Balance at 31 March 2023
and 1 April 2023
124.6
34.1
101.0
1.8
37. 3
4.3
303.1
Additions \u2013 business combinations
5.4
0.2
10.1
\u2013
\u2013
0.1
15.8
Additions \u2013 internally generated
\u2013
\u2013
\u2013
\u2013
0.7
0.2
0.9
Disposals
\u2013
\u2013
\u2013
\u2013
(2.8)
\u2013
(2.8)
Effect of movements in foreign
exchange rates
(0.8)
(0.4)
(1.3)
\u2013
\u2013
\u2013
(2.5)
Balance at 31 March 2024
129.2
33.9
109.8
1.8
35.2
4.6
314.5
Amortisation and impairment losses
Balance at 1 April 2022
22.2
24.8
71.9
1.5
45.2
2.9
168.5
Amortisation and impairment charged
\u2013
1.4
7.8
0.1
2.2
\u2013
11.5
Disposals \u2013 other
Effect of movements in foreign
\u2013
\u2013
\u2013
\u2013
(12.5)
\u2013
(12.5)
exchange rates
0.7
0.8
1.9
\u2013
\u2013
0.1
3.5
Balance at 31 March 2023
and 1 April 2023
22.9
27.0
81.6
1.6
34.9
3.0
171.0
Amortisation and impairment charged
\u2013
1.2
7.9
\u2013
0.6
0.1
9.8
Disposals
\u2013
\u2013
\u2013
\u2013
(2.8)
\u2013
(2.8)
Effect of movements in foreign
exchange rates
(0.3)
(0.4)
(0.6)
(0.3)
0.1
0.1
(1.4)
Balance at 31 March 2024
22.6
27.8
88.9
1.3
32.8
3.2
176.6
Carrying amounts
Balance at 1 April 2022
100.4
8.3
26.3
0.3
4.0
1.4
140.7
Balance at 31 March 2023
and 1 April 2023
101.7
7.1
19.4
0.2
2.4
1.3
132.1
Balance at 31 March 2024
106.6
6.1
20.9
0.5
2.4
1.4
137.9
During the year the Group made impairments of \u00a3nil (2023: \u00a30.8m) in respect of capitalised development costs. Further information can be found in Note 1 The following intangible assets are considered material by the Directors as they represent 98% (2023: 97%) of total acquired intangible assets:
2024
2023
Remaining
Amortisation amortisation
\u00a3m period years
period years
\u00a3m
Trademarks \u2013 Andor
3.9
15.0
4.8
4.7
Technology, know\u2013how and patents \u2013 Andor:
\u2013 Product related
7.3
12.0
1.8
11.9
\u2013 Software related
\u2013
10.0
\u2013
0.9
Trademarks \u2013 WITec
2.0
10.0
7.6
2.3
Technology, know\u2013how and patents \u2013 WITec
2.4
5.0
2.6
3.6
Trademarks \u2013 First Light Imaging
0.2
2.0
1.8
\u2013
Technology, know\u2013how and patents \u2013 First Light Imaging:
\u2013 OCAM
0.3
12.0
11.8
\u2013
\u2013 C-RED
9.3
14.0
13.8
\u2013
Technology, know\u2013how and patents \u2013 Asylum
1.0
12.0
0.7
2.4
Goodwill acquired in a business combination is allocated, at acquisition, to the cash-generating units (CGUs) that are expected to benefit from that business combination. The carrying amount of goodwill was allocated to individual CGUs as follows:
2024 2023
\u00a3m \u00a3m
Materials & Characterisation
NanoAnalysis
9.9
10.0
Magnetic Resonance
2.3
2.3
WITec
21.0
21.5
Research & Discovery
Andor
66.7
61.2
NanoScience
6.7
6.7
106.6
101.7
In the current year, Andor includes a provisional goodwill amount of \u00a35.4m relating to the acquisition of First Light Imaging as shown in Note 11. All other movements in the year relate to changes in exchange rates. The Group tests goodwill annually for impairment, or more frequently if there are indications that goodwill might be impaired. Accounting standards require an impairment test to be carried out by determining the recoverable amount of each CGU which contains goodwill. The recoverable amount is calculated as the higher of the fair value less costs to sell or the value in use of the CGU. In the Group\u2019s case, the recoverable amount is based on value in use calculations. Value in use is calculated by discounting expected future cash flows and in particular Board-approved five-year cash flow forecasts, prepared by the management of each CGU and reviewed and amended by Group management as necessary, together with 2.5% per annum growth for the subsequent 20 years. This rate was considered to be at or below long-term market trends for the Group\u2019s businesses.
Key assumptions
The key assumptions are those regarding discount rates and growth rates.
The growth rates are at or below the Group\u2019s view on long-term trends within its markets. Changes in selling prices and direct
costs are based on past practices and expectations of future changes in the market.
The post-tax weighted average costs of capital used for Materials & Characterisation and Research & Discovery in
impairment testing are 13.1%-13.6% (2023: 12.8%-13.3%) and 13.1%-13.6% (2023: 12.8%-13.3%) respectively, in line with the
risk associated with each of the business segments. Management has estimated these discount rates by reference to past
experience and an industry average weighted cost of capital as adjusted for appropriate risk factors reflecting current
economic circumstances and the risk profiles of each CGU.
Sensitivity analysis
The Group\u2019s estimate of impairments are most sensitive to changes in the discount rate and forecast growth rate. Sensitivity
analysis has been carried out by reference to both of these assumptions. This demonstrated that a 460 basis point increase
in the discount rate would be required in order to eliminate the headroom of \u00a327.1m in the recently acquired WITec business
\u2013 along with a 20% deterioration from the five-year forecast. Similarly, a reduction in the growth rate to -6.2% \u2013 again, along
with a 20% deterioration from the five-year forecast, would be required in order to result in an impairment in that business. No
reasonably possible change in assumptions would result in an impairment in the other businesses .
", "dimensions": { "concept": "ifrs-full:DisclosureOfGoodwillExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-466": { "value": "13 Intangible assets
Customer- Technology- Development Development
related related costs costs
acquired acquired acquired internally
Goodwill intangibles intangibles intangibles generated Software Total
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Cost
Balance at 1 April 2022
122.6
33.1
98.2
1.8
49.2
4.3
309.2
Additions \u2013 internally generated
\u2013
\u2013
\u2013
\u2013
0.6
\u2013
0.6
Disposals
\u2013
\u2013
\u2013
\u2013
(12.5)
\u2013
(12.5)
Effect of movements in foreign
exchange rates
2.0
1.0
2.8
\u2013
\u2013
\u2013
5.8
Balance at 31 March 2023
and 1 April 2023
124.6
34.1
101.0
1.8
37. 3
4.3
303.1
Additions \u2013 business combinations
5.4
0.2
10.1
\u2013
\u2013
0.1
15.8
Additions \u2013 internally generated
\u2013
\u2013
\u2013
\u2013
0.7
0.2
0.9
Disposals
\u2013
\u2013
\u2013
\u2013
(2.8)
\u2013
(2.8)
Effect of movements in foreign
exchange rates
(0.8)
(0.4)
(1.3)
\u2013
\u2013
\u2013
(2.5)
Balance at 31 March 2024
129.2
33.9
109.8
1.8
35.2
4.6
314.5
Amortisation and impairment losses
Balance at 1 April 2022
22.2
24.8
71.9
1.5
45.2
2.9
168.5
Amortisation and impairment charged
\u2013
1.4
7.8
0.1
2.2
\u2013
11.5
Disposals \u2013 other
Effect of movements in foreign
\u2013
\u2013
\u2013
\u2013
(12.5)
\u2013
(12.5)
exchange rates
0.7
0.8
1.9
\u2013
\u2013
0.1
3.5
Balance at 31 March 2023
and 1 April 2023
22.9
27.0
81.6
1.6
34.9
3.0
171.0
Amortisation and impairment charged
\u2013
1.2
7.9
\u2013
0.6
0.1
9.8
Disposals
\u2013
\u2013
\u2013
\u2013
(2.8)
\u2013
(2.8)
Effect of movements in foreign
exchange rates
(0.3)
(0.4)
(0.6)
(0.3)
0.1
0.1
(1.4)
Balance at 31 March 2024
22.6
27.8
88.9
1.3
32.8
3.2
176.6
Carrying amounts
Balance at 1 April 2022
100.4
8.3
26.3
0.3
4.0
1.4
140.7
Balance at 31 March 2023
and 1 April 2023
101.7
7.1
19.4
0.2
2.4
1.3
132.1
Balance at 31 March 2024
106.6
6.1
20.9
0.5
2.4
1.4
137.9
During the year the Group made impairments of \u00a3nil (2023: \u00a30.8m) in respect of capitalised development costs. Further information can be found in Note 1 The following intangible assets are considered material by the Directors as they represent 98% (2023: 97%) of total acquired intangible assets:
2024
2023
Remaining
Amortisation amortisation
\u00a3m period years
period years
\u00a3m
Trademarks \u2013 Andor
3.9
15.0
4.8
4.7
Technology, know\u2013how and patents \u2013 Andor:
\u2013 Product related
7.3
12.0
1.8
11.9
\u2013 Software related
\u2013
10.0
\u2013
0.9
Trademarks \u2013 WITec
2.0
10.0
7.6
2.3
Technology, know\u2013how and patents \u2013 WITec
2.4
5.0
2.6
3.6
Trademarks \u2013 First Light Imaging
0.2
2.0
1.8
\u2013
Technology, know\u2013how and patents \u2013 First Light Imaging:
\u2013 OCAM
0.3
12.0
11.8
\u2013
\u2013 C-RED
9.3
14.0
13.8
\u2013
Technology, know\u2013how and patents \u2013 Asylum
1.0
12.0
0.7
2.4
Goodwill acquired in a business combination is allocated, at acquisition, to the cash-generating units (CGUs) that are expected to benefit from that business combination. The carrying amount of goodwill was allocated to individual CGUs as follows:
2024 2023
\u00a3m \u00a3m
Materials & Characterisation
NanoAnalysis
9.9
10.0
Magnetic Resonance
2.3
2.3
WITec
21.0
21.5
Research & Discovery
Andor
66.7
61.2
NanoScience
6.7
6.7
106.6
101.7
In the current year, Andor includes a provisional goodwill amount of \u00a35.4m relating to the acquisition of First Light Imaging as shown in Note 11. All other movements in the year relate to changes in exchange rates. The Group tests goodwill annually for impairment, or more frequently if there are indications that goodwill might be impaired. Accounting standards require an impairment test to be carried out by determining the recoverable amount of each CGU which contains goodwill. The recoverable amount is calculated as the higher of the fair value less costs to sell or the value in use of the CGU. In the Group\u2019s case, the recoverable amount is based on value in use calculations. Value in use is calculated by discounting expected future cash flows and in particular Board-approved five-year cash flow forecasts, prepared by the management of each CGU and reviewed and amended by Group management as necessary, together with 2.5% per annum growth for the subsequent 20 years. This rate was considered to be at or below long-term market trends for the Group\u2019s businesses. Key assumptions The key assumptions are those regarding discount rates and growth rates. The growth rates are at or below the Group\u2019s view on long-term trends within its markets. Changes in selling prices and direct costs are based on past practices and expectations of future changes in the market. The post-tax weighted average costs of capital used for Materials & Characterisation and Research & Discovery in impairment testing are 13.1%-13.6% (2023: 12.8%-13.3%) and 13.1%-13.6% (2023: 12.8%-13.3%) respectively, in line with the risk associated with each of the business segments. Management has estimated these discount rates by reference to past experience and an industry average weighted cost of capital as adjusted for appropriate risk factors reflecting current economic circumstances and the risk profiles of each CGU. Sensitivity analysis The Group\u2019s estimate of impairments are most sensitive to changes in the discount rate and forecast growth rate. Sensitivity analysis has been carried out by reference to both of these assumptions. This demonstrated that a 460 basis point increase in the discount rate would be required in order to eliminate the headroom of \u00a327.1m in the recently acquired WITec business \u2013 along with a 20% deterioration from the five-year forecast. Similarly, a reduction in the growth rate to -6.2% \u2013 again, along with a 20% deterioration from the five-year forecast, would be required in order to result in an impairment in that business. No reasonably possible change in assumptions would result in an impairment in the other businesses ", "dimensions": { "concept": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-434": { "value": "13 Intangible assets
Customer- Technology- Development Development
related related costs costs
acquired acquired acquired internally
Goodwill intangibles intangibles intangibles generated Software Total
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Cost
Balance at 1 April 2022
122.6
33.1
98.2
1.8
49.2
4.3
309.2
Additions \u2013 internally generated
\u2013
\u2013
\u2013
\u2013
0.6
\u2013
0.6
Disposals
\u2013
\u2013
\u2013
\u2013
(12.5)
\u2013
(12.5)
Effect of movements in foreign
exchange rates
2.0
1.0
2.8
\u2013
\u2013
\u2013
5.8
Balance at 31 March 2023
and 1 April 2023
124.6
34.1
101.0
1.8
37. 3
4.3
303.1
Additions \u2013 business combinations
5.4
0.2
10.1
\u2013
\u2013
0.1
15.8
Additions \u2013 internally generated
\u2013
\u2013
\u2013
\u2013
0.7
0.2
0.9
Disposals
\u2013
\u2013
\u2013
\u2013
(2.8)
\u2013
(2.8)
Effect of movements in foreign
exchange rates
(0.8)
(0.4)
(1.3)
\u2013
\u2013
\u2013
(2.5)
Balance at 31 March 2024
129.2
33.9
109.8
1.8
35.2
4.6
314.5
Amortisation and impairment losses
Balance at 1 April 2022
22.2
24.8
71.9
1.5
45.2
2.9
168.5
Amortisation and impairment charged
\u2013
1.4
7.8
0.1
2.2
\u2013
11.5
Disposals \u2013 other
Effect of movements in foreign
\u2013
\u2013
\u2013
\u2013
(12.5)
\u2013
(12.5)
exchange rates
0.7
0.8
1.9
\u2013
\u2013
0.1
3.5
Balance at 31 March 2023
and 1 April 2023
22.9
27.0
81.6
1.6
34.9
3.0
171.0
Amortisation and impairment charged
\u2013
1.2
7.9
\u2013
0.6
0.1
9.8
Disposals
\u2013
\u2013
\u2013
\u2013
(2.8)
\u2013
(2.8)
Effect of movements in foreign
exchange rates
(0.3)
(0.4)
(0.6)
(0.3)
0.1
0.1
(1.4)
Balance at 31 March 2024
22.6
27.8
88.9
1.3
32.8
3.2
176.6
Carrying amounts
Balance at 1 April 2022
100.4
8.3
26.3
0.3
4.0
1.4
140.7
Balance at 31 March 2023
and 1 April 2023
101.7
7.1
19.4
0.2
2.4
1.3
132.1
Balance at 31 March 2024
106.6
6.1
20.9
0.5
2.4
1.4
137.9
During the year the Group made impairments of \u00a3nil (2023: \u00a30.8m) in respect of capitalised development costs. Further information can be found in Note 1
The following intangible assets are considered material by the Directors as they represent 98% (2023: 97%) of total acquired
intangible assets:
2024
2023
Remaining
Amortisation amortisation
\u00a3m period years
period years
\u00a3m
Trademarks \u2013 Andor
3.9
15.0
4.8
4.7
Technology, know\u2013how and patents \u2013 Andor:
\u2013 Product related
7.3
12.0
1.8
11.9
\u2013 Software related
\u2013
10.0
\u2013
0.9
Trademarks \u2013 WITec
2.0
10.0
7.6
2.3
Technology, know\u2013how and patents \u2013 WITec
2.4
5.0
2.6
3.6
Trademarks \u2013 First Light Imaging
0.2
2.0
1.8
\u2013
Technology, know\u2013how and patents \u2013 First Light Imaging:
\u2013 OCAM
0.3
12.0
11.8
\u2013
\u2013 C-RED
9.3
14.0
13.8
\u2013
Technology, know\u2013how and patents \u2013 Asylum
1.0
12.0
0.7
2.4
Goodwill acquired in a business combination is allocated, at acquisition, to the cash-generating units (CGUs) that are expected
to benefit from that business combination. The carrying amount of goodwill was allocated to individual CGUs as follows:
2024 2023
\u00a3m \u00a3m
Materials & Characterisation
NanoAnalysis
9.9
10.0
Magnetic Resonance
2.3
2.3
WITec
21.0
21.5
Research & Discovery
Andor
66.7
61.2
NanoScience
6.7
6.7
106.6
101.7
In the current year, Andor includes a provisional goodwill amount of \u00a35.4m relating to the acquisition of First Light Imaging as
shown in Note 11. All other movements in the year relate to changes in exchange rates.
The Group tests goodwill annually for impairment, or more frequently if there are indications that goodwill might be impaired.
Accounting standards require an impairment test to be carried out by determining the recoverable amount of each CGU which
contains goodwill. The recoverable amount is calculated as the higher of the fair value less costs to sell or the value in use of the
CGU. In the Group\u2019s case, the recoverable amount is based on value in use calculations. Value in use is calculated by discounting
expected future cash flows and in particular Board-approved five-year cash flow forecasts, prepared by the management of
each CGU and reviewed and amended by Group management as necessary, together with 2.5% per annum growth for the
subsequent 20 years. This rate was considered to be at or below long-term market trends for the Group\u2019s businesses.
Key assumptions The key assumptions are those regarding discount rates and growth rates. The growth rates are at or below the Group\u2019s view on long-term trends within its markets. Changes in selling prices and direct costs are based on past practices and expectations of future changes in the market. The post-tax weighted average costs of capital used for Materials & Characterisation and Research & Discovery in impairment testing are 13.1%-13.6% (2023: 12.8%-13.3%) and 13.1%-13.6% (2023: 12.8%-13.3%) respectively, in line with the risk associated with each of the business segments. Management has estimated these discount rates by reference to past experience and an industry average weighted cost of capital as adjusted for appropriate risk factors reflecting current economic circumstances and the risk profiles of each CGU. Sensitivity analysis The Group\u2019s estimate of impairments are most sensitive to changes in the discount rate and forecast growth rate. Sensitivity analysis has been carried out by reference to both of these assumptions. This demonstrated that a 460 basis point increase in the discount rate would be required in order to eliminate the headroom of \u00a327.1m in the recently acquired WITec business \u2013 along with a 20% deterioration from the five-year forecast. Similarly, a reduction in the growth rate to -6.2% \u2013 again, along with a 20% deterioration from the five-year forecast, would be required in order to result in an impairment in that business. No reasonably possible change in assumptions would result in an impairment in the other businesses .", "dimensions": { "concept": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-435": { "value": "
14 Leases
The Group leases a number of properties in the jurisdictions from which it operates. In some jurisdictions it is customary for
lease contracts to provide for payments to increase each year by inflation and in others to be reset periodically to market
rental rates. In some jurisdictions\u2019 property leases, the periodic rent is fixed over the lease term.
The Group also leases certain items of plant and equipment. In some contracts for services with distributors, those contracts
contain a lease of vehicles. Leases of plant, equipment and vehicles comprise only fixed payments over the lease terms.
The Group sometimes negotiates break clauses in its property leases. On a case-by-case basis, the Group will consider
whether the absence of a break clause would expose the Group to excessive risk. Typically factors considered in deciding to
negotiate a break clause include:
\u2022 the length of the lease term;
\u2022 the economic stability of the environment in which the property is located; and
\u2022 whether the location represents a new area of operations for the Group.
The Group leases assets including land and buildings, vehicles and machinery. Information about leases for which the Group
is a lessee is presented below.
Right-of-use assets
Property leases Other leases Total
\u00a3m \u00a3m \u00a3m
Cost
Balance at 1 April 2022
25.0
2.6
27.6
Additions
17.4
0.8
18.2
Modifications
(1.0)
\u2013
(1.0)
Disposals
\u2013
(0.5)
(0.5)
Exchange differences
1.1
0.1
1.2
Balance at 31 March 2023
42.5
3.0
45.5
Additions \u2013 business combinations
0.7
\u2013
0.7
Additions
5.8
0.2
6.0
Disposals
(1.1)
(0.2)
(1.3)
Exchange differences
(1.5)
(0.1)
(1.6)
Balance at 31 March 2024
46.4
2.9
49.3
Amortisation and impairment losses Balance at 1 April 2022 8.4 1.3 9.7 Amortisation charge for the year 4.1 0.5 4.6 Disposals \u2013 (0.5) (0.5) Exchange differences 0.3 \u2013 0.3 Balance at 31 March 2023 12.8 1.3 14.1 Amortisation charge for the year 4.5 0.5 5.0 Disposals (1.6) (0.1) (1.7) Exchange differences (0.5) \u2013 (0.5) Balance at 31 March 2024 15.2 1.7 16.9 Carrying amounts Balance at 1 April 2022 16.6 1.3 17.9 Balance at 31 March 2023 and 1 April 2023 29.7 1.7 31.4 Balance at 31 March 2024 31.2 1.2 32.4 Lease payables
2024 2023
\u00a3m \u00a3m
Balance at beginning of year
31.4
18.4
Additions \u2013 business combinations
0.7
\u2013
Additions
6.0
18.1
Modifications
\u2013
(1.0)
Payments made (cash flows from financing activities)
(4.8)
(5.6)
Interest charge
0.8
0.5
Effect of movements in foreign exchange rates
(0.7)
1.0
33.4
31.4
Amounts falling due after more than one year
28.6
26.2
Amounts falling due in less than one year
4.8
5.2
Amounts recognised in Consolidated Statement of Income
2024 2023
\u00a3m \u00a3m
Interest on lease liabilities
(0.8)
(0.5)
Amortisation of right-of-use assets
(5.0)
(4.6)
Amounts recognised in Consolidated Statement of Cash Flows The total cash outflow for leases in the year ended 31 March 2024 was \u00a34.8m (2023: \u00a35.6m)", "dimensions": { "concept": "ifrs-full:DisclosureOfLeasesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-467": { "value": "Right-of-use assets
Property leases Other leases Total
\u00a3m \u00a3m \u00a3m
Cost
Balance at 1 April 2022
25.0
2.6
27.6
Additions
17.4
0.8
18.2
Modifications
(1.0)
\u2013
(1.0)
Disposals
\u2013
(0.5)
(0.5)
Exchange differences
1.1
0.1
1.2
Balance at 31 March 2023
42.5
3.0
45.5
Additions \u2013 business combinations
0.7
\u2013
0.7
Additions
5.8
0.2
6.0
Disposals
(1.1)
(0.2)
(1.3)
Exchange differences
(1.5)
(0.1)
(1.6)
Balance at 31 March 2024
46.4
2.9
49.3
", "dimensions": { "concept": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-436": { "value": "
15 Inventories
2024 2023
\u00a3m \u00a3m
Raw materials and consumables
59.0
39.8
Work in progress
27.3
23.5
Finished goods
22.1
18.1
108.4
81.4
The amount of inventory recognised as an expense was \u00a3182.4m (2023: \u00a3172.8m). In the ordinary course of business, the
Group makes impairment provisions for slow-moving, excess and obsolete inventory as appropriate. Inventory is stated after
charging impairments of \u00a31.2m in the current period (2023: \u00a31.3m). In the current year, \u00a3nil (2023: \u00a3nil) was reversed relating to
previous impairments. Impairments are included within gross profit.
Inventory carried at net realisable value is \u00a30.2m (2023: \u00a31.7m).
", "dimensions": { "concept": "ifrs-full:DisclosureOfInventoriesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-437": { "value": "
16 Trade and other receivables
2024 2023 as restated
\u00a3m \u00a3m
Trade receivables
88.5
91.3
Less provision for impairment of receivables
(3.6)
(3.5)
Net trade receivables
84.9
87.8
Accrued income
11.7
9.4
Prepayments
9.9
6.6
Other receivables
8.2
9.4
114.7
113.2
1
1. The trade receivable and accrued income amounts in the table above have been restated to correct an amount recognised within revenue
which had not been invoiced to the customer. As a result, at 31st March 2023 trade receivables have reduced by \u00a34.6m, and accrued income
has increased by \u00a34.6m.
Trade receivables are non-interest-bearing. Standard credit terms provided to customers differ according to business and
country and are typically between 30 and 60 days.
The maximum exposure to credit risk for trade and other receivables plus accrued income, by geographic region, was:
2024 2023
\u00a3m 3m
UK
11.6
17.5
China
16.1
16.2
Japan
15.5
15.8
USA
24.3
29.8
Germany
6.4
7.4
Rest of Europe
16.1
10.6
Rest of Asia
10.4
6.3
Rest of World
4.4
3.0
104.8
106.6
The ageing of financial assets comprising net trade receivables and other receivables plus accrued income at the reporting
date was:
2024 2023
\u00a3m \u00a3m
Current (not overdue)
54.7
63.1
Less than 31 days overdue
20.5
18.8
More than 30 but less than 91 days overdue
15.2
10.8
More than 90 days overdue
14.4
13.9
104.8
106.6
In the current year \u00a30.2m (2023: nil) of the provision against trade receivables and other receivables plus accrued income
relates to balances less than 90 days overdue. The remaining balance relates to balances more than 90 days overdue.
The movement of the Group\u2019s expected credit losses provision in respect of trade receivables and other receivables plus
accrued income are as follows:
2024 2023
\u00a3m \u00a3m
Balance at start of year
3.5
3.6
Increase/(decrease) in loss allowance recognised in the
Consolidated Statement of Income during the year
0.1
(0.1)
Balance at end of year
3.6
3.5
The loss allowance is recognised in the administration and shared services line in the Consolidated Statement of Income .
", "dimensions": { "concept": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-493": { "value": "16 Trade and other receivables
2024 2023 as restated
\u00a3m \u00a3m
Trade receivables
88.5
91.3
Less provision for impairment of receivables
(3.6)
(3.5)
Net trade receivables
84.9
87.8
Accrued income
11.7
9.4
Prepayments
9.9
6.6
Other receivables
8.2
9.4
114.7
113.2
1 1. The trade receivable and accrued income amounts in the table above have been restated to correct an amount recognised within revenue which had not been invoiced to the customer. As a result, at 31st March 2023 trade receivables have reduced by \u00a34.6m, and accrued income has increased by \u00a34.6m. Trade receivables are non-interest-bearing. Standard credit terms provided to customers differ according to business and country and are typically between 30 and 60 days. The maximum exposure to credit risk for trade and other receivables plus accrued income, by geographic region, was:
2024 2023
\u00a3m 3m
UK
11.6
17.5
China
16.1
16.2
Japan
15.5
15.8
USA
24.3
29.8
Germany
6.4
7.4
Rest of Europe
16.1
10.6
Rest of Asia
10.4
6.3
Rest of World
4.4
3.0
104.8
106.6
The ageing of financial assets comprising net trade receivables and other receivables plus accrued income at the reporting date was:
2024 2023
\u00a3m \u00a3m
Current (not overdue)
54.7
63.1
Less than 31 days overdue
20.5
18.8
More than 30 but less than 91 days overdue
15.2
10.8
More than 90 days overdue
14.4
13.9
104.8
106.6
In the current year \u00a30.2m (2023: nil) of the provision against trade receivables and other receivables plus accrued income relates to balances less than 90 days overdue. The remaining balance relates to balances more than 90 days overdue. The movement of the Group\u2019s expected credit losses provision in respect of trade receivables and other receivables plus accrued income are as follows:
2024 2023
\u00a3m \u00a3m
Balance at start of year
3.5
3.6
Increase/(decrease) in loss allowance recognised in the
Consolidated Statement of Income during the year
0.1
(0.1)
Balance at end of year
3.6
3.5
The loss allowance is recognised in the administration and shared services line in the Consolidated Statement of Income ", "dimensions": { "concept": "ifrs-full:DisclosureOfOtherAssetsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-468": { "value": "The ageing of financial assets comprising net trade receivables and other receivables plus accrued income at the reporting date was:
2024 2023
\u00a3m \u00a3m
Current (not overdue)
54.7
63.1
Less than 31 days overdue
20.5
18.8
More than 30 but less than 91 days overdue
15.2
10.8
More than 90 days overdue
14.4
13.9
104.8
106.6
In the current year \u00a30.2m (2023: nil) of the provision against trade receivables and other receivables plus accrued income relates to balances less than 90 days overdue. The remaining balance relates to balances more than 90 days overdue. The movement of the Group\u2019s expected credit losses provision in respect of trade receivables and other receivables plus accrued income are as follows:
2024 2023
\u00a3m \u00a3m
Balance at start of year
3.5
3.6
Increase/(decrease) in loss allowance recognised in the
Consolidated Statement of Income during the year
0.1
(0.1)
Balance at end of year
3.6
3.5
The loss allowance is recognised in the administration and shared services line in the Consolidated Statement of Income .", "dimensions": { "concept": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-438": { "value": "17 Contract assets and liabilities 2024 2023 as restated Contract Contract asset Contract liability asset Contract liability Accrued Customer Deferred Accrued Customer Deferred income deposits income income deposits income \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m Balance at 1 April 9.4 (52.1) (21.3) 4.2 (41.3) (21.2) Acquired balances \u2013 (0.4) (0.7) \u2013 \u2013 \u2013 Transfers in the period from contract assets to trade receivables (9.4) \u2013 \u2013 (4.2) \u2013 \u2013 Amounts included in contract liabilities that were recognised as revenue during the period \u2013 48.5 21.3 \u2013 38.6 21.2 Excess of revenue recognised over cash (or rights to cash) being recognised during the period 11.7 \u2013 \u2013 9.4 \u2013 \u2013 Cash received in advance of performance and not recognised as revenue during the period \u2013 (54.4) (22.2) \u2013 (49.4) (21.3) Balance at 31 March 11.7 (58.4) (22.9) 9.4 (52.1) (21.3) 1 1. Details of restatement of prior year numbers can be found in note 16. Contract assets and contract liabilities are included within trade and other receivables and trade and other payables respectively on the face of the Consolidated Statement of Financial Position. Payment terms for the sale of large goods typically require payment of a deposit on order, with the remaining payments due on shipment, and in some cases installation. For lower value goods, payment is typically required at shipment. Maintenance and service contracts are generally paid in full at inception. There is no financing component in the arrangements, and contracts are for specified, pre-agreed amounts with no variable element.", "dimensions": { "concept": "oxfordinstrumentplc:DisclosureOfContractAssetsAndLiabilities", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-469": { "value": "
19 Borrowings
2024 2023
\u00a3m \u00a3m
Current
Bank loans at First Light Imaging
0.4
\u2013
Covid-19 loan at WITec
0.4
0.4
Bank overdrafts
12.3
11.2
At the end of the year
13.1
11.6
2024 2023
\u00a3m \u00a3m
Non-current
Bank loans at First Light Imaging
0.4
\u2013
Covid-19 loan at WITec
0.5
0.9
At the end of the year
0.9
0.9
On 19 March 2024, the Group entered into a new multi-currency revolving facility agreement, which is committed until March
2028 with 15-month and 12-month extension options at the end of the first and second years respectively. The facility has
been entered into with four banks and comprises a euro-denominated multi-currency facility of \u20ac95m and a US dollar
denominated multi-currency facility of $150m. Debt covenants are net debt to EBITDA less than 3.0 times and EBITDA to
interest greater than 4.0 times.
The Group\u2019s undrawn committed facilities available at 31 March 2024 were \u00a3200.2m, comprising the undrawn portion of the
Group\u2019s \u00a3200.2m revolving credit facilities.
Bank overdrafts reflect the aggregated overdrawn balances of Group companies (even if those companies have other
positive cash balances). The overdrafts are held with the Group\u2019s relationship banks.
The Group\u2019s uncommitted overdraft facilities at 31 March 2024 were \u00a318.3m (2023: \u00a318.8m).
A reconciliation of the Group\u2019s borrowings balances is shown below.
2024 2023
\u00a3m \u00a3m
Balance at the beginning of the year
12.5
10.5
Increase in borrowings (from acquisition of First Light Imaging)
2.2
\u2013
Repayment of borrowings (cash flow from financing activities)
(1.8)
(0.5)
Increase/(decrease) in bank overdrafts
1.1
2.5
Interest charged
0.9
0.7
Interest paid
(0.9)
(0.7)
At the end of the year
14.0
12.5
", "dimensions": { "concept": "ifrs-full:DisclosureOfBorrowingsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-439": { "value": "19 Borrowings
2024 2023
\u00a3m \u00a3m
Current
Bank loans at First Light Imaging
0.4
\u2013
Covid-19 loan at WITec
0.4
0.4
Bank overdrafts
12.3
11.2
At the end of the year
13.1
11.6
2024 2023
\u00a3m \u00a3m
Non-current
Bank loans at First Light Imaging
0.4
\u2013
Covid-19 loan at WITec
0.5
0.9
At the end of the year
0.9
0.9
On 19 March 2024, the Group entered into a new multi-currency revolving facility agreement, which is committed until March 2028 with 15-month and 12-month extension options at the end of the first and second years respectively. The facility has been entered into with four banks and comprises a euro-denominated multi-currency facility of \u20ac95m and a US dollar denominated multi-currency facility of $150m. Debt covenants are net debt to EBITDA less than 3.0 times and EBITDA to interest greater than 4.0 times. The Group\u2019s undrawn committed facilities available at 31 March 2024 were \u00a3200.2m, comprising the undrawn portion of the Group\u2019s \u00a3200.2m revolving credit facilities. Bank overdrafts reflect the aggregated overdrawn balances of Group companies (even if those companies have other positive cash balances). The overdrafts are held with the Group\u2019s relationship banks. The Group\u2019s uncommitted overdraft facilities at 31 March 2024 were \u00a318.3m (2023: \u00a318.8m). A reconciliation of the Group\u2019s borrowings balances is shown below.
2024 2023
\u00a3m \u00a3m
Balance at the beginning of the year
12.5
10.5
Increase in borrowings (from acquisition of First Light Imaging)
2.2
\u2013
Repayment of borrowings (cash flow from financing activities)
(1.8)
(0.5)
Increase/(decrease) in bank overdrafts
1.1
2.5
Interest charged
0.9
0.7
Interest paid
(0.9)
(0.7)
At the end of the year
14.0
12.5
22 Financial instruments
Fair values of financial assets and liabilities
The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their
levels in the fair value hierarchy. It does not include fair value information for financial assets and financial liabilities not
measured at fair value if the carrying amount is a reasonable approximation of fair value.
2024
2023 as restated
Fair value Carrying Carrying
hierarchy amount Fair value amount Fair value
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Financial assets measured at fair value
Derivative financial assets:
\u2013 Foreign currency contracts
2
2.5
2.5
2.0
2.0
Financial assets measured at amortised cost
Long-term receivables
1.3
0.5
Trade receivables
84.9
87.8
Other receivables and accrued income
15.1
13.0
Cash and cash equivalents
97. 8
112.7
Financial liabilities measured at fair value
Derivative financial liabilities:
\u2013 Foreign currency contracts
2
(0.1)
(0.1)
(1.2)
(1.2)
Financial liabilities measured at amortised cost
Trade and other payables
(78.6)
(79.9)
Bank overdrafts
(12.3)
(11.2)
Borrowings
(1.7)
(1.3)
Lease payables
(33.4)
(31.4)
1, 2
1. The other receivables and accrued income and trade and other payables balances in the table above, as at 31 March 2023, have been restated to
remove the tax-related balances which do not meet the accounting definition of financial assets and liabilities. As a result, at 31 March 2023, other
receivables and accrued income were reduced by \u00a35.8m, while trade and other payables were reduced by \u00a36.1m.
2. Details of restatements of prior period numbers for trade receivables and other receivables and accrued income can be found in note 16.
The following summarises the major methods and assumptions used in estimating the fair values of financial instruments
reflected in the above table.
Derivative financial instruments
Derivative financial instruments are marked-to-market using market prices.
Fixed and floating rate borrowings
The fair value of fixed and floating rate borrowings is estimated by discounting the future contracted principal and interest
cash flows using the market rate of interest at the reporting date.
Trade and other receivables/payables
For receivables/payables with a remaining life of less than one year, the carrying amount is deemed to reflect the fair value.
All other receivables/payables are discounted to determine their fair value. Advances received are excluded from other
payables above as these are not considered to be financial liabilities. Tax-related receivables and payables are excluded
from the above table as these are not considered to be financial assets and liabilities.
Lease payables
The lease liability is measured at amortised cost using the effective interest method.
The table above gives details of the valuation method used in arriving at the fair value of financial instruments. The different levels have been identified as follows: \u2013 Level 1: quoted prices (unadjusted) in active markets for identical assets and liabilities. \u2013 Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (ie as prices) or indirectly (ie derived from prices). \u2013 Level 3: inputs for the asset or liability that are not based on observable market data. There have been no transfers between levels during the year .", "dimensions": { "concept": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-441": { "value": "
20 Trade and other payables
2024 2023
\u00a3m \u00a3m
Trade payables
32.6
30.3
Customer deposits
58.4
52.1
Social security and other taxes
6.3
6.1
Accrued expenses
39.3
44.9
Deferred income
22.9
21.3
Other payables
6.7
4.7
166.2
159.4
", "dimensions": { "concept": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-471": { "value": "20 Trade and other payables
2024 2023
\u00a3m \u00a3m
Trade payables
32.6
30.3
Customer deposits
58.4
52.1
Social security and other taxes
6.3
6.1
Accrued expenses
39.3
44.9
Deferred income
22.9
21.3
Other payables
6.7
4.7
166.2
159.4
", "dimensions": { "concept": "ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-494": { "value": "20 Trade and other payables
2024 2023
\u00a3m \u00a3m
Trade payables
32.6
30.3
Customer deposits
58.4
52.1
Social security and other taxes
6.3
6.1
Accrued expenses
39.3
44.9
Deferred income
22.9
21.3
Other payables
6.7
4.7
166.2
159.4
21 Provisions for other liabilities and charges
Warranties IP-related claims Other Total
\u00a3m \u00a3m \u00a3m \u00a3m
Balance as at 1 April 2023
3.6
0.6
3.4
7.6
Provisions made during the year
3.5
\u2013
1.3
4.8
Provisions used during the year
(1.8)
\u2013
(1.3)
(3.1)
Provisions released during the year
(2.1)
\u2013
(0.7)
(2.8)
Exchange differences
\u2013
\u2013
(0.1)
(0.1)
Balance as at 31 March 2024
3.2
0.6
2.6
6.4
Amounts falling due before one year
3.2
0.6
2.6
6.4
Amounts falling due after more than one year
\u2013
\u2013
\u2013
\u2013
Warranty provisions Product warranty provisions reflect commitments made to customers on the sale of goods in the ordinary course of business and included within the Group companies\u2019 standard terms and conditions. Warranty commitments typically apply for a 12-month period. The provision represents the Directors\u2019 best estimate of the Group\u2019s liability based on past experience. Intellectual property-related claims The company has on occasion been required to take legal or other actions to defend itself against proceedings brought by other parties. Provisions are made for the expected costs associated with such matters, based on past experience of similar items and other known factors, taking into account professional advice received, and represent the Directors\u2019 best estimate of the likely outcome. The timing of utilisation of these provisions is frequently uncertain, reflecting the complexity of issues and the outcome of various court proceedings and negotiations. Contractual and other provisions represent the Directors\u2019 best estimate of the future cost of settling obligations arising from past activity and reflect the Directors\u2019 assessment of the likely settlement method, which may change over time. However, no provision is made for proceedings which have been brought by other parties against Group companies unless the Directors, taking into account professional advice received, assess that it is more likely than not that such proceedings may be successful. In respect of the provision for IP-related claims the range of possible outcomes is between \u00a3nil and \u00a30.6m. Other provisions Other provisions relate to various obligations including obligations in respect of onerous contracts, product-related liabilities, dilapidation provisions and provisions for other claims ", "dimensions": { "concept": "ifrs-full:DisclosureOfOtherLiabilitiesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-470": { "value": "21 Provisions for other liabilities and charges
Warranties IP-related claims Other Total
\u00a3m \u00a3m \u00a3m \u00a3m
Balance as at 1 April 2023
3.6
0.6
3.4
7.6
Provisions made during the year
3.5
\u2013
1.3
4.8
Provisions used during the year
(1.8)
\u2013
(1.3)
(3.1)
Provisions released during the year
(2.1)
\u2013
(0.7)
(2.8)
Exchange differences
\u2013
\u2013
(0.1)
(0.1)
Balance as at 31 March 2024
3.2
0.6
2.6
6.4
Amounts falling due before one year
3.2
0.6
2.6
6.4
Amounts falling due after more than one year
\u2013
\u2013
\u2013
\u2013
Warranty provisions Product warranty provisions reflect commitments made to customers on the sale of goods in the ordinary course of business and included within the Group companies\u2019 standard terms and conditions. Warranty commitments typically apply for a 12-month period. The provision represents the Directors\u2019 best estimate of the Group\u2019s liability based on past experience. Intellectual property-related claims The company has on occasion been required to take legal or other actions to defend itself against proceedings brought by other parties. Provisions are made for the expected costs associated with such matters, based on past experience of similar items and other known factors, taking into account professional advice received, and represent the Directors\u2019 best estimate of the likely outcome. The timing of utilisation of these provisions is frequently uncertain, reflecting the complexity of issues and the outcome of various court proceedings and negotiations. Contractual and other provisions represent the Directors\u2019 best estimate of the future cost of settling obligations arising from past activity and reflect the Directors\u2019 assessment of the likely settlement method, which may change over time. However, no provision is made for proceedings which have been brought by other parties against Group companies unless the Directors, taking into account professional advice received, assess that it is more likely than not that such proceedings may be successful. In respect of the provision for IP-related claims the range of possible outcomes is between \u00a3nil and \u00a30.6m. Other provisions Other provisions relate to various obligations including obligations in respect of onerous contracts, product-related liabilities, dilapidation provisions and provisions for other claims ", "dimensions": { "concept": "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-440": { "value": "21 Provisions for other liabilities and charges
Warranties IP-related claims Other Total
\u00a3m \u00a3m \u00a3m \u00a3m
Balance as at 1 April 2023
3.6
0.6
3.4
7.6
Provisions made during the year
3.5
\u2013
1.3
4.8
Provisions used during the year
(1.8)
\u2013
(1.3)
(3.1)
Provisions released during the year
(2.1)
\u2013
(0.7)
(2.8)
Exchange differences
\u2013
\u2013
(0.1)
(0.1)
Balance as at 31 March 2024
3.2
0.6
2.6
6.4
Amounts falling due before one year
3.2
0.6
2.6
6.4
Amounts falling due after more than one year
\u2013
\u2013
\u2013
\u2013
Warranty provisions Product warranty provisions reflect commitments made to customers on the sale of goods in the ordinary course of business and included within the Group companies\u2019 standard terms and conditions. Warranty commitments typically apply for a 12-month period. The provision represents the Directors\u2019 best estimate of the Group\u2019s liability based on past experience. Intellectual property-related claims The company has on occasion been required to take legal or other actions to defend itself against proceedings brought by other parties. Provisions are made for the expected costs associated with such matters, based on past experience of similar items and other known factors, taking into account professional advice received, and represent the Directors\u2019 best estimate of the likely outcome. The timing of utilisation of these provisions is frequently uncertain, reflecting the complexity of issues and the outcome of various court proceedings and negotiations. Contractual and other provisions represent the Directors\u2019 best estimate of the future cost of settling obligations arising from past activity and reflect the Directors\u2019 assessment of the likely settlement method, which may change over time. However, no provision is made for proceedings which have been brought by other parties against Group companies unless the Directors, taking into account professional advice received, assess that it is more likely than not that such proceedings may be successful. In respect of the provision for IP-related claims the range of possible outcomes is between \u00a3nil and \u00a30.6m. Other provisions Other provisions relate to various obligations including obligations in respect of onerous contracts, product-related liabilities, dilapidation provisions and provisions for other claims .", "dimensions": { "concept": "ifrs-full:DisclosureOfProvisionsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-472": { "value": "22 Financial instruments Fair values of financial assets and liabilities The following table shows the carrying amounts and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy. It does not include fair value information for financial assets and financial liabilities not measured at fair value if the carrying amount is a reasonable approximation of fair value.
2024
2023 as restated
Fair value Carrying Carrying
hierarchy amount Fair value amount Fair value
\u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Financial assets measured at fair value
Derivative financial assets:
\u2013 Foreign currency contracts
2
2.5
2.5
2.0
2.0
Financial assets measured at amortised cost
Long-term receivables
1.3
0.5
Trade receivables
84.9
87.8
Other receivables and accrued income
15.1
13.0
Cash and cash equivalents
97. 8
112.7
Financial liabilities measured at fair value
Derivative financial liabilities:
\u2013 Foreign currency contracts
2
(0.1)
(0.1)
(1.2)
(1.2)
Financial liabilities measured at amortised cost
Trade and other payables
(78.6)
(79.9)
Bank overdrafts
(12.3)
(11.2)
Borrowings
(1.7)
(1.3)
Lease payables
(33.4)
(31.4)
1, 2 1. The other receivables and accrued income and trade and other payables balances in the table above, as at 31 March 2023, have been restated to remove the tax-related balances which do not meet the accounting definition of financial assets and liabilities. As a result, at 31 March 2023, other receivables and accrued income were reduced by \u00a35.8m, while trade and other payables were reduced by \u00a36.1m. 2. Details of restatements of prior period numbers for trade receivables and other receivables and accrued income can be found in note 16. The following summarises the major methods and assumptions used in estimating the fair values of financial instruments reflected in the above table.
The table above gives details of the valuation method used in arriving at the fair value of financial instruments. The different
levels have been identified as follows:
\u2013 Level 1: quoted prices (unadjusted) in active markets for identical assets and liabilities.
\u2013 Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly
(ie as prices) or indirectly (ie derived from prices).
\u2013 Level 3: inputs for the asset or liability that are not based on observable market data.
There have been no transfers between levels during the year .
", "dimensions": { "concept": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-489": { "value": "Fair value hierarchy The table above gives details of the valuation method used in arriving at the fair value of financial instruments. The different levels have been identified as follows: \u2013 Level 1: quoted prices (unadjusted) in active markets for identical assets and liabilities. \u2013 Level 2: inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (ie as prices) or indirectly (ie derived from prices). \u2013 Level 3: inputs for the asset or liability that are not based on observable market data. There have been no transfers between levels during the year ", "dimensions": { "concept": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-473": { "value": "Derivative financial instruments Derivative financial instruments are marked-to-market using market prices. ", "dimensions": { "concept": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-442": { "value": "
23 Financial risk management
The Group\u2019s multinational operations and debt financing expose it to a variety of financial risks. In the course of its business,
the Group is exposed to foreign currency risk, interest rate risk, liquidity risk, commodity risk and credit risk. Financial risk
management policies are set by the Board of Directors. These policies are implemented by a central treasury function that
has formal procedures to manage foreign exchange risk, interest rate risk and liquidity risk, including, where appropriate, the
use of derivative financial instruments. Commodity risk is managed locally by the operating businesses. The Group has clearly
defined authority and approval limits.
In accordance with its Treasury Policy, the Group does not hold or use derivative financial instruments for trading or
speculative purposes. Such instruments are only used to manage the risks arising from operating or financial assets or
liabilities or highly probable future transactions.
The Group uses derivative financial instruments to hedge its exposure to fluctuations in foreign exchange rates. In
common with a number of other companies, the Group has decided that the additional costs of meeting the extensive
documentation requirements of IFRS 9 to apply hedge accounting to derivative financial instruments used for hedging
exposure to foreign currency and interest rate volatility cannot be justified. Accordingly, the Group does not use hedge
accounting for such derivatives.
Foreign currency risk
Foreign currency risk arises both where sale or purchase transactions are undertaken in currencies other than the respective
functional currencies of Group companies (transactional exposures) and where the results of overseas companies are
consolidated into the Group\u2019s reporting currency of Sterling (translational exposures). The Group has operations around the
world which record their results in a variety of different local functional currencies. In countries where the Group does not have
operations, it invariably has some customers or suppliers that transact in a foreign currency. The Group is therefore exposed to
the changes in foreign currency exchange rates between a number of different currencies but the Group\u2019s primary exposures
relate to the US Dollar, the Euro and the Japanese Yen. To reduce uncertainty, the Group maintains a rolling hedge of forward
contracts equivalent to 80% (2023: 80%) of the exposure expected to arise over the following 12 months. The remaining 20%
is sold on the spot market. The fair value of outstanding currency contracts recognised as a liability as at 31 March 2024
amount to \u00a30.1m (2023: \u00a31.2m) and those recognised as an asset amount to \u00a32.5m (2023: \u00a32.0m).
Movements in the fair value of derivative financial instruments are recognised in the Consolidated Statement of Income
immediately. However, in order to facilitate a more meaningful comparison of the Group\u2019s performance year-on-year,
the elements of these movements that relate to hedges in respect of future sales are treated as an adjusting item in the
calculation of adjusted earnings (Note 2).
The Group\u2019s translational exposures to foreign currency risks can relate both to the Consolidated Statement of Income and
net assets of overseas subsidiaries. The Group\u2019s policy is not to hedge the translational exposure that arises on consolidation
of the Consolidated Statements of Income of overseas subsidiaries.
Interest rate risk
Interest rate risk comprises both the interest rate price risk that results from borrowing at fixed rates of interest and also the
interest cash flow risk that results from borrowing at variable rates. The Group\u2019s policy is to use a mixture of revolving short
and medium-term floating rate debt underpinned by longer-term fixed rate debt. The short and medium-term floating rate
debt provides flexibility to reduce debt levels as appropriate. The longer-term fixed rate debt provides stability and cost
certainty to the Group\u2019s financing structure.
Liquidity risk
Liquidity risk represents the risk that the Group will not be able to meet its financial obligations as they fall due. The Group\u2019s
approach to managing this risk is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities
when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the
Group\u2019s reputation. The Group manages this risk by maintaining adequate committed lines of funding from high-quality
lenders. The facilities committed to the Group as at 31 March 2024 are set out in Note 19.
Credit risk Credit risk arises because a counterparty may fail to perform its obligations. The Group is exposed to credit risk on financial assets such as cash balances, derivative financial instruments, accrued income, trade and other receivables. The Group\u2019s credit risk is primarily attributable to its trade receivables and cash balances. The amounts recognised in the Consolidated Statement of Financial Position are net of expected credit losses, which are estimated by the Group\u2019s management based on the Group\u2019s historical experience of losses, along with consideration of any reasonably and supportable forward-looking information and expectations. Due to its wide geographic base and large number of customers, the Group is not exposed to material concentrations of credit risk on its trade receivables. The Group\u2019s experience of credit loss is minimal, which has and continues to be mitigated through receiving payment in advance of delivery or using trade guarantees provided by the Group\u2019s relationship banks. In the unusual event of a particular issue with a particular customer, a specific provision will be made if appropriate. Trade receivables are subject to credit limits and control and approval procedures in the operating companies. There has been no material change in the Group\u2019s experience of credit losses over the reporting period. Credit risk associated with cash balances and derivative financial instruments is managed by transacting with financial institutions with high-quality credit rating. In particular, a Board-approved policy sets out guidelines for which categories of institutions may be used and the maximum amount which may be invested with each institution within a particular category. Accordingly, the Group\u2019s associated credit risk is limited. The Group has no significant concentration of credit risk. The Group\u2019s maximum exposure to credit risk is represented by the carrying amount of each financial asset, including derivative financial instruments, in the Group Consolidated Statement of Financial Position. Exposure to credit risk The carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk by type of asset at 31 March 2024 is as shown below:
2024 2023 as restated
\u00a3m \u00a3m
Long-term receivables
1.3
0.5
Trade receivables
84.9
87.8
Other receivables and accrued income
15.1
13.0
Cash and cash equivalents
97. 8
112.7
Derivative financial instruments
2.5
2.0
201.6
216.0
1 1. Details of restatements of prior period numbers for trade receivables and other receivables and accrued income can be found in note 16. The maximum exposure to credit risk for trade receivables is discussed in Note 16. Other receivables include \u00a34.8m (2023: \u00a35.8m) in respect of VAT and similar taxes which are not past due date. Capital management The Group\u2019s objectives when managing capital are to safeguard the Group\u2019s ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital. The Board\u2019s long-term objective is to have an efficient capital structure by maintaining a balance between the higher returns that might be possible with higher levels of borrowings and the advantages and security afforded by a sound capital position. This is monitored by reference to the ratio of net debt to earnings before interest, tax, depreciation and amortisation (EBITDA) and the Board has set itself internal limits, which are well inside any covenants the Group has with lenders. The Group maintains the right to purchase its own shares in the market; the timing of these purchases would depend on market prices. Buy and sell decisions are made on a specific transaction basis by the Board. Each year the Board carefully considers the appropriate level of dividend payments. In doing this, the Board looks to increase dividends in line with underlying earnings, although the Board will also take into account other considerations in its decision-making process. The Board does not have a policy to pay a fixed dividend yield or to maintain a fixed rate of dividend cover but assesses both of these metrics in line with sustained earnings growth. The Board encourages employees to hold shares in the company. As well as various share option plans (full details of which are given in Note 26), from April 2008 all UK employees have been offered the opportunity to take part in a Share Incentive Plan (SIP). Under this plan, employees are able to invest up to \u00a31,800 each tax year in shares in the company. The company awards one additional free share (a matching share) for every five shares bought by each employee. There were no changes to the Group\u2019s approach to capital management during the year. Neither the company nor any of its subsidiaries are subject to externally imposed capital requirements.
Maturity of financial liabilities
Carrying Contractual Due within Due one to Due more than
amount cash flows one year five years five years
2024 \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Foreign exchange contracts
(0.1)
0.1
0.1
\u2013
\u2013
Trade and other payables
(78.6)
78.6
78.6
\u2013
\u2013
Bank overdrafts
(12.3)
12.3
12.3
\u2013
\u2013
Borrowings
(1.7)
1.7
1.2
0.5
\u2013
Lease payables
(33.4)
36.8
5.3
17.3
14.2
(126.1)
129.5
97.5
17.8
14.2
Carrying Contractual Due within Due one to Due more than
amount cash flows one year five years five years
2023 \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m
Foreign exchange contracts
(1.2)
1.2
1.2
\u2013
\u2013
Trade and other payables
(79.9)
79.9
79.9
\u2013
\u2013
Bank overdrafts
(11.2)
11.2
11.2
\u2013
\u2013
Borrowings
(1.3)
1.3
0.4
0.9
\u2013
Lease payables
(31.4)
31.4
4.5
13.8
13.0
(125.0)
125.0
97. 2
14.7
13.0
Carrying amount Carrying amount
2024 2023
\u00a3m \u00a3m
Variable rate instruments
Cash and cash equivalents
97. 8
112.7
Bank overdrafts
(12.3)
(11.2)
Fixed rate instruments
Financial assets
\u2013
\u2013
Bank loans
(1.7)
(1.3)
Sensitivity analysis
The Group has estimated the impact on the Consolidated Statement of Income and on equity of the following changes in
market conditions at the balance sheet date:
\u2022 one percentage point increase in interest rates;
\u2022 ten percentage point weakening in the value of Sterling against all currencies; and
\u2022 ten percentage point strengthening in the value of Sterling against all currencies.
The sensitivities above represent the Directors\u2019 view of reasonably possible changes in each risk variable, not worst-case
scenarios or stress tests. The outputs from the sensitivity analysis are estimates of the impact of market risk assuming that the
specified changes occur at the year end and are applied to the risk exposures at that date. Accordingly, they show the impact
on the balance sheet of an instantaneous shock. The calculations include all hedges in place at the year end.
Actual results in the future may differ materially from these estimates due to commercial actions taken to mitigate
any potential losses from such rate movements, to the interaction of more than one sensitivity occurring and to further
developments in global financial markets. As such, this table should not be considered as a projection of likely future
gains and losses.
1% increase in 10% weakening 10% strengthening interest rates in Sterling in Sterling \u00a3m \u00a3m \u00a3m Impact on adjusted profit (Note 2) 0.9 (15.4) 15.5 Impact on reported profit 0.9 (12.2) 12.2 Impact on equity 0.7 (11.6) 11.6
1% increase in 10% weakening 10% strengthening
interest rates in Sterling in Sterling
2023 \u00a3m \u00a3m \u00a3m
Impact on adjusted profit (Note 2)
0.9
(10.2)
10.2
Impact on reported profit
0.9
( 7. 5)
7.5
Impact on equity
0.8
(6.1)
6.1
", "dimensions": { "concept": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-474": { "value": "Foreign currency risk Foreign currency risk arises both where sale or purchase transactions are undertaken in currencies other than the respective functional currencies of Group companies (transactional exposures) and where the results of overseas companies are consolidated into the Group\u2019s reporting currency of Sterling (translational exposures). The Group has operations around the world which record their results in a variety of different local functional currencies. In countries where the Group does not have operations, it invariably has some customers or suppliers that transact in a foreign currency. The Group is therefore exposed to the changes in foreign currency exchange rates between a number of different currencies but the Group\u2019s primary exposures relate to the US Dollar, the Euro and the Japanese Yen. To reduce uncertainty, the Group maintains a rolling hedge of forward contracts equivalent to 80% (2023: 80%) of the exposure expected to arise over the following 12 months. The remaining 20% is sold on the spot market. The fair value of outstanding currency contracts recognised as a liability as at 31 March 2024 amount to \u00a30.1m (2023: \u00a31.2m) and those recognised as an asset amount to \u00a32.5m (2023: \u00a32.0m). Movements in the fair value of derivative financial instruments are recognised in the Consolidated Statement of Income immediately. However, in order to facilitate a more meaningful comparison of the Group\u2019s performance year-on-year, the elements of these movements that relate to hedges in respect of future sales are treated as an adjusting item in the calculation of adjusted earnings (Note 2). The Group\u2019s translational exposures to foreign currency risks can relate both to the Consolidated Statement of Income and net assets of overseas subsidiaries. The Group\u2019s policy is not to hedge the translational exposure that arises on consolidation of the Consolidated Statements of Income of overseas subsidiaries. Interest rate risk Interest rate risk comprises both the interest rate price risk that results from borrowing at fixed rates of interest and also the interest cash flow risk that results from borrowing at variable rates. The Group\u2019s policy is to use a mixture of revolving short and medium-term floating rate debt underpinned by longer-term fixed rate debt. The short and medium-term floating rate debt provides flexibility to reduce debt levels as appropriate. The longer-term fixed rate debt provides stability and cost certainty to the Group\u2019s financing structure. ", "dimensions": { "concept": "ifrs-full:DisclosureOfMarketRiskExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-475": { "value": "Liquidity risk Liquidity risk represents the risk that the Group will not be able to meet its financial obligations as they fall due. The Group\u2019s approach to managing this risk is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Group\u2019s reputation. The Group manages this risk by maintaining adequate committed lines of funding from high-quality lenders. The facilities committed to the Group as at 31 March 2024 are set out in Note 19. ", "dimensions": { "concept": "ifrs-full:DisclosureOfLiquidityRiskExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-476": { "value": "
Credit risk
Credit risk arises because a counterparty may fail to perform its obligations. The Group is exposed to credit risk on financial
assets such as cash balances, derivative financial instruments, accrued income, trade and other receivables. The Group\u2019s
credit risk is primarily attributable to its trade receivables and cash balances. The amounts recognised in the Consolidated
Statement of Financial Position are net of expected credit losses, which are estimated by the Group\u2019s management based
on the Group\u2019s historical experience of losses, along with consideration of any reasonably and supportable forward-looking
information and expectations. Due to its wide geographic base and large number of customers, the Group is not exposed
to material concentrations of credit risk on its trade receivables. The Group\u2019s experience of credit loss is minimal, which has
and continues to be mitigated through receiving payment in advance of delivery or using trade guarantees provided by the
Group\u2019s relationship banks. In the unusual event of a particular issue with a particular customer, a specific provision will be
made if appropriate. Trade receivables are subject to credit limits and control and approval procedures in the operating
companies. There has been no material change in the Group\u2019s experience of credit losses over the reporting period.
Credit risk associated with cash balances and derivative financial instruments is managed by transacting with financial
institutions with high-quality credit rating. In particular, a Board-approved policy sets out guidelines for which categories of
institutions may be used and the maximum amount which may be invested with each institution within a particular category.
Accordingly, the Group\u2019s associated credit risk is limited. The Group has no significant concentration of credit risk. The Group\u2019s
maximum exposure to credit risk is represented by the carrying amount of each financial asset, including derivative financial
instruments, in the Group Consolidated Statement of Financial Position.
Exposure to credit risk
The carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk by
type of asset at 31 March 2024 is as shown below:
2024 2023 as restated
\u00a3m \u00a3m
Long-term receivables
1.3
0.5
Trade receivables
84.9
87.8
Other receivables and accrued income
15.1
13.0
Cash and cash equivalents
97. 8
112.7
Derivative financial instruments
2.5
2.0
201.6
216.0
1
1. Details of restatements of prior period numbers for trade receivables and other receivables and accrued income can be found in note 16.
The maximum exposure to credit risk for trade receivables is discussed in Note 16.
Other receivables include \u00a34.8m (2023: \u00a35.8m) in respect of VAT and similar taxes which are not past due date.
", "dimensions": { "concept": "ifrs-full:DisclosureOfCreditRiskExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-477": { "value": "
Capital management
The Group\u2019s objectives when managing capital are to safeguard the Group\u2019s ability to continue as a going concern in order to
provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the
cost of capital.
The Board\u2019s long-term objective is to have an efficient capital structure by maintaining a balance between the higher returns
that might be possible with higher levels of borrowings and the advantages and security afforded by a sound capital position.
This is monitored by reference to the ratio of net debt to earnings before interest, tax, depreciation and amortisation (EBITDA)
and the Board has set itself internal limits, which are well inside any covenants the Group has with lenders. The Group
maintains the right to purchase its own shares in the market; the timing of these purchases would depend on market prices.
Buy and sell decisions are made on a specific transaction basis by the Board.
Each year the Board carefully considers the appropriate level of dividend payments. In doing this, the Board looks to
increase dividends in line with underlying earnings, although the Board will also take into account other considerations in
its decision-making process. The Board does not have a policy to pay a fixed dividend yield or to maintain a fixed rate of
dividend cover but assesses both of these metrics in line with sustained earnings growth.
The Board encourages employees to hold shares in the company. As well as various share option plans (full details of which
are given in Note 26), from April 2008 all UK employees have been offered the opportunity to take part in a Share Incentive
Plan (SIP). Under this plan, employees are able to invest up to \u00a31,800 each tax year in shares in the company. The company
awards one additional free share (a matching share) for every five shares bought by each employee.
There were no changes to the Group\u2019s approach to capital management during the year. Neither the company nor any of its
subsidiaries are subject to externally imposed capital requirements.
", "dimensions": { "concept": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-443": { "value": "
24 Retirement benefit obligations
The Group operates a defined benefit plan in the UK. The plan offers pensions in retirement and death in service benefit to
members. Pension benefits are related to members\u2019 final salary at retirement and their length of service. The scheme has
been closed to new members since 2001 and closed to future accrual since 2010.
The amounts recognised in the Consolidated Statement of Financial Position are:
2024 2023
\u00a3m \u00a3m
Present value of funded obligations
223.6
225.1
Fair value of plan assets
(239.7)
(251.5)
Recognised asset for defined benefit obligations
(16.1)
(26.4)
The reconciliation of the opening and closing balances of the present value of the defined benefit obligation is as follows:
2024 2023
\u00a3m \u00a3m
Benefit obligation at the beginning of the year
225.1
300.0
Past service cost
0.4
\u2013
Interest on defined benefit obligation
10.5
8.2
Benefits paid
(11.0)
(12.3)
Remeasurement (gain)/loss on obligation
(1.4)
(70.8)
Benefit obligation at the end of the year
223.6
225.1
The reconciliation of the opening and closing balances of the present value of the fair value of plan assets is as follows:
2024 2023
\u00a3m \u00a3m
Fair value of plan assets at the beginning of the year
251.5
351.7
Interest on plan assets
12.0
9.8
Contributions by employer
8.5
12.2
Benefits paid
(11.0)
(12.3)
Administrative expenses
(0.5)
(0.5)
Actual return on assets excluding interest income
(20.8)
(109.4)
Fair value of plan assets at the end of the year
239.7
251.5
Defined contribution schemes
In the UK, employees are offered participation in the defined contribution Oxford Instruments Stakeholder Plan. The company
contribution rate and employee contribution rate varies between grades and whether the individual had previously been in
the defined benefit scheme. The company contribution ranges between 4% and 14% of base salary. The Group also operates
a 401k defined distribution plan in the US. Details of pension schemes contributions made in respect of Directors can be found
in the Remuneration Report.
The expense recognised in the Consolidated Statement of Income is:
2024 2023
\u00a3m \u00a3m
Total defined benefit income
(1.0)
(1.1)
Contributions to defined contribution schemes
6.5
6.2
5.5
5.1
Pension costs are recorded in the following lines in the Consolidated Statement of Income:
2024 2023
\u00a3m \u00a3m
Cost of sales
2.1
1.7
Research and development
1.6
1.5
Selling and marketing costs
1.3
1.4
Administration and shared services
2.0
2.1
Financial income
(1.5)
(1.6)
5.5
5.1
The Group has agreed a basis for deficit recovery payments with the trustees of the UK pension scheme. The deficit
recovery payments are payable through to and including 2026 and will rise by approximately 3% per annum. The annual
deficit recovery payment was \u00a38.5m (2023: \u00a38.2m) for the financial year. In the prior year, the Directors decided to make an
additional one-off payment of \u00a34.0m to the UK pension scheme to reduce the Group\u2019s exposure.
In 2018 the trustees of the UK defined benefit scheme, in consultation with the company, reduced its exposure to on-risk
assets (a portfolio of market-focused asset classes, the majority being equities) with a corresponding increase in its liability-
driven investments, with the objective of steering a more stable journey to being fully funded. The pension fund\u2019s gross
exposure to on-risk assets fell from 85% to 45%; the majority of transactions required to make this change were completed
in February 2018. As a result, the level of risk inherent in the investment strategy is now significantly lower than previously, in
addition to a substantial reduction in funding level volatility. Following investment outperformance and contributions made by
the Group in the year to 31 March 2022 the allocation to on-risk assets has been further reduced to 35%, with a view to further
reduction in funding level volatility.
The Group has considered the requirements of IFRIC 14. The terms of the scheme give the Group the right to recover any
surplus assets on the scheme upon wind-up and therefore management has concluded that there is no impact on the
amounts recognised in respect of retirement benefit obligations, i.e. there is no need to apply the \u2018asset ceiling\u2019.
The Group expects to contribute approximately \u00a38.7m to the UK defined benefit plan in the next financial year.
Remeasurement gains and losses shown in the Consolidated Statement of Comprehensive Income:
2024 2023
\u00a3m \u00a3m
Actual return on assets excluding interest income
(20.8)
(109.4)
Experience loss on scheme obligations
(5.4)
(10.3)
Changes in assumptions underlying the present value of scheme obligations:
\u2013 Financial
3.1
78.3
\u2013 Demographic
3.7
2.8
Actuarial losses recorded in the Statement of Comprehensive Income
(19.4)
(38.6 )
The table below shows the sensitivity of the Consolidated Statement of Financial Position to changes in the significant
pension assumptions:
Discount rate Inflation rate Life expectancy
2024 (-0.1% p.a.) (+0.1% p.a.) (+one year)
\u00a3m \u00a3m \u00a3m \u00a3m
Present value of funded obligations
223.6
226.5
225.9
231.0
Fair value of plan assets
(239.7)
(239.7)
(239.7)
(239.7)
Surplus
(16.1)
(13.2)
(13.8)
(8.7)
The valuation of defined benefit liabilities is most sensitive to changes in the discount rate, inflation rate and mortality
rate. The sensitivities have been calculated by running the liability calculations in full using the alternative assumptions.
In each case, only the indicated assumption has changed by the amount stated. For the inflation sensitivity, the impact
on the assumptions that are based on RPI inflation, such as CPI inflation and the inflation-linked pension increases, has
been included.
Defined benefit scheme \u2013 UK
A full actuarial valuation of the UK plan was carried out as at 31 March 2021 which, for reporting purposes, has been updated
to 31 March 2024 by a qualified independent actuary.
The major assumptions used by the actuary for the purposes of IAS 19 were (in nominal terms):
2024 2023
% %
Discount Rate
4.8
4.8
Rate of increase in pensions in payment (\u20183LPI\u2019)
2.2
2.3
Rate of increase in pensions in payment (\u20185LPI\u2019)
2.9
3.0
Rate of inflation (\u2018CPI\u2019)
2.3
2.4
Rate of inflation (\u2018RPI\u2019)
3.0
3.2
91% of S2PA tables 97% of S2PA tables
(93% for females) future (99% for females) future
improvement in line with CMI improvement in line with CMI
Mortality \u2013 pre and post-retirement 2022 with 1.25% long-term trend 2021 with 1.25% long-term trend
As at 31 March 2024 the weighted average duration of the defined benefit obligations was 13 years (2023: 13.5 years).
The mortality assumptions imply the following expected future lifetime from age 65:
2024 2023
years years
Pre-retirement \u2013 males
23.2
23.2
Pre-retirement \u2013 females
25.3
25.3
Post-retirement \u2013 males
21.8
21.9
Post-retirement \u2013 females
23.8
23.8
The assumptions have been chosen by the Directors from a range of possible actuarial assumptions, which, due to the
timescales covered, may not be borne out in practice.
The assets in the plan were:
2024 2023
\u00a3m \u00a3m
Equities
7.5
62.9
Corporate and Emerging Market Bonds
22.9
22.1
Gilts
174.3
113.5
Property
\u2013
5.4
Insurance-linked funds
5.8
12.2
Credit and global loan funds
0.1
0.1
Hedge funds
24.3
25.5
Cash
4.8
9.8
239.7
251.5
Where assets have no observable market price a valuation will be provided by the fund manager. The scheme\u2019s investment
manager will accept that valuation if it is within the expected range of performance. Otherwise, the investment manager will
query the valuation with the fund manager. Complex financial instruments are valued by the scheme\u2019s investment manager
who uses financial models which take as their input the characteristics of the instrument and observable market data such
as swap rates.
The UK pension scheme implements a liability hedge strategy which is designed to protect the scheme\u2019s funding level from
changes in gilt yields and inflation expectations. The liability hedge strategy consists of a portfolio of gilts, gilt derivatives,
interest rate and inflation swaps. At 31 March 2019, the liability hedge strategy fully covered the scheme\u2019s liabilities from
changes in gilt yields and inflation expectations. However, this is not a precise match for the IAS 19 defined benefit obligation,
which is based on corporate bond yields rather than gilt yields.
26 Share option schemes
Share Incentive Plan (SIP)
UK employees may be eligible to participate in the Group\u2019s HM Revenue and Customs-approved SIP. Participating employees
may make a cash contribution to the SIP of up to \u00a31,800 each year. The Group contributes a further amount equal to 20% of
the employee\u2019s contribution. Independent trustees then purchase partnership and matching shares in the market on behalf
of the employees. Subject to the rules of the SIP, matching shares may be withdrawn without forfeiture after they have been
held for three years\u2019, provided the participant has remained an employee. On a similar basis, shares can be withdrawn tax-
free after five years\u2019 service.
Long-Term Incentive Plan (LTIP)
Under the LTIP awards of nominally priced options of \u00a30.05, conditional share awards or cash conditional awards may be
made annually to certain senior managers.
Subject to vesting based on the achievement of performance targets and the rules of the LTIP, options granted under the
plan may have a life of ten years, including a vesting period of three years. Subject to vesting based on performance and the
rules of the LTIP, conditional share awards and cash conditional awards will vest appropriately three years after the award
date. Awards were valued using the Black-Scholes option pricing models with the exception of options relating to the total
shareholder return tranche which were valued using Stochastic option-pricing models. Under the LTIP, Richard Tyson was
granted two awards of nominally priced options of \u00a30.05, which comprised part of the buy-out arrangements to replace the
2021 and 2022 LTIP awards from his previous employer, TT Electronics plc, which lapsed in connection with his joining the
company. Further information can be found in the Directors\u2019 Remuneration Report on page 136.
Share option schemes that have been discontinued but for which options were outstanding at the year end include the following:
Performance Share Plan (PSP)
Under the PSP, awards of nominally priced options of \u00a30.05 were made annually to certain senior managers. The last grants
were made under this scheme in 2022. Awards to persons other than the Executive Directors may also be referred to as
Medium Term Incentive Plan awards (\u2018MTIP\u2019). Subject to vesting based on the achievement of performance targets and the
rules of the PSP, awards may have a life of ten years, including a vesting period of a minimum of three years. Options were
valued using the Black-Scholes option-pricing models.
Executive Share Option Scheme (ESO)
Under the ESO awards of approved options, unapproved options and share appreciation rights were made annually to certain
senior managers. The last grants were made under this scheme in 2016. The exercise prices were determined according
to the mid-market closing share price on the day before the date of grant. Subject to vesting based on the achievement of
performance targets and the rules of the ESO, awards may have a life of ten years, including a vesting period of a minimum of
three years. Options were valued using the Black-Scholes option-pricing models.
Performance conditions
Awards under the ESO, PSP and LTIP schemes may be or may have been subject to the achievement of certain performance
conditions. The performance conditions applicable for the Executive Directors of Oxford Instruments plc, can be found in the
Directors\u2019 Remuneration Report on pages 120 to 143.
Administrative expenses include a charge of \u00a33.0m (2023: \u00a32.4m) in respect of the cost of providing share-based
remuneration. The cost of share awards is calculated by estimating the fair value of the award at grant date and spreading
that amount over the vesting period after adjusting for an expectation of non-vesting.
For awards granted in the years ended 31 March 2024 and 2023, the fair value and the assumptions used in the calculation
are as follows:
LTIP:
LTIP CEO LTIP CEO Conditional
LTIP: CEO buy-out 2021 buy-out 2022 LTIP CFO LTIP: Options Shares
November November November September September September PSP: MTIP PSP June
2023 2023 2023 2023 2023 2023 June 2022 2022
Weighted average fair
value of options granted
\u00a316.99
\u00a311.04
\u00a313.38
\u00a318.19
\u00a319.09
\u00a321.16
\u00a318.86
\u00a318.86
Share price at grant date
\u00a320.55
\u00a320.55
\u00a320.55
\u00a321.75
\u00a321.75
\u00a321.75
\u00a319.40
\u00a315.80
Exercise price
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
Expected volatility
41.3%
31.5%
30.9%
40.5%
40.5%
n/a
47. 3%
47.3%
Expected option life
3 years
0.5 years
1.5 years
3 years
3 years
3 years
3 years
3 years
Expected dividend yield
\u2013
\u2013
\u2013
\u2013
0.9%
0.9%
0.9%
0.9%
Risk-free interest rate
4.4%
5.3%
4.9%
4.4%
4.4%
n/a
2.1%
2.1%
Movements in the share option schemes during the year were as follows:
Executive Share Performance Long-Term
Option Scheme Share Plan Incentive Plan
Weighted Weighted Weighted
Number average Number average Number average
of shares exercise price of shares exercise price of shares exercise price
Outstanding at 1 April 2022
137,278
\u00a38.83
741,768
\u00a30.05
\u2013
\u2013
Granted
\u2013
\u2013
163,687
\u00a30.05
\u2013
\u2013
Forfeited
\u2013
\u2013
(4,989)
\u00a30.05
\u2013
\u2013
Exercised
(8,163)
\u00a38.80
(52,260)
\u00a30.05
\u2013
\u2013
Lapsed
(3,446)
\u00a39.44
(19,830)
\u00a30.05
\u2013
\u2013
Outstanding at 31 March 2023
125,669
\u00a38.82
828,376
\u00a30.05
\u2013
\u2013
Granted
\u2013
\u2013
\u2013
\u2013
216,207
\u00a30.05
Forfeited
\u2013
\u2013
(25,533)
\u00a30.05
\u2013
\u2013
Exercised
(18,623)
\u00a38.93
(180,018)
\u00a30.05
\u2013
\u2013
Lapsed
(8,317)
\u00a310.28
(318)
\u00a30.05
(15,635)
\u00a30.05
Outstanding at 31 March 2024
98,729
\u00a38.68
622,507
\u00a30.05
200,572
\u00a30.05
Exercisable at 31 March 2024
98,729
\u00a38.68
362,419
\u00a30.05
12,237
\u00a30.05
Exercisable at 31 March 2023
125,669
\u00a38.82
402,140
\u00a30.05
\u2013
\u2013
The number and weighted average exercise prices of those options are as follows: The weighted average share price at the time of exercise of the options was \u00a323.42 (2023: \u00a322.03). The weighted average remaining contractual life for the share options as at 31 March 2024 was one year (2023: one year). The total consideration received from exercise of options in the year was \u00a30.0m (2023: \u00a30.1m )", "dimensions": { "concept": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-478": { "value": "Defined contribution schemes In the UK, employees are offered participation in the defined contribution Oxford Instruments Stakeholder Plan. The company contribution rate and employee contribution rate varies between grades and whether the individual had previously been in the defined benefit scheme. The company contribution ranges between 4% and 14% of base salary. The Group also operates a 401k defined distribution plan in the US. Details of pension schemes contributions made in respect of Directors can be found in the Remuneration Report. The expense recognised in the Consolidated Statement of Income is:
2024 2023
\u00a3m \u00a3m
Total defined benefit income
(1.0)
(1.1)
Contributions to defined contribution schemes
6.5
6.2
5.5
5.1
Pension costs are recorded in the following lines in the Consolidated Statement of Income:
2024 2023
\u00a3m \u00a3m
Cost of sales
2.1
1.7
Research and development
1.6
1.5
Selling and marketing costs
1.3
1.4
Administration and shared services
2.0
2.1
Financial income
(1.5)
(1.6)
5.5
5.1
The Group has agreed a basis for deficit recovery payments with the trustees of the UK pension scheme. The deficit recovery payments are payable through to and including 2026 and will rise by approximately 3% per annum. The annual deficit recovery payment was \u00a38.5m (2023: \u00a38.2m) for the financial year. In the prior year, the Directors decided to make an additional one-off payment of \u00a34.0m to the UK pension scheme to reduce the Group\u2019s exposure. In 2018 the trustees of the UK defined benefit scheme, in consultation with the company, reduced its exposure to on-risk assets (a portfolio of market-focused asset classes, the majority being equities) with a corresponding increase in its liability- driven investments, with the objective of steering a more stable journey to being fully funded. The pension fund\u2019s gross exposure to on-risk assets fell from 85% to 45%; the majority of transactions required to make this change were completed in February 2018. As a result, the level of risk inherent in the investment strategy is now significantly lower than previously, in addition to a substantial reduction in funding level volatility. Following investment outperformance and contributions made by the Group in the year to 31 March 2022 the allocation to on-risk assets has been further reduced to 35%, with a view to further reduction in funding level volatility. The Group has considered the requirements of IFRIC 14. The terms of the scheme give the Group the right to recover any surplus assets on the scheme upon wind-up and therefore management has concluded that there is no impact on the amounts recognised in respect of retirement benefit obligations, i.e. there is no need to apply the \u2018asset ceiling\u2019. The Group expects to contribute approximately \u00a38.7m to the UK defined benefit plan in the next financial year. Remeasurement gains and losses shown in the Consolidated Statement of Comprehensive Income: 2024 2023 \u00a3m \u00a3m Actual return on assets excluding interest income (20.8) (109.4) Experience loss on scheme obligations (5.4) (10.3) Changes in assumptions underlying the present value of scheme obligations: \u2013 Financial 3.1 78.3 \u2013 Demographic 3.7 2.8 Actuarial losses recorded in the Statement of Comprehensive Income (19.4) (38.6 The table below shows the sensitivity of the Consolidated Statement of Financial Position to changes in the significant pension assumptions:
Discount rate Inflation rate Life expectancy
2024 (-0.1% p.a.) (+0.1% p.a.) (+one year)
\u00a3m \u00a3m \u00a3m \u00a3m
Present value of funded obligations
223.6
226.5
225.9
231.0
Fair value of plan assets
(239.7)
(239.7)
(239.7)
(239.7)
Surplus
(16.1)
(13.2)
(13.8)
(8.7)
The valuation of defined benefit liabilities is most sensitive to changes in the discount rate, inflation rate and mortality rate. The sensitivities have been calculated by running the liability calculations in full using the alternative assumptions. In each case, only the indicated assumption has changed by the amount stated. For the inflation sensitivity, the impact on the assumptions that are based on RPI inflation, such as CPI inflation and the inflation-linked pension increases, has been included. Movements in the share option schemes during the year were as follows:
Executive Share Performance Long-Term
Option Scheme Share Plan Incentive Plan
Weighted Weighted Weighted
Number average Number average Number average
of shares exercise price of shares exercise price of shares exercise price
Outstanding at 1 April 2022
137,278
\u00a38.83
741,768
\u00a30.05
\u2013
\u2013
Granted
\u2013
\u2013
163,687
\u00a30.05
\u2013
\u2013
Forfeited
\u2013
\u2013
(4,989)
\u00a30.05
\u2013
\u2013
Exercised
(8,163)
\u00a38.80
(52,260)
\u00a30.05
\u2013
\u2013
Lapsed
(3,446)
\u00a39.44
(19,830)
\u00a30.05
\u2013
\u2013
Outstanding at 31 March 2023
125,669
\u00a38.82
828,376
\u00a30.05
\u2013
\u2013
Granted
\u2013
\u2013
\u2013
\u2013
216,207
\u00a30.05
Forfeited
\u2013
\u2013
(25,533)
\u00a30.05
\u2013
\u2013
Exercised
(18,623)
\u00a38.93
(180,018)
\u00a30.05
\u2013
\u2013
Lapsed
(8,317)
\u00a310.28
(318)
\u00a30.05
(15,635)
\u00a30.05
Outstanding at 31 March 2024
98,729
\u00a38.68
622,507
\u00a30.05
200,572
\u00a30.05
Exercisable at 31 March 2024
98,729
\u00a38.68
362,419
\u00a30.05
12,237
\u00a30.05
Exercisable at 31 March 2023
125,669
\u00a38.82
402,140
\u00a30.05
\u2013
\u2013
The number and weighted average exercise prices of those options are as follows: The weighted average share price at the time of exercise of the options was \u00a323.42 (2023: \u00a322.03). The weighted average remaining contractual life for the share options as at 31 March 2024 was one year (2023: one year). The total consideration received from exercise of options in the year was \u00a30.0m (2023: \u00a30.1m ", "dimensions": { "concept": "ifrs-full:DisclosureOfDefinedContributionPlansExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-479": { "value": "Defined benefit scheme \u2013 UK A full actuarial valuation of the UK plan was carried out as at 31 March 2021 which, for reporting purposes, has been updated to 31 March 2024 by a qualified independent actuary. The major assumptions used by the actuary for the purposes of IAS 19 were (in nominal terms):
2024 2023
% %
Discount Rate
4.8
4.8
Rate of increase in pensions in payment (\u20183LPI\u2019)
2.2
2.3
Rate of increase in pensions in payment (\u20185LPI\u2019)
2.9
3.0
Rate of inflation (\u2018CPI\u2019)
2.3
2.4
Rate of inflation (\u2018RPI\u2019)
3.0
3.2
91% of S2PA tables 97% of S2PA tables
(93% for females) future (99% for females) future
improvement in line with CMI improvement in line with CMI
Mortality \u2013 pre and post-retirement 2022 with 1.25% long-term trend 2021 with 1.25% long-term trend
As at 31 March 2024 the weighted average duration of the defined benefit obligations was 13 years (2023: 13.5 years). The mortality assumptions imply the following expected future lifetime from age 65:
2024 2023
years years
Pre-retirement \u2013 males
23.2
23.2
Pre-retirement \u2013 females
25.3
25.3
Post-retirement \u2013 males
21.8
21.9
Post-retirement \u2013 females
23.8
23.8
The assumptions have been chosen by the Directors from a range of possible actuarial assumptions, which, due to the timescales covered, may not be borne out in practice. The assets in the plan were:
2024 2023
\u00a3m \u00a3m
Equities
7.5
62.9
Corporate and Emerging Market Bonds
22.9
22.1
Gilts
174.3
113.5
Property
\u2013
5.4
Insurance-linked funds
5.8
12.2
Credit and global loan funds
0.1
0.1
Hedge funds
24.3
25.5
Cash
4.8
9.8
239.7
251.5
Where assets have no observable market price a valuation will be provided by the fund manager. The scheme\u2019s investment manager will accept that valuation if it is within the expected range of performance. Otherwise, the investment manager will query the valuation with the fund manager. Complex financial instruments are valued by the scheme\u2019s investment manager who uses financial models which take as their input the characteristics of the instrument and observable market data such as swap rates. The UK pension scheme implements a liability hedge strategy which is designed to protect the scheme\u2019s funding level from changes in gilt yields and inflation expectations. The liability hedge strategy consists of a portfolio of gilts, gilt derivatives, interest rate and inflation swaps. At 31 March 2019, the liability hedge strategy fully covered the scheme\u2019s liabilities from changes in gilt yields and inflation expectations. However, this is not a precise match for the IAS 19 defined benefit obligation, which is based on corporate bond yields rather than gilt yields. ", "dimensions": { "concept": "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2022-04-01T00:00:00/2023-04-01T00:00:00" } }, "fact-444": { "value": "
25 Capital and reserves
Issued and fully paid ordinary shares:
2024 2023
Number Number
of shares of shares
At the beginning of the year
57,712,508
57,654,455
Issued for cash
201,284
58,053
At the end of the year
57,913,792
57,712,508
2024
2023
Number of shares
\u00a3m
Number of shares
\u00a3m
Allotted, called up and fully paid
Ordinary shares of 5 pence each
57,913,792
2.9
57,712,508
2.9
The holders of the ordinary shares are entitled to receive dividends as declared, a proportionate amount of capital on a
winding up of the company and one vote per share at meetings of the company.
Other reserves comprise the capital redemption reserve, which represents the nominal value of shares repurchased and then
cancelled during the year ended 31 March 1999.
The foreign exchange translation reserve comprises all foreign exchange differences arising since 1 April 2004 from the
translation of the Group\u2019s net investments in foreign subsidiaries into Sterling.
", "dimensions": { "concept": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-480": { "value": "25 Capital and reserves Issued and fully paid ordinary shares:
2024 2023
Number Number
of shares of shares
At the beginning of the year
57,712,508
57,654,455
Issued for cash
201,284
58,053
At the end of the year
57,913,792
57,712,508
2024
2023
Number of shares
\u00a3m
Number of shares
\u00a3m
Allotted, called up and fully paid
Ordinary shares of 5 pence each
57,913,792
2.9
57,712,508
2.9
The holders of the ordinary shares are entitled to receive dividends as declared, a proportionate amount of capital on a winding up of the company and one vote per share at meetings of the company. Other reserves comprise the capital redemption reserve, which represents the nominal value of shares repurchased and then cancelled during the year ended 31 March 1999. The foreign exchange translation reserve comprises all foreign exchange differences arising since 1 April 2004 from the translation of the Group\u2019s net investments in foreign subsidiaries into Sterling.", "dimensions": { "concept": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-481": { "value": "26 Share option schemes Share Incentive Plan (SIP) UK employees may be eligible to participate in the Group\u2019s HM Revenue and Customs-approved SIP. Participating employees may make a cash contribution to the SIP of up to \u00a31,800 each year. The Group contributes a further amount equal to 20% of the employee\u2019s contribution. Independent trustees then purchase partnership and matching shares in the market on behalf of the employees. Subject to the rules of the SIP, matching shares may be withdrawn without forfeiture after they have been held for three years\u2019, provided the participant has remained an employee. On a similar basis, shares can be withdrawn tax- free after five years\u2019 service. Long-Term Incentive Plan (LTIP) Under the LTIP awards of nominally priced options of \u00a30.05, conditional share awards or cash conditional awards may be made annually to certain senior managers. Subject to vesting based on the achievement of performance targets and the rules of the LTIP, options granted under the plan may have a life of ten years, including a vesting period of three years. Subject to vesting based on performance and the rules of the LTIP, conditional share awards and cash conditional awards will vest appropriately three years after the award date. Awards were valued using the Black-Scholes option pricing models with the exception of options relating to the total shareholder return tranche which were valued using Stochastic option-pricing models. Under the LTIP, Richard Tyson was granted two awards of nominally priced options of \u00a30.05, which comprised part of the buy-out arrangements to replace the 2021 and 2022 LTIP awards from his previous employer, TT Electronics plc, which lapsed in connection with his joining the company. Further information can be found in the Directors\u2019 Remuneration Report on page 136. Share option schemes that have been discontinued but for which options were outstanding at the year end include the following: Performance Share Plan (PSP) Under the PSP, awards of nominally priced options of \u00a30.05 were made annually to certain senior managers. The last grants were made under this scheme in 2022. Awards to persons other than the Executive Directors may also be referred to as Medium Term Incentive Plan awards (\u2018MTIP\u2019). Subject to vesting based on the achievement of performance targets and the rules of the PSP, awards may have a life of ten years, including a vesting period of a minimum of three years. Options were valued using the Black-Scholes option-pricing models. Executive Share Option Scheme (ESO) Under the ESO awards of approved options, unapproved options and share appreciation rights were made annually to certain senior managers. The last grants were made under this scheme in 2016. The exercise prices were determined according to the mid-market closing share price on the day before the date of grant. Subject to vesting based on the achievement of performance targets and the rules of the ESO, awards may have a life of ten years, including a vesting period of a minimum of three years. Options were valued using the Black-Scholes option-pricing models. Performance conditions Awards under the ESO, PSP and LTIP schemes may be or may have been subject to the achievement of certain performance conditions. The performance conditions applicable for the Executive Directors of Oxford Instruments plc, can be found in the Directors\u2019 Remuneration Report on pages 120 to 143. Administrative expenses include a charge of \u00a33.0m (2023: \u00a32.4m) in respect of the cost of providing share-based remuneration. The cost of share awards is calculated by estimating the fair value of the award at grant date and spreading that amount over the vesting period after adjusting for an expectation of non-vesting. For awards granted in the years ended 31 March 2024 and 2023, the fair value and the assumptions used in the calculation are as follows:
LTIP:
LTIP CEO LTIP CEO Conditional
LTIP: CEO buy-out 2021 buy-out 2022 LTIP CFO LTIP: Options Shares
November November November September September September PSP: MTIP PSP June
2023 2023 2023 2023 2023 2023 June 2022 2022
Weighted average fair
value of options granted
\u00a316.99
\u00a311.04
\u00a313.38
\u00a318.19
\u00a319.09
\u00a321.16
\u00a318.86
\u00a318.86
Share price at grant date
\u00a320.55
\u00a320.55
\u00a320.55
\u00a321.75
\u00a321.75
\u00a321.75
\u00a319.40
\u00a315.80
Exercise price
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
\u00a30.05
Expected volatility
41.3%
31.5%
30.9%
40.5%
40.5%
n/a
47. 3%
47.3%
Expected option life
3 years
0.5 years
1.5 years
3 years
3 years
3 years
3 years
3 years
Expected dividend yield
\u2013
\u2013
\u2013
\u2013
0.9%
0.9%
0.9%
0.9%
Risk-free interest rate
4.4%
5.3%
4.9%
4.4%
4.4%
n/a
2.1%
2.1%
", "dimensions": { "concept": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-490": { "value": "2 828
28 Commitments and contingencies
The Group has entered into agreements in respect of the new Severn Beach site for its Plasma Technology business. At 31
March 2024 commitments for future expenditure are \u00a38.0m (2023: \u00a35.6m) and include capital expenditure, fit-out costs, plant
and machinery, furniture and computer equipment.
In an international group of companies, a variety of legal claims arise from time to time. The Board, having taken legal advice,
is of the opinion that any ongoing actions and investigations will not have a material impact on the Group\u2019s financial position .
", "dimensions": { "concept": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-445": { "value": "27 Working capital movements Reconciliation of movements in working capital 1 Payables and Customer Inventories Receivables provisions Deposits Total \u00a3m \u00a3m \u00a3m \u00a3m \u00a3m As at 1 April 2022 65.3 95.8 (107. 5) (41.3) 12.3 Working capital movement 15.6 19.6 (16.9) (9.2) 9.1 WITec-related flows \u2013 \u2013 5.3 \u2013 5.3 Exchange differences 0.5 0.3 \u2013 (1.6) (0.8) FV movement on financial derivatives \u2013 \u2013 3.0 \u2013 3.0 As at 31 March 2023 and 1 April 2023 81.4 115.7 (116.1) (52.1) 28.9 Working capital movement 26.3 2.7 2.8 (7.1) 24.7 First Light Imaging-related flows 1.9 2.9 (5.0) (0.4) (0.6) Exchange differences (1.2) (2.8) 4.7 1.2 1.9 FV movement on financial derivatives \u2013 \u2013 (0.7) \u2013 (0.7) As at 31 March 2024 108.4 118.5 (114.3) (58.4) 54.2 1 1. Receivables and payables include derivative financial instruments", "dimensions": { "concept": "oxfordinstrumentplc:DisclosureOfWorkingCapitalMovements", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-482": { "value": "28 Commitments and contingencies The Group has entered into agreements in respect of the new Severn Beach site for its Plasma Technology business. At 31 March 2024 commitments for future expenditure are \u00a38.0m (2023: \u00a35.6m) and include capital expenditure, fit-out costs, plant and machinery, furniture and computer equipment. In an international group of companies, a variety of legal claims arise from time to time. The Board, having taken legal advice, is of the opinion that any ongoing actions and investigations will not have a material impact on the Group\u2019s financial position ", "dimensions": { "concept": "ifrs-full:DisclosureOfCommitmentsExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-446": { "value": "28 Commitments and contingencies The Group has entered into agreements in respect of the new Severn Beach site for its Plasma Technology business. At 31 March 2024 commitments for future expenditure are \u00a38.0m (2023: \u00a35.6m) and include capital expenditure, fit-out costs, plant and machinery, furniture and computer equipment. In an international group of companies, a variety of legal claims arise from time to time. The Board, having taken legal advice, is of the opinion that any ongoing actions and investigations will not have a material impact on the Group\u2019s financial position .", "dimensions": { "concept": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-483": { "value": "
29 Related parties
All transactions with related parties are conducted on an arm\u2019s length basis and in accordance with normal business terms.
Transactions between the company and its subsidiaries, which are related parties, have been eliminated on consolidation
and are not disclosed in this note.
The remuneration of key management personnel is as follows:
2024 2023
\u00a3m \u00a3m
Short-term employee benefits
4.8
4.2
Post-employment benefits
0.2
0.1
Share-based payment charges
2.6
1.8
Total
7.6
6.1
Key management personnel include the Executive Directors and the Management Board.
Short-term employee benefits comprise salary and benefits earned during the year and bonuses awarded for the year.
", "dimensions": { "concept": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-447": { "value": "29 Related parties All transactions with related parties are conducted on an arm\u2019s length basis and in accordance with normal business terms. Transactions between the company and its subsidiaries, which are related parties, have been eliminated on consolidation and are not disclosed in this note. The remuneration of key management personnel is as follows:
2024 2023
\u00a3m \u00a3m
Short-term employee benefits
4.8
4.2
Post-employment benefits
0.2
0.1
Share-based payment charges
2.6
1.8
Total
7.6
6.1
Key management personnel include the Executive Directors and the Management Board. Short-term employee benefits comprise salary and benefits earned during the year and bonuses awarded for the year", "dimensions": { "concept": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } }, "fact-448": { "value": "30 Subsequent events Acquisition of FemtoTools AG On 7 June 2024, the Group agreed to purchase 100% of the share capital of FemtoTools AG for an initial consideration of CHF 17m, subject to certain closing conditions which are expected to be satisfied within four weeks of signing these financial statements. Additional consideration of up to CHF 7m is conditional on trading performance over a period of 33 months", "dimensions": { "concept": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "language": "en", "entity": "scheme:213800J364EZD6UCE231", "period": "2023-04-01T00:00:00/2024-04-01T00:00:00" } } } }